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Abstract
The ErbB 1 receptor is an important receptor tyrosine kinase implicated in many 
forms of human cancer. The current picture of how the receptor functions is 
heavily influenced by the few solved crystal structures of ErbB 1 fragments that 
have been published to date.
This thesis describes the development of a method for investigating the three 
dimensional structure of membrane proteins in situ in order to gain insights into 
the relationship between their structure and function not gained from their high 
resolution structure determined in vitro. Driven by the need to explain 
discrepancies between the emerging picture of the three-dimensional architecture 
of signalling ErbBl complexes in cell membranes and the accepted crystal 
structures, the developed method evaluates the distance of closest approach of 
the ErbBl ligand binding site to the surface of adherent cells using Forster 
resonance energy transfer (FRET) a spectroscopic ruler widely used to report on 
distances less than 10 nm. These results are then correlated with the efficiency of 
FRET between donor and acceptor labelled ligand binding sites under the same 
experimental conditions, which provides information regarding the lateral 
topology of interacting receptors. The development of the method was made 
possible by the implementation of a multidimensional, multicolour confocal 
microscope which is also described.
Application of the method to ErbBl receptors in the membranes of cancer cells 
demonstrated that two functionally distinct classes of the receptor - which 
transduce different signals in response to ligand binding despite being expressed 
as a single translation product - adopt different extracellular conformations with 
respect to the cell surface. This is entirely unanticipated by crystallographic 
models and not seen in previous FRET studies of receptors in suspended, isolated 
membranes.
It was shown that the consequences of these different conformations for the 
function of the receptor can be investigated by repeating the FRET 
measurements under a range of experimental conditions that disrupt normal 
ErbBl function in cells. The orientation and topology of signalling ErbBl in 
complexes was found to be variable and these variations may be caused by 
interactions between ErbBl receptors and intracellular proteins. Further 
comparison of the results with complementary biochemical data regarding the 
phosphorylation state of receptors (which defines the signalling outcome of 
activated receptors) suggests the possibility that intracellular interaction primed 
extracellular conformations can produce different signalling outcomes upon 
ligand binding.
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Non-pathogenic diseases such as cancer and neurodegenerative disorders are 
often caused by the malfunctioning of cellular signalling networks that produce 
transcriptional changes that control cell growth, differentiation and apoptosis1. 
Structural malfunction of specific proteins (due to mutation in the corresponding 
gene) in the relevant signal pathways are often associated with these disease 
states, which are able to ensure that the deregulated signals causing the diseased 
continue and can somehow bypass therapies targeted at the malfunctioning 
proteins. The functions of any biological system emerge from the selective 
interaction of functionally diverse biomolecules2. The systems level approach to 
biology recognises that both the properties of the overall network and the 
functional properties of individual bio molecules combine to produce coherent 
behaviours3. It is becoming clear that a full understanding of the functioning of 
signalling networks at a systems level is required to understand non-intuitive 
features of the networks, the behaviour of diseased states and the mechanisms by 
which treatments can be evaded by diseased states. While the large numbers of 
possible interactions between proteins can be catalogued with high throughput 
proteomic assays4, elucidating the kinetics and functional properties of 
interacting proteins is more complicated.
A major step towards understanding how any protein functions is the 
determination of its three dimensional structure. From this its overall shape, 
electrostatic properties, juxtaposition of domains, molecular composition of its 
surface and quaternary structure can be derived5. Techniques for determining 
high resolution protein structures such as x-ray diffraction (XRD) or nuclear 
magnetic resonance (NMR) provide snapshots of proteins in an unnatural 
environment (in crystals or at high concentration in solution). Although the static 
structures of protein-ligand complexes provide some functional insight by 
specifying the location of the ligand binding sites, what are needed are 
techniques that bridge the gap between the high resolution structures and the 
functioning protein in situ. A technique for investigating the link between protein
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structure and function needs to selectively observe proteins of interest in a non­
destructive way and with minimum perturbation to the system being studied. 
Methods such as protein tomography (PT) are a step in the right direction as they 
can produce three dimensional images of protein structure in cells6,1. However, 
PT suffers from several drawbacks; the position of the cell membrane relative to 
the protein has to be inferred as it is invisible to the technique, proteins need to 
be tagged with large gold conjugated antibodies and the technique requires the 
sample to be mechanically sectioned and fixed. PT can therefore provide insight 
into protein structures in cell membranes but is far from being a perfect method 
for relating structure to function in situ. Fluorescence imaging is currently 
favoured for observing proteins in live cells, as despite requiring the introduction 
of extrinsic labels (and potentially disrupting normal protein function), it is a 
non-destructive optical technique that provides contrast between labelled 
molecules and the rest of the sample. Multiple types of bio molecules or 
structures can be observed by labelling with multiple probes that emit 
fluorescence at different wavelengths. Other properties of the observed 
fluorescence emission can also be used to report on the environment of the 
fluorophore (via the fluorescence lifetime) and its rotational mobility (via the 
fluorescence anisotropy). The effects of Forster resonance energy transfer 
(FRET) between different fluorophores can also be used to determine their 
separation. Often referred to as a ‘spectroscopic ruler’8, FRET is widely used to 
investigate protein interactions below the resolution limit of optical microscopy9. 
With site-specific 1:1 labelling of proteins, the properties of fluorescence 
emission can be used to infer motions and separations of the labelled sites in situ 
and relate them to known high resolution protein structures.
Two examples of proteins that have recently had their static high resolution 
structure related to their function by quantitative fluorescence imaging are 
kinesin and ATP synthase. Kinesin is an ATP fuelled molecular motor that 
transports cargo along microtubules. The high resolution structure of kinesin is a 
homodimer with each monomer possessing an identical catalytic head group that 
bind to microtubules and ATP. In order to move along the microtubule without 
completely dissociating, the head groups must bind and dissociate in a co­
ordinated manner, but the high resolution structure provides no clues as to how
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this is achieved. The exact method (hand-over-hand) has been observed with 
single molecule fluorescence tracking in vitro]0 and in situu . Likewise the 
stepwise rotation of y-subunit of EF0F1-ATP synthase was not predicted from its 
high resolution structure, but was observed in liposomes by single-molecule 
FRET12. In both of the above examples it is notable that different methods are 
required to address the biological problem at hand. There is no one technique that 
is applicable to all proteins in all situations and experimental techniques have to 
be found or developed to ask the correct questions of the problem under 
investigation. Also notable is the interdisciplinary nature of the techniques which 
involve the production of biological samples, chemical or genetic modification of 
proteins for 1:1 labelling with fluorescent molecules and quantitative 
fluorescence microscopy.
The biological problem that drives the work in this thesis concerns the ErbB 
family of receptors which are a paradigm for transmembrane receptor tyrosine 
kinases13. Membrane proteins are important and up to 30% of all proteins 
encoded in most genomes are membrane proteins14. Membrane receptors 
transduce signals from the cellular environment across the membrane to allow 
the cell to respond to external stimuli. ErbBl plays a fundamental role in 
controlling crucial cellular processes such as proliferation and survival13,15,16. It 
is commonly over expressed or mutated in a number of epithelial malignancies 
and amplification of the ErbBl gene is often associated with aggressive tumour 
phenotypes17. Targeting of ErbBl is a major challenge in oncology, and several 
anti-ErbBl antibodies and tyrosine kinase inhibitors have been investigated as 
potential antitumour agents18. Despite decades of research the mechanism by 
which ErbBl activation by ligand binding produces a variety of signalling 
outcomes is poorly understood, but is known to involve oligomerisation of 
receptors19'25 and allosteric activation of intracellular ErbBl tyrosine kinase 
activity26. The current model is heavily influenced by the structure of ErbB 
receptors pieced together from crystallised receptor fragments19. Previous FRET 
studies have sought to investigate the three dimensional architecture of activated 
receptor oligomers in situ by measuring ensemble FRET between fluorescently 
labelled ligands25,21' 28. This approach provides lateral structural information but
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requires prior assumptions regarding the structure of interacting receptors to 
estimate the separation of ligand binding sites. However, experimental data has 
consistently been in conflict with the assumption that receptors exclusively form 
the back-to-back dimers seen in crystallised ErbBl extracellular domains. Single 
molecule FRET between labelled ligands requires no structural assumptions to 
determine inter-ligand separations and confirms distances inconsistent with back- 
to-back dimers29. To gain insight into the discrepancy between the in situ FRET 
results and high-resolution structure an improved method of probing the 3d 
architecture of activated receptor complexes is required.
In this thesis a method is developed for investigating the spatial relationship 
between the high resolution structures of membrane receptors and the membrane 
in which they are embedded. The method provides quantitative distance 
estimation in an additional dimension that can be correlated with the results of 
lateral FRET between ligand binding sites under identical experimental 
conditions. The combination of the two FRET measurements provides a starting 
point for the determination of a realistic model of the 3D architecture of the 
protein complex at the plasma membrane. This bi-directional FRET method also 
allows large scale changes in the receptor orientation to be observed that are not 
predicted by XRD or NMR snapshots of soluble proteins in vitro. These changes 
may come about from influence of the plasma-membrane or interactions with 
other plasma-membrane constituents. An important aspect of the method is that 
the membrane proteins are observed, in cultured adherent cells and are an 
integral part of a complete biological system when the measurement is made. 
This is an important progression from previous studies that have observed the 
location of the ErbBl ligand binding site in suspended artificial membranes 
and/or purified cell membranes30 as ErbBl receptors outside of the natural 
cellular environment are known to lack functional aspects of receptors in vivo 
such as high affinity binding31. As the method probes membrane protein 
conformations in adherent cells, the structural measurements can be made under 
experimental conditions that disrupt normal receptor function or switch on or off 
parts of the signalling networks that interact with the receptors at the cell surface.
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The aspects of fluorescence and FRET theory crucial to relating quantitative 
FLIM-FRET measurements to distances in biological samples are explained in 
chapter 2. The current understanding of the biology of ErbB receptors is 
discussed in chapter 3. Chapter 4 outlines the design and implementation of a 
multi-dimensional, multi-colour confocal microscope that was crucial to the 
development of the method. Chapter 5 outlines the additional steps required to 
quantitatively measure the distance of closest approach between a fluorescently 
labelled protein and the cell surface. These include Förster radius measurement 
and consideration of the theory for FRET between multiple donors and acceptors. 
Chapter 6 details the application of the technique to activated ErbB 1 receptors to 
measure the distance of closest approach of ligand binding sites to the 
membranes of cancerous cells. The relationship between the three dimensional 
architecture of ErbB 1 receptors and their function is then investigated.
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2 The properties of fluorescence emission and the 
theoretical basis of quantitative FRET measurement
The phenomenon of fluorescence is used in biological imaging to gain colour 
contrast between molecular components of interest labelled with a light-emitting 
molecular tag (fluorophore), and the myriad different molecular components that 
make up cells and tissues. The properties of fluorescence photons emitted by 
fluorophores can be further used to gain information regarding their local 
environment, rotational motion and proximity to other fluorophores. When 
combined with site specific labelling these observables can be related to the 
kinetics and dynamics of the interactions between their conjugated biomolecules. 
This chapter reviews the photophysical origins of fluorescence and the 
measurable characteristics of the fluorescence emission used throughout this 
thesis to investigate receptor structural changes at the plasma membrane of intact 
cells. In addition to fluorescence intensity spectra, these are the fluorescence 
lifetime and anisotropy. Different approaches to determining the characteristic 
lifetime of fluorescence intensity decays are outlined. Several different types of 
fluorescent probe are discussed along with strategies for labelling specific sites 
of proteins. Finally the theory of Forster resonance energy transfer (FRET) - a 
popular technique for measuring molecular separations below the resolution limit 
of fluorescence microscopy to identify molecular interactions - is discussed.
2.1 Luminescence
Luminescence is the name given to light emitted as the result of relaxation of an 
atom or molecule from electronically excited states to the ground state. 
Luminescence is formally split into two categories depending upon the electronic 
states involved in the process. Phosphorescence refers to the process of decay 
from a triplet excited state to the singlet ground state and the rate of 
phosphorescence emission is between ~1 and 1000 s'1. Fluorescence refers to
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decay from an excited singlet state to the ground state and emission occurs at a 
much faster rate (~108 -  109 s'1).
Figure 2.1 A simplified Jablonski diagram detailing the processes available to a 
single molecule excited from the ground state (So) into the first singlet state (Si) 
state by absorption of a photon with energy hv. These are fluorescence emission 
(FI), Internal Conversion (IC) and collisional quenching (CQ) to return to the 
ground state. Additionally intersystem crossing (ISC) to the first triplet state (Ti) 
can be followed by phosphorescence emission (Ph) or ISC to the ground state or 
absorption of another photon to a higher triplet state (Tn). From the TN state 
reverse intersystem crossing (RISC) back to a singlet state is possible, IC back to 
the T i state or an excited state reaction with reactive oxygen species resulting in 
photobleaching. Photochemical reactions that produce non-fluorescent species or 
resonance energy transfer of excited state energy to another molecule are not 
shown.
Fluorescence typically occurs in excited aromatic molecules. Figure 2.1 shows a 
simplified Jablonski diagram that outlines the processes that can occur after 
excitation of a molecule into an electronically excited state by absorption of a 
single photon with energy h v (alternatively multiple photons of lower energy 
may be absorbed simultaneously). Shown are the singlet ground state (So) and 
the first (Si) and a higher (Sn) excited singlet state with the first and higher triplet
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States (Ti and Tn respectively). Excitation transitions between electronic states 
occur on a timescale that precludes significant displacement of the nuclei in the 
molecule (~10‘15 s). This is known as the Franck-Condon principle. At room 
temperature the molecule will not have sufficient vibrational energy to populate 
the higher vibrational energy levels of the ground state and absorption occurs 
from the lowest level of the ground state. Excitation to a vibrational level within 
one of the excited singlet states is followed by relaxation to the lowest 
vibrational level in that state by internal conversion (IC). IC occurs on a much 
faster timescale (~1012 s) than radiative emission, so fluorescence can be 
considered to occur from the lowest vibrational level of the excited state. Upon 
returning to the ground state, internal conversion will again ensure that the 
molecule relaxes to the lowest vibrational energy level. When the So and Si states 
possess similar vibrational energy levels, the fluorescence absorption and 
emission spectra have a mirror image relationship.
Alternative to fluorescence emission, an excited molecule may undergo 
intersystem crossing (ISC) to an excited triplet state and decay by 
phosphorescence. Transitions between triplet states and the singlet ground state 
are forbidden by the selection rule governing spin multiplicity for electronic 
transitions. However, coupling of vibrational and electronic motions (vibronic 
coupling) in the molecule means that the forbidden transitions are actually 
weakly allowed1. Consequently triplet states are long lived and the molecule may 
absorb another photon and transfer to a higher triplet state (Tn). These high 
energy states are also long-lived allowing the molecule to undergo 
photochemical reactions that irreversibly destroy its ability to emit fluorescence. 
Loss of fluorescence through this mechanism is called photobleaching. 
Molecules in higher excited triplet states can undergo reverse ISC (RISC) back to 
an excited singlet state and decay by fluorescence. This photophysical 
phenomenon is visible in the fluorescence intensity of a continuously excited 
single fluorescent molecule as 'blinking'.
There are also non-radiative processes available by which the excited molecule 
can lose energy. These include collisional quenching (CQ), IC to the So state and 
non-radiative energy transfer to another molecule (see section 2.4).
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2.2 Characteristics o f Fluorescence Em ission
The energy of the photons emitted by fluorescence is generally lower than the 
energy of the absorbed light. Loss of energy by IC, emission to higher So 
vibrational levels and solvent relaxation combine to produce this effect which 
results in the band of emission wavelengths being red-shifted with respect to the 
absorption band. This is referred to as the Stake’s shift and allows fluorescence 
emission to be separated from scattered excitation photons. A consequence of the 
rapid IC from Si vibrational levels to the lowest Si state is that for a single 
species of fluorophore, the shape of the emission spectrum is usually independent 
of the absorption wavelength (for photon wavelengths longer that the excitation 
wavelength). In addition to the dependence of fluorescence intensity upon 
excitation and emission wavelengths there are other properties of fluorescence 
that can be measured in order to obtain information regarding the environment of 
the fluorescence molecules. These properties are the fluorescence lifetime and 
anisotropy of the emitted light and are explained in this section.
2.2.1 Fluorescence lifetime
The emission of fluorescence photons is a random process. Under the same 
environmental conditions each molecule in a population of excited fluorophores 
will have the same probability of emitting a fluorescence photon in a given time. 
Fluorescence emission competes with non-radiative decay mechanisms (e.g. 
quenching, IC, photobleaching etc.) available to the molecules. The quantum 
yield Q of a fluorescent molecule is defined as the ratio of the number of 
fluorescence photons emitted to the number of photons absorbed and is related to 
the rates of radiative (T) and non-radiative (kNR ) decay by
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r Eqn. 2-1
r  + kNR
Usually the intensity of fluorescence is measured. When a population of non­
interacting fluorophores in an isotropic environment is excited by an infinitely 
short pulse the time dependence of the measured intensity follows
^  = - ( r  + * „ )/(()  Eqn. 2-2
at
which can be solved to provide the time dependent intensity decay 
<(')=h  exp(-t/r) Eqn. 2-3
where To is the fluorescence intensity at time t = 0 and t is the fluorescence 
lifetime of the fluorophores
t = ---------  Eqn. 2-4
r  + kNR
The fluorescence lifetime is the time at which the fluorescence intensity of the 
sample decreases to 1/e of its initial intensity. For true mono-exponential decays 
it is also the average time that a fluorophore stays in the excited state. From Eqn. 
2-4 it can be seen that the fluorescence lifetime is sensitive to environmental 
factors that alter the overall emission rate of the sample or provide non-radiative 
pathways for the molecule to return to the ground state. For example the 
fluorescent dye fluorescein exists in equilibrium between different ionisation 
states which have different values of T 2’3. The overall emission rate and hence 
the lifetime of a sample of fluorescein depends upon the relative proportions of 
the different ionic species which is dependent upon the pH of their local 
environment3. The presence of nearby energy transfer partners will increase the 
non-radiative decay rate (and is covered in more detail in section 2.4) as will
32
dynamic interactions with quenchers of fluorescence. The steady state 
fluorescence intensity F is the integral of Eqn. 2-3 over all time
F = J7(t)<afr = j70 exp(— t /t d̂t = I0t Eqn. 2-5
0 0
The initial fluorescence intensity will depend upon the number of fluorescent 
molecules, the intensity of excitation and the detection efficiency of the 
experimental set-up. In the case of mono-exponential intensity decays, the steady 
state fluorescence intensity is proportional to the fluorescence lifetime.
Fluorescence intensity decays in real samples rarely follow mono-exponential 
decay laws. In biological samples especially, different fluorophores may be in 
different environments, each combination displaying a different lifetime. Any 
measured intensity decay will contain contributions from each. Consequently, 
measured intensity decays are usually fit to a multi-exponential model with i 
components
l{t) = X  a i exP(-  tl Ti) Ecln- 2-6
i
where = 1. Usually it is difficult to relate the obtained values of a, and r, to
/
any properties of the sample and the expectation value of the lifetime (r) is often 
reported as it is proportional to the steady state fluorescence
(t) = ^]a,r,. oc | l(t)dt Eqn. 2-7
i 0
This is particularly important when calculating the efficiency of Forster 
resonance energy transfer (FRET) from fluorescence lifetime measurements, 
which is discussed in section 2.4.
33
2.2.2 Measurement of fluorescence lifetimes
Measurement of fluorescence lifetimes may be achieved using either time- 
domain or frequency-domain techniques. Figure 2.2 illustrates both concepts.
Time domain techniques involve exciting a sample with a short pulse of light and 
measuring the subsequent time-resolved intensity decay. The pulse is made to be 
much shorter than the fluorescence lifetime of the fluorophore species in sample 
being studied. The fluorescence lifetime is obtained from the intensity decay and 
is equal to the time taken for the intensity to decrease to 1/e of its initial value. 
This time can be accurately measured by fitting the slope of log 7(7) to the multi­
exponential decay model that fits best the data.
Figure 2.2 a. Time-domain fluorescence lifetime measurement of a sample 
exhibiting a mono-exponential decay. Excitation with a short pulse of light 
(green) produces an initial intensity Io that decays to Io / e in time x. b. Frequency 
domain lifetime measurement of the same sample. Excitation is amplitude 
modulated (green, peak intensity Ei) and the fluorescence emission (orange, peak 
intensity Fi) is modulated with the same angular frequency co, but with lower 
modulation amplitude and a phase difference A<|>.
Frequency domain measurements make use of intensity modulated illumination, 
often sinusoidal, at a frequency comparable to the expected decay rate of the 
sample. The fluorescence intensity is modulated at the same frequency as the 
excitation, but the emission intensity is convoluted with the impulse decay
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(Eqn. 2-3). The consequence of this is a difference in the phase and amplitude 
modulations between the excitation and fluorescence emission. It is possible to 
obtain a value for the average lifetime from both measurable differences. The 
phase lifetime (r^) and the modulation lifetime ( rm) are given by
tj = co~' tan(A^) Eqn. 2-8
T* = 0 ) - ' 2- l )
FXE0m =
E\F0
Neither of these lifetimes completely describes the intensity decay of the sample 
and are unequal for complex decays. In this case both represent a different 
weighted average of the lifetimes present in the sample.
Frequency domain measurement requires an electro-optical modulator to produce 
intensity modulation frequencies ~109 Hz. Cross-correlation detection makes it 
possible to obtain the phase shift and modulation of the high frequency 
fluorescence emission by measuring a low frequency PMT signal. Fast PMTs are 
desirable as the width of transit time spread (TTS -  the spread in the arrival times 
of electrons at the PMT anode in response to an incident photon) limits the upper 
modulation frequency that can be resolved.
There are two major methods of acquiring time domain data. The time profde of 
the fluorescence intensity decay can be obtained by sequentially measuring the 
number of fluorescence photons emitted at different times after the excitation 
pulse in sequential short time windows, a technique known as time-gating. Time­
gating can be accomplished either by gating the gain of the detector for a short 
period of the intensity decay following an excitation pulse, or by electronically 
sampling the response of the detector after an excitation pulse. Time gating has 
the advantage of being able to reject the earliest response to the excitation pulse 
which will contain short lifetime components from biological auto-fluorescence 




can be used with widefield fluorescence microscopy to produce FLIM images. 
The shortest direct time-gate achievable with most commercial CCDs is limited 
to ~1 ms so these are combined with multi-channel plate intensifiers (MCPI) 
which can be gated on ns timescales. It is, however, possible to directly time-gate 
some small commercial CCDs on nanosecond timescales4,5 avoiding the need for 
an MCPI.
Alternatively, time-correlated single photon counting (TCSPC) can be used to 
acquire a distribution of photon arrival times that is representative of the intensity 
decay. TCSPC is suitable for use with point scanning microscope techniques6'8 
and provides high temporal accuracy and high detection efficiency by measuring 
the arrival times of fluorescence photons at the detector relative to the timing of a 
pulsed light source used to excite the sample. The technique relies upon low 
excitation levels to avoid biasing the sampled fluorescence photons to those with 
early arrival times (known as pile-up), which is also beneficial to avoid 
photodamage to biological samples. To optimise the speed of data collection 
pulsed sources with high repetition rates (MHz) are used. Figure 2.3 outlines the 
components that are required to perform TCSPC.
The ‘reverse stop-start’ method is used so that the TCSPC electronics need only 
operate at the rate of photon detection rather than the much higher rate of the 
excitation pulses9 The time interval that is measured is between the arrival of a 
fluorescence photon at the detector and the next pulse of the excitation source. 
Upon detection of a fluorescence photon - recognised by a constant fraction 
discriminator (CFD) as a voltage signal pulse over a certain threshold and with a 
steep enough leading edge -  a time to amplitude converter (TAC) linearly 
increases a voltage until stopped by the next reference pulse from the excitation 
source. This voltage is assigned to a discrete time interval. By repeating the 
measurement many times and storing the frequency that photons are assigned to 
these time intervals in a histogram memory, a distribution of photon arrival times 
can be built up that is representative of the fluorescence intensity decay of the 
sample. TCSPC can be easily combined with point scanning microscopy 
techniques by assigning the photons both time values and to the pixels they came 




Figure 2.3 The components required for time-correlated single photon counting. 
A signal input from the fluorescence detector and reference pulses from the 
excitation source are vetted by constant fraction discriminators (CFDs). In 
reverse stop-start mode, a time to analogue converter (TAC) converts the interval 
between detecting a fluorescence photon and receiving the next reference pulse 
to a voltage which is then assigned to a discrete time interval by the analogue to 
digital converter (ADC). A histogram memory records the number of photons 
assigned to each time interval.
2.2.3 Fluorescence anisotropy
Fluorescence anisotropy is widely used to investigate molecular rotations and 
segmental motions of proteins in solution. When a population of fluorescent 
molecules is excited with linearly polarised light, the resulting fluorescence 
emission will also be polarised. In the absence of molecular rotation, the 
fluorescence emission polarisation of a molecule will be rotated by an angle that 
depends on the relative orientation of its transition moments for absorption and 
emission, which lay in specific directions along the structure a fluorescent 
molecule. The interaction between the exciting photon and a molecule depends 
on the dot product of the electric vector of the photon and the dipolar excitation 
moment of the molecule. Molecules that are oriented so that their absorption 
transition moments are aligned with the electric vector of the incident linearly 
polarised light will therefore be preferentially excited, an effect known as 
photoselection. The fluorescence anisotropy r is a measure of the degree of 
polarisation of the fluorescence emission, which can be reduced from the initial
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highly polarised photoselected state by rotational diffusion of the molecules or 








Figure 2.4 a. Experimental measurement of fluorescence anisotropy. Vertically 
polarised light (with the electric field vector aligned with the z-axis) is incident 
upon a sample and the fluorescence intensity parallel (In) or perpendicular (lx) to 
the z-axis is selected to proceed to the detector by the polariser, b. The projection 
of a dipole (dotted arrow) in the z- and x-axis. The dipole is oriented at angles 0 
and <() from the z- and y-axes respectively.
Figure 2.4a illustrates the measurement of r and shows a fluorescent sample 
illuminated with vertically polarized light (the electric vector of the light is 
oriented parallel to the vertical z-axis in the diagram). The intensity of the 
emission is measured at a right angle to the direction of excitation to avoid 
detection of unabsorbed excitation illumination and a polarizer is used to allow 
light to the detector that is polarised either parallel to the excitation polarisation 
{In) or perpendicular to it (7x). The anisotropy of the emission r is defined as the 




Figure 2.4b illustrates the anisotropy measurement at the level of a single 
fluorescent molecule. The molecule is assumed to be stationary and have parallel 
absorption and emission transition moments which are indicated by the black 
dashed arrow. It is oriented with respect to the z and x axes by the angles 0 and (¡> 
respectively. Fluorescent molecules behave like radiating dipoles and the 
intensity of light radiated from a dipole is proportional to the square of its vector 
projected in the axis of detection. If the emission is polarized along the emission 
transition moment then the intensities observed when selecting In or l± with a 
polarizer will be
77/= cos2<9 Eqn. 2-12
I L = sin2 <9sin2 <j> Eqn. 2-13
Averaged over many molecules in solution, the dependence of /± on (j) is 
eliminated by noting that the population of fluorescent molecules excited by z 
polarized light will be symmetrically distributed around the z-axis. The average 
value of sin2̂  is therefore 0.5 and by substituting Eqn.s 2-12 and 2-13 into Eqn. 
2-11 and using the identity sin2 6 = 1 -  cos2 0 the following expression for r can 
be obtained
3/cos2 d \ - \
r = —-------- -----
2
Eqn. 2-14
For the ideal case where the entire population of excited fluorescent molecules 
have collinear transition moments that are oriented exclusively parallel to the 
excitation polarisation, then the average value of cos2 6 would be 1 resulting in 
r = 1. However, this situation is unrealistic even if rotational diffusion is 
neglected as fluorescent molecules rarely have collinear transition moments and 
photoselection on a population of randomly oriented molecules doesn’t produce 
an excited state population perfectly oriented parallel to the excitation 
polarisation. The probability that a given molecule will absorb vertically
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polarized light is also proportional to cos 9, meaning that the transition moment 
of the fluorophore does not have to be perfectly aligned with the z-axis to be 
excited. The distribution of fluorescent molecules excited by z polarized light 
(single photon absorption) as a function of 9,J[9) is
f W e  = cos2 0 sin 9 dO Eqn. 2-15




(cos1 0^ = ———2-------------  Eqn. 2-16
jf(0 )d 0
Substitution of Eqn. 2-15 into Eqn. 2-16 gives the result i ĉos2 0^ = j .  From Eqn.
2-14 the maximum anisotropy is r — 0.4. For two-photon excitation the 
distribution of excited molecules 9) is different and
f 2{0)d0 = cos4 9sin9 d9 Eqn. 2-17
The maximum observable anisotropy for two-photon excitation is 0.57.
2.3 Extrinsic fluorescent probes
Extrinsic fluorescent probes are fluorescent molecules that are not naturally 
found in the sample being studied. They are introduced with the specific purpose 
of labelling naturally non-fluorescent components of the sample to investigate 
their localisation and environment. Three major classes of commercially
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available extrinsic probe are commonly used for fluorescence imaging; organic 
dyes, quantum dots and fluorescent fusion proteins.
2.3.1 Organic fluorescent dyes
Organic fluorescent dyes are small carbon based molecules that usually contain 
multiple aromatic ring systems. The dyes can often be produced with a number 
of different reactive groups enabling them to be covalently bound to 
biomolecules such as DNA and proteins. Succinimidyl esters, carboxylic esters 
and sulfonyl chlorides of dyes can be bound to the amine group, which is the 
functional group of the amino acid lysine10. Dyes with a maleimide group can 
bind to the thiol group found in the amino-acid cysteine10. Although these are the 
most common labelling targets in proteins, other functional groups such as 
aldehydes, ketones and alcohols can be used10. It is difficult to control the 
labelling of proteins as they may contain more than one accessible functional 
group for reaction with the functionalised dye.
Organic dyes are widely used due to their small size and the vast variety of 
commercially available dyes that allow for many different applications. Not all 
applications necessitate covalent 1:1 binding of the dye to a target bio-molecule. 
For example, fluorescein has two ionic forms that exist in a pH dependent 
equilibrium. These two isomers display distinctly different lifetimes and 
measurement of the mean lifetime can be used for example to estimate the pH of 
the local environment of the dye in a cellular organelle. Likewise the calcium 
indicators Fura-Red11 and Fluo-412 show [Ca2+] dependent absorption and 
emission spectra and need only be loaded into the cytosolic fluid of a cell to 



















FITC 494 521 0.97* 92,000* 13, a
Alexa 488 495 518 0.92 71,000 14, a
Alexa 532 532 553 0.61 81,000 14, a
Alexa 546 556 572 0.79 104,000 14, a
Alexa 594 590 617 0.66 73,000 14, a
Alexa 647 650 665 0.33 239,000 14, a
Atto 488 501 523 0.80 90,000 b
Atto 532 532 553 0.90 115,000 b
Atto 550 554 576 0.80 120,000 b
Atto 594 601 627 0.85 120,000 b
Atto 647 645 669 0.20 120,000 b
Atto 647N 644 669 0.65 150,000 b
Cy3 550 570 0.24 150,000 15
Cy5 640 670 0.20 215,000 15
Vybrant Dil 549 565 - 148,000 a
Vybrant DiD 644 665 - 193,000 a
DY-485XL 485 560 - 50,000 c
DY-480XL 500 630 - 50,000 c
TMR 554 573 0.28 103,000 13, a
Fluo-4 494 516 0.14** 88,000** 12, a
Fura-red 458 597 - 43,000 11,a
Table 2.1 Fluorescence properties of commercially available organic dyes 
(unconjugated). *Measured in basic ethanol. All other quantum yields and 
extinction coefficients pertain to the unconjugated dye in phosphate buffered 
saline (PBS). **When bound to Ca2+. Values originate from the references 
shown, or are provided by the commercial supplier indicated (Key - a. Invitrogen 
b. Atto-tec c. Dyomics).
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Membrane probes are another class of fluorescent dye that do not require 
covalent modification of target molecules. Instead membrane probes are 
amphipathic (containing a hydrophobic and a hydrophilic portion) which 
facilitates their insertion into lipid membranes. The properties of 
Dialkylcarbocyanine dyes which are extensively used in this thesis are discussed 
in the next section.
Many commercially available dyes have been developed specifically to suppress 
environmental sensitivity of their fluorescence and provide bright photostable 
probes for imaging applications. These include the Alexa Fluor14 (Invitrogen) 
and the Atto16 (Atto-tec) series of dyes. Dyomics have recently developed dyes 
with extremely large Stokes shifts17 that minimise the possibility of reabsorption 
of a fluorescence photon (inner filter effects) and allow multiple probes to be 
excited by the same laser line.
2.3.2 Dialkylcarbocyanine membrane probes
Dialkylcarbocyanine dyes are fluorescent molecules that are amphipathic 
(possessing both hydrophobic and hydrophilic regions) and are structurally 
similar to phospholipids (figure 2.5) in that they have a charged headgroup with 
two hydrophobic carbon chains. However, they possess two saturated alkyl 
chains instead of the acyl chains more usual in phospholipids. They are 
amphipathic because of a positive charge that resonates between the nitrogens of 
the two indole rings and insert into the outer leaflet of membranes with the 
fluorophore transition dipoles nearly parallel to the membrane surface18. Despite 
being free to rotate along the axis perpendicular to the membrane surface and 
diffuse laterally, they are not known to 'flip' between the leaflets of a lipid 
bilayer19. The fluorescence properties of the dyes can be altered by substituting 
the dimethylated carbon atoms with other groups and altering the separation of 
the indole groups. Many Dialkylcarbocyanine dyes are commercially available 
with absorption and emission spectra covering the whole range of visible
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wavelengths. Due to the complexity of their full chemical names, they are 
usually referred to in the form CnDiX, where Cn gives the number of carbon 
atoms in the alkyl chains and X is a letter that denotes the particular fluorescent 
variation. Two of the most commonly used are Dil and DiD which are spectrally 
similar to the fluorescent dyes Cy3 and Cy5 respectively. Fluorescent filter sets 
for these popular carbocyanine dyes can therefore also be used to image Dil and 
DiD. Dialkylcarbocyanine dyes exhibit highly quenched fluorescence in aqueous 
solution, but are highly fluorescent in lipid environments exhibiting short (~lns) 
fluorescence lifetimes characterised by bi-exponential decays20.
Figure 2.5a. The chemical structure of the lipophilic fluorescent dye, CigDiD. 
b. The chemical structure of Phosphatidylcholine.
2.3.3 Quantum dots
Quantum dots (QDs) are semiconductor nanocrystals that posess intense 
fluorescence emission and are highly resistant to photobleaching 2I'23. This
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property makes them useful for tracking singly labelled proteins and their large 
2-photon absorption cross-sections are beneficial for imaging at greater depths 
within a sample24. QDs have broad absorption spectra but narrow emission 
spectra tunable by varying the QD size21. However, QDs are disadvantaged by 
their large size (comparable with the size of GFP) and often need multiple layers 
of functionalisation and binding intermediates to attach them to the protein of 
interest25.
2.3.4 Fluorescent proteins
The importance of the isolation of the green fluorescent protein (GFP) from the 
jellyfish Aequorea Victoria26, the cloning of the GFP gene for use as a 
fluorescent probe27 and the mutation of this protein and others to provide 
fluorescent proteins over the range of visible wavelengths28"30 has recently been 
recognized with the 2008 Nobel prize in Chemistry. Fusion of a gene for a 
fluorescent protein to the gene encoding a protein of interest results in 
simultaneous expression of both, covalently linked. This provides a way of 
monitoring gene expression and the localisation of proteins in living organisms29. 
Expression of fluorescent proteins is generally non-toxic to cells, but fluorescent 
proteins are large (GFP is ~ 27 kDa) and may interfere with the normal 
functioning of the protein to which it is fused.
Despite this, fluorescent proteins offer several advantages over extrinsic 
fluorescent probes: they do not require purifying and production of tagged 
proteins and their introduction into the cell is performed entirely by cellular 
machinery resulting in specific 1:1 labelling of the protein of interest. However, 
they do require the protein of interest to be identified and cloned and the correct 
functioning of the fusion protein must be verified to ensure that it is not disrupted 
by the presence of the added protein. Fluorescent proteins are also often able to 
form dimers and higher order oligomers at high concentrations which can pose a 
problem for fusion proteins that are localized in cellular compartments. A single 
point mutation is capable of preventing dimérisation of GFP variants31 and this
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mutation should be present in any GFP variant used for experiments aiming to 
determine protein interactions or intermolecular distances.
Labelling of cells with fluorescent proteins can also encounter problems due to 
the inefficiency of gene transfer techniques. DNA encoding a fusion protein is 
placed in a plasmid (a ring of DNA in this context also known as a vector) and 
introduced into animal cells either by co-precipitation with calcium phosphate32 
or strontium phosphate33, electroporation34 (transient formation of pores in the 
plasma membrane with an electric field), lipofection35 (DNA is introduced with 
cationic liposomes), microinjection36 of DNA directly to the cytoplasm (or 
nucleus) or using viral vectors37. Only cells that take up the DNA will express 
the foreign gene and with the exception of microinjection the amount taken up is 
difficult to control resulting in large variations in expression levels.
Over time most of the foreign DNA taken up by the cells is degraded and the 
transfection is only transient. Lipofection is commonly used to achieve transient 
transfection as it has been proven in a variety of cell types and there are a number 
of commercially available cationic liposome preparations such as Lipofectamine 
(Invitrogen) and Fugene (Roche). Stable expression only occurs if the foreign 
gene is incorporated into a chromosome of the host cell; a rare event that occurs 
is less than 1% of cells. Isolation of these stably transfected cells can be difficult 
and time consuming.
Variants of GFP commonly used in imaging applications are based on the 
enhanced version of the protein (eGFP). The peak of natural GFP absorption is at 
395nm, which excites considerable auto-fluorescence in biological samples. 
eGFP contains a single altered amino-acid which shifts this peak to 488nm38. 
Similar mutations have been used to produce fluorescent proteins with shorter 
(enhanced cyan fluorescent protein, eCFP) or longer (enhanced yellow 
fluorescent protein, eYFP) excitation and emission spectra29.
Further mutations of these variants are commonly used to address complications 
in their photophysical properties such as the environmental sensitivity and poor 
photostability of eYFP (mutated to produce Citrine). Additionally, other
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fluorescent proteins that emit in the orange and red regions have been cloned 
from the sea anemone Discosoma striata 9. These proteins are known as 
Ds-orange and Ds-red. A list of commonly used fluorescent protein vectors and 















eCFP 433 475 0.40 26,000 29
CyPet 435 477 0.51 35,000 40
Cerulean 433 475 0.62 - 41
eGFP 488 507 0.60 56,000 38, 42
eYFP 514 527 0.61 - 29
YPet 517 530 0.77 104,000 40
Venus 515 528 0.57 92,000 43
Citrine 516 529 0.76 - 44
mOrange 548 562 0.69 71,000 39
tdTomato 554 581 0.69 138,000 39
Ds-Red 556 586 0.10 75,000 39
m Strawberry 574 596 0.29 90,00 39
mCherry 587 610 0.22 72,000 39
mPlum 590 649 0.10 41,000 39
Table 2.2 Commonly used commercially available fluorescent proteins.
2.3.5 DNA transfer based site specific labeling strategies
Recently a new strategy for site specific labelling combining genetic 
manipulation and labelling with small artificial probes has been developed. 
Instead of fusing the protein of interest with a protein that is itself fluorescent, a
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small peptide sequence is added which will react with a specific functional group 
under certain conditions. This functional group is placed on a fluorescent probe 
which can then be bound specifically to the peptide tag that has been added to the 
protein.
Several different tags have been developed from different natural systems. These 
include the Histidine (Hise) tag which binds nickle-nitrilotriacetic acid (Ni- 
NTA)45, 46, the acyl carrier protein (ACP) or peptide carrier protein (PCP) to 
which a probe is transfered from coenzyme A (CoA) by the enzyme Pptase46, and 
the acceptor peptide (AP) sequence that can be biotinylated by biotin ligase for 
subsequent binding to a streptavidin functionalised probe47. The probe itself is 
chosen depending upon the location in the cell of protein and the tag. If the tag is 
outside the plasma membrane on the extracellular portion of a membrane protein 
then any organic dye or Qdot can be used. If the protein is inside the cell then the 
probe must be cell permeable.
Figure 2.6 The basic principle of introducing small peptide sequences into 
proteins for site specific labelling. Cells are transfected with a vector that 
encodes the protein (grey) plus the added peptide sequence (red). These proteins 
are expressed by the cell and transported to their site of function (in this case the 
plasma membrane) where they can be covalently bound to a fluorescent probe 






2.4 Förster resonance energy transfer
In a system of molecules that are well separated (by distances ~10'9 -  10'8 m), 
Förster resonance energy transfer (FRET) is the process of non-radiative transfer 
of excited state energy from a fluorescent molecule that has absorbed a photon to 
another molecule in its ground state via Van der Waals (dipole-dipole) 
interactions. FRET occurs without conversion of the excited state energy to 
thermal vibrational energy or the molecules involved in the transfer process 
coming into contact through a kinetic collision. FRET was first observed in 1922 
as sensitised fluorescence in a mixture of mercury and thallium vapour although 
transfer of energy by collisions of gaseous atoms could not be ruled out in this 
case48,49. The non-trivial nature of the non-radiative energy transfer involved was 
subsequently confirmed, but it was not until 1948 that an accurate theoretical 
description of FRET was formulated by Theodore Förster49.
In Forster’s theory, the molecule excited by the excitation photon is referred to as 
the donor, and the molecule to which donor excited state energy is transferred to 
by FRET is known as the acceptor. If the energy difference for fluorescence 
emission of the donor corresponds exactly to a transition in a close acceptor 
molecule, there may be sufficient energetic coupling for the FRET process to be 
significant in comparison with donor fluorescence emission. The broad emission 
and absorption spectra of molecules ensures that this condition is met if the 
emission spectrum of the donor and the absorption spectrum of the acceptor 
overlap. This condition is exactly the same as the condition required for re­
absorption of a donor fluorescence photon by the acceptor, which depends upon 
Coulombic interactions and has inverse square distance dependence. In contrast 
the dipole-dipole nature of the non-radiative interaction between the donor and 
acceptor in FRET results in an inverse sixth power dependence upon the donor- 
acceptor separation.
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2.1.1 FRET between a single donor and acceptor
The rate of transfer kt between a donor and acceptor separated by a distance r at 
thermal equilibrium is given by50
Eqn. 2-18
where To is the donor fluorescence lifetime in the absence of acceptor and Ro is 
the Forster radius which is defined as the donor-acceptor separation at which the 
rate of donor de-excitation by resonance energy transfer is equal to the rate of de­
excitation by fluorescence emission. It is simple to demonstrate that Ro is the 
separation at which the efficiency of FRET is 0.5 for a single donor-acceptor pair 
and hence this quantity is useful for calculating the donor-acceptor separation 
from a measured FRET efficiency.
Ro is related to the fluorescence properties of the donor and the acceptor by




where Qd is the quantum yield of the donor in the absence of energy transfer, x2 
is the orientation factor, TV is Avogadro’s constant, n is the refractive index of the 
medium containing the donor and acceptor, is the extinction coefficient of 
the acceptor at wavelength X and FD(X) is the normalized fluorescence emission 
spectrum of the donor. FRET is independent of the donor excitation wavelength 
as long as FRET does not occur before relaxation of the donor to the lowest 
excited state vibrational energy level.
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The efficiency of FRET E fret is given by
J FRET
kt 
k t + Ro+ r6
Eqn. 2-20
Figure 2.7 graphically displays the dependence of E fret on the donor-acceptor 
separation. By measuring the efficiency of FRET between donors and acceptors 
with known Ro values, this relationship can be used to calculate the separation of 
donors and acceptors in a sample as long as FRET pairs can be considered to be 
independent of each other. The dependence of FRET efficiency upon the inverse 
sixth power of the separation has been experimentally verified at the ensemble 
and single molecule levels50,51.
Figure 2.7 The dependence of FRET efficiency (E fret) upon the donor-acceptor 
separation r expressed in multiples of the Forster radius R0.
In the range 0.5 < r / Ro < 1.5 there is measurable variation in EFREt• The values 
of Ro of FRET pairs comprising fluorescent molecules are usually < 8 nm and 
donor and acceptor molecules must be separated by < 12 nm for FRET to be 
unambiguously observable.
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The value of Ro for a given donor-acceptor pair can therefore be calculated by 
measuring the spectral properties of the donor and acceptor (to calculate the 
overlap integral), the donor quantum yield and specifying a value for tC. The 
following sections discuss the measurement of the overlap integral and donor 
quantum yield, plus the errors introduced by assuming an average value for x2.
2.4.1 The overlap integral
The overlap integral quantifies the overlap between the donor fluorescence 
emission and acceptor absorption spectra and is given by50
ooJ fd
J(X) = f f„ (x)eA (X)X'd,l = ----------------  Eqn. 2-21
°
0
fo(X) is the corrected fluorescence intensity of the donor (with the area under the 
emission spectrum normalised to unity) and Sa(A) is the extinction coefficient of 
the acceptor at A. Alternatively, the uncorrected fluorescence intensity of the 
donor, Fo(A) can be used and the overlap integral normalized by the area under 
the donor emission spectrum. Therefore J(X) can be calculated by measuring the 
donor emission spectrum and the acceptor absorption spectrum and numerically 
integrating Eqn. 2-21.
If the wavelength is in nm and the units of sa are M'cnT1 then J(X) is in units of 
M'1cm'1nm4. The Forster radius can be calculated in angstroms using47
R0 = 0.21 l[n aQdk 2 J{A^< (in units of A) Eqn. 2-22
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2.4.2 Donor quantum yield determination
The fluorescence quantum yield is the ratio of photons absorbed to the number of 
fluorescence photons emitted by a fluorescent molecule. This property can be 
measured for an uncharacterised sample by comparing it to standard samples 
with known quantum yields. If these standard and unknown samples have the 
same absorbance at a given wavelength, then they will absorb the same number 
of photons under the same illumination conditions. From this assumption it 
follows that the ratio of the integrated intensities of an unknown solution and the 
standard solution obtained under the same experimental conditions gives the ratio 
of their quantum yields. The quantum yield of the unknown sample could then be 
calculated from the known quantum yield of the standard.
However, quantum yield determination with real samples must avoid inner filter 
effects (re-absorption of fluorescence emission that can lead to an apparent 
decrease in the quantum yield or distortion of fluorescence spectra) and it is not 
always possible to maintain the exact same experimental conditions as those used 
for the standard sample. Different solvents may have to be used for different 
samples and as a consequence the observed fluorescence intensity will vary due 
to their different refractive indices. Consequently a more reliable way of 
comparing an unknown sample with a standard is to obtain the integrated 
fluorescence intensities I f  over a range of sample concentrations with an 
absorbance < 0.1 53. In the absence of concentration effects the integrated 
intensity will be a linear function of the absorbance with a gradient proportional 
to the quantum yield of the sample. The fluorescence intensity observed from a 
medium of refractive index n\ by a detector in a medium of refractive index n0 is 
scaled by a factor of (n jn 0)2. The unknown quantum yield can then be 
calculated using the equation
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Eqn. 2-23Q x  ~  Q h
Grad „V „ A
Gradr y y
where Q* is the unknown quantum yield to be determined, QR is the quantum 
yield of the reference sample, Gradx R are the gradients of the integrated 
fluorescence intensity vs. absorbance plots for the unknown and reference 
samples and nx• r are the refractive indices of the solvents in the two samples.
This approach can also be extended to the comparison of samples that are not 
excited at the same wavelength by correcting the integrated fluorescence 
intensity for wavelength dependent changes in excitation intensity.
2.4.3 The Orientation factor
The orientation factor k2 is defined as40
k 2 -  (cos 9t -  3 cos 9D cos 9A )2 = (sin 9D sin 9A cos <j)-2 cos 9D cos 9A )2
Eqn. 2-24
where 9r is the angle between the donor emission dipole and the acceptor 
absorption dipole, 6b and 9A are the angles between the same dipoles and the 
vector joining the donor and acceptor positions, (j) is the angle between the planes 
of the two dipoles. Figure 2.8 is a diagram showing these angles.
The possible range of k2 values is between 0 (perpendicular dipoles) and 4 
(collinear dipoles), k2 = 1 for parallel dipoles. An ensemble of FRET pairs tagged 
to elements of a biological sample will contain a distribution of k  values and it 
is usual practice to assume an average value for the orientation factor when 
calculating Rq54.
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Figure 2.8 A donor emission dipole (D) and an acceptor absorption dipole (A) 
separated by a distance r. The angles relevant to the determination of the 
orientation factor k  are also shown.
Fluorophores attached to proteins usually retain a limited freedom of motion 
about the point of conjugation which can randomise their orientation. Donors and 
acceptors can be considered as having some ability to reorient with respect to the 
proteins they are bound to, with the macromolecular structures of the proteins 
defining their separation, x2 = 2/3 is the value expected for donor and acceptor 
transition dipoles that are free to sample all possible orientations through 
rotational diffusion during the time the donor spends in the excited state, hence 
randomising the value of k  for each FRET pair. This is referred to as the 
dynamic averaging limit. The range and speed of the allowed motion will vary 
between different conjugations of proteins and dyes, but will make the value of 
x2 close to the dynamic averaging limit. Determination of intramolecular 
distances in the protein F-actin by FRET (with x2 = 2/3 assumed) and by x-ray 
diffraction of crystallized protein has been shown to give the same results55, 
providing confidence that it is valid to use the dynamic averaging limit when 
dealing with FRET pairs tagged to proteins. The average value expected for a 
range of static donor-acceptor orientations (the static averaging limit) is 
k = 0.476, but the use of this static averaging limit was shown to be 
inappropriate for fluorophores conjugated to biomolecules56.
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Fluorescence anisotropy measurements can be used to characterise the mobility 
of a conjugated dye. A population of fluorophores excited with vertically 
polarised light will be photoselected for molecules with absorption dipoles 
aligned in the same direction. Any ability of the dye molecule to reorient during 
the excited state lifetime results in a reduction of the measured anisotropy from 
the maximum possible value, ( rmax = 0.4 for single photon excitation). From the 
measurable depolarisation of the donor and acceptor it is possible to set lower 
and upper bounds on the value of k2 54,56. An alternative approach to estimating 
the error introduced by using k2 = 2/3 considers the consequences of a population 
of randomly oriented but static fluorophores that have overlapping electronic 
transitions. Many fluorescent dyes exhibit mixed transitions that reduce their 
fundamental anisotropy below rmax and further reduce any error introduced by 
using the dynamic averaging limit. From this approach, the error in any distance 
determined via an R0 value calculated with k2 = 2/3 is < 10% when the measured 
donor and acceptor anisotropies are less than 0.22 .
2.4.4 Methods of observing FRET
There are three main approaches to the observation of FRET through its
influence on different properties of donor and acceptor fluorescence emission .
These are by measurement of
1 changes in the donor and acceptor fluorescence intensities (either 
separately or together)
2 the apparent reduction in donor fluorescence lifetime resulting from 
competition with FRET
3 the reduction in anisotropy of the total fluorescence emission that 
accompanies FRET.
These three methods are illustrated in figure 2.9.
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Monitoring intensity changes in the donor and acceptor fluorescence emission is 
perhaps the easiest method to implement as no specialised equipment is required 
beyond a standard widefield fluorescence microscope equipped with suitable 
filter sets. The FRET efficiency is related to the donor fluorescence intensity in 











Figure 2.9 The effect of FRET upon measurable fluorescent properties, a. The 
donor fluorescence intensity (Fd) is quenched in the presence of a FRET (Fda). 
FRET also leads to sensitised acceptor fluorescence emission (Fa*). (Fa) is the 
acceptor fluorescence emission due to direct excitation, b. The fluorescence 
lifetime of the donor (blue intensity decay) is reduced in the presence of the 
acceptor (red dashed intensity decay), c. Arrows represent the orientation of 
excited donor molecules (green), unexcited donors and acceptors (grey) and 
excited acceptors (orange). Transfer of excited state energy to non-photoselected 
acceptors will reduce the fluorescence anisotropy of a sample.
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Alternatively it can be shown that it is also related to the intensity of the 








However, intensity based methods are complicated by cross-talk between donor 
and acceptor channels, and residual direct excitation of the acceptor at the 
wavelength used to excite the donor. Many different variations of intensity 
measurements exist that attempt to address these issues59'61. Commonly used is 
the ‘three cube’ technique61,62 that measures the fluorescence intensity of donors 
and acceptors when directly excited before using these to correct the measured 
sensitised acceptor intensity. This method has the advantage of fast acquisition, 
but the corrected FRET measurement is still a function of the concentration of 
donors and acceptors, the excitation intensity, excitation wavelength and the 
detection efficiency of the instrument used. Consequently it is difficult to 
compare FRET efficiencies measured this way between different experiments or
• 58instruments .
In contrast FRET efficiency determination from the reduction in donor lifetime 
caused by FRET is independent of the donor and acceptor concentrations and 
unaffected by donor photobleaching. As the lifetime of the intensity decay is 
proportional to the area underneath it (the integrated fluorescence intensity) the 
lifetime in the presence ( tda) and absence of acceptor ( zt>) is related to the FRET 
efficiency in a manner analogous to Eqn. 2-25
EFret= 1 ——  Eqn. 2-27
t d
This expression assumes that there is a single donor-acceptor separation and that 
both fluorescence decays are described by single exponential functions so that 
their lifetimes are proportional to the area under the intensity decay. It is also
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valid for multi-exponential decays as long as the tda and td used are the 
weighted means of the multi-exponential lifetime components60, td can be 
obtained either from a separate sample lacking acceptor or from the same sample 
after complete photobleaching of the acceptor. Acceptor bleaching can also be 
used as an independent test to verify that any measured reduction in donor 
lifetime is indeed due to FRET. Intensity decay measurements have the 
disadvantages of taking relatively long times to acquire large numbers of 
photons. This also increases the possibility of causing photodamage or bleaching 
of the sample.
Finally, fluorescence anisotropy measurements can be used63"65. The excited state 
population of donors is photoselected by the polarisation of the illuminating light 
(described in section 2.2.3). The fluorescence emission of these donors is 
similarly polarised unless depolarised by rotational diffusion of the donors. 
FRET provides another mechanism for depolarisation as excited state energy can 
be transfered to any acceptor within the range of FRET, providing the relative 
orientations of donor emission and acceptor absorption dipoles are not 
perpendicular. The correlation between the highly oriented population of excited 
donors does not extend to the total fluorescence emission from both the donors 
and acceptors. As well as being able to quantify FRET between different 
fluorescent species63 (hetero-FRET) it has the advantage of being the only 
method capable of measuring FRET when the donor and acceptor are the same 
fluorescent species (homo-FRET)58,64,65.
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3 ErbB transmembrane receptors: A paradigm in 
membrane protein signalling
3.1 The Epidermal Growth Factor
Growth factors are small, soluble proteins that are produced by cells and released 
into the extracellular environment to act as chemical messengers. The function of 
signalling molecules is to allow communication between cells that are not in 
physical contact, or necessarily in the same tissue. To achieve this they must 
produce a response from the cells that they come into contact with. As the name 
suggests, growth factors are important in controlling the growth and proliferation 
of cells within multicellular organisms. They are especially important in the 
development of embryos where well timed signals are required to instruct cells to 
continue dividing, to become specialised (differentiate) or undergo programmed 
cell death (apoptosis) depending upon their location in the embryo at a particular 
stage of development1.
The first growth factor to be identified was the Epidermal Growth Factor (EGF) 
which was isolated from the submaxillary gland of mice in 1962 by Stanley 
Cohen . It was identified due to its ability to promote tooth growth and eyelid 
opening in newborn mice. EGF is produced as a precursor transmembrane 
protein that is biologically active at the cell surface, before cleavage of the 
extracellular portion of this protein releases the soluble growth factor into the 
extracellular environment3. The family of membrane bound metalloproteases 
known as ADAMs (a disintegrin and metalloprotease) appears to be responsible 
for this cleavage3, 4, but the exact mechanisms controlling such a major step in 
the regulation of growth factor signals is not yet known.
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3.2 The ErbB family of growth factor receptors
In order for extracellular chemical messengers to induce a cellular growth 
response they must either: (i) cross the cell plasma membrane to interact directly 
with precursors, activators or regulators of DNA replication or transcription; or 
(ii) their presence in the extracellular environment must be detected at the cell 
boundary (the plasma membrane) and be translated across this barrier leading to 
activation of other signalling molecules inside the cell. EGF is far too large to 
pass across the plasma membrane, but instead binds to a receptor protein at the 
cell surface. The EGF receptor (EGFR, also known as ErbBl and HER1 in 
humans) is a transmembrane protein with a glycosylated extracellular region that 
binds to growth factor ligands, a single pass a-helix transmembrane domain and 
a large cytoplasmic region. The cytoplasmic region includes a flexible domain 
juxtaposed to the inner leaflet of the plasma membrane (known as the 
juxtamembrane domain), a tyrosine kinase domain and a c-terminal domain 
containing multiple tyrosine residues5. A map of the secondary structure of 
ErbBl highlighting the different regions can is shown in figure 3.1. 
Transmembrane proteins such as ErbBl are known as receptor tyrosine kinases 
(RTKs).
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Figure 3.1 The domain structure of ErbBl. Amino-acid residues are numbered 
from the N-terminus at the start of domain I. The boundary of the transmembrane 
region (TM) is indicated by dashed lines. JM is the juxtamembrane domain. The 
kinase domain is divided into two lobes named for their proximity in the 
secondary structure to the N- and C-termini of the receptor.
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A tyrosine kinase is an enzyme that catalyses a reversible covalent modification 
that adds a phosphate group to the hydroxyl group of the amino acid tyrosine. 
The phosphate group can be removed by other enzymes known as phosphatases. 
Phosphorylation is a simple method of altering the tertiary structure of a protein 
in order to activate or deactivate an enzyme or adjust its ability to bind to other 
proteins. The early realisation that growth factor-induced ErbBl activation is 
associated with dimerisation and/or oligomerisation suggested that trans­
phosphorylation of ErbBl tyrosine residues by neighbouring ErbBl kinase 
domains was involved in receptor activation6. This suggests an intuitive 
mechanism for how growth factor signals might be transduced across the plasma 
membrane by a single pass transmembrane receptor like ErbBl, where the 
tyrosine kinase is inactive in the absence of extracellular ligand binding but is 
able to trans-phosphorylate its own tyrosine residues or those of other 
intracellular proteins when growth factor binding causes clustering of two or 
more receptors. The tyrosine residues in the C-terminal domain serve as docking 
sites for signalling molecules with SH2 and PTB homologies7. The pattern of 
phosphorylation influences which molecules are able to bind and hence which 
signals are transduced upon activation.
Subsequent to the discovery of ErbB 1, three more homologous receptors were 
identified that are now known as ErbB2-4. The ErbB family (also known as the 
HER family in humans) bind to ligands that all contain a conserved EGF-like 
binding domain. Table 3.1 lists all the known ErbB ligands, any commonly used 
acronyms and the ErbB members to which they bind8"24. ErbB ligands are 
generally divided into two groups -  those that bind to ErbB 1 and the neuregulins 
which bind to ErbB3 and ErbB4 only7. Three ErbBl binding ligands can also 
bind to ErbB4 and are known as the bispecific ligands. Notably, ErbB2 has no 
known ligand and ErbB3 possesses a non-functioning kinase domain, suggesting 
that their activity is dependent upon heterodimerisation with other ErbB family 
members25. ErbB4 is the most recently identified family member and the least 
well characterised26. ErbB4 is known to exist in a number of isoforms that 
possess differences in their justamembrane and c-terminal domains that alter the 
receptors ability to bind to intracellular effectors7’26.
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Receptors
Ligand ErbBl ErbB2 ErbB3 ErbB4 Reference
Epidermal growth factor (EGF) X 2
Transforming growth factor 
alpha (TGF-a)
X 9
Heparin binding EGF like 
growth factor (HB-EGF)
X X 1 0
Amphiregulin X 1 1
Betacellulin X X 1 2
Epigen X 13
Epiregulin X X 14
Neuregulin-1 (NRG-1) X X 15-18
Neuregulin-2 (NRG-2) X X 19-22
Neuregulin-3 (NRG-3) X 23
Neuregulin-4 (NRG-4) X 24
Table 3.1 The known growth factor ligands that bind to the four members of the 
ErbB family of receptor tyrosine kinases. Isoforms of the Neuregulins are not 
listed.
3.3 ErbB structure and signal transduction
The currently accepted model of ErbB signal transduction is heavily influenced 
by recently solved crystal structures of extracellular domain fragments of ErbB 
receptors and of the intracellular tyrosine kinase domain of ErbBl27'34. X-ray 
crystallography provides high resolution structural information about proteins 
and macromolecular complexes providing that they can be grown as a crystal. 
Unexpectedly, the crystallographic extracellular dimer fragment that dominates 
the current model was found to be mediated entirely by receptor-receptor 
contacts (on domain II) in a conformation that placed the bound ligands far from 
the dimérisation interface27'34. In the absence of ligand all ErbB members with 
the exception of ErbB2 crystallised in the form of an autoinhibited ‘tethered’
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monomer . In this conformation, domains II and IV are held together burying 
the regions of domain II involved in dimérisation29. In order for a ligand to bind 
to both binding sites on domains I and II a large rearrangement of domains is 
required from the tethered conformation. Mutations designed to disrupt the tether 
don’t, however, lead to an increased affinity for ligand or constitutively activated 
receptors ’ . It is thought that the ErbB extracellular domain exists in a
dynamic equilibrium of different conformations and that ligand binding stabilises 
the extended conformation of the receptor and allowing the formation of receptor 
dimers29, 33. Stable dimers then allow transactivation of tyrosine kinases and
7 c
transphosphorylation of tyrosine residues . ErbB2 was found to adopt an 
extended conformation stabilised by a direct interaction between domains I and
iz:
III . As ErbB2 appears to have no available ligand binding site it has been 
proposed that no ErbB2 ligands will ever be found . That ErbB2 exists in a 
conformation constitutively primed to interact with other ErbB receptors is 
consistent with the observation that ErbB2 over expression (but not ErbBl) 
results in the transformation of cells ’ . ErbB2 doesn’t appear to homodimerise 
due to small but important deviations between the extended ErbB2 structure and 
that of ErbB 1 which might be optimal for heterodimerisation38.
Early crystal structures of the ErbBl intracellular kinase domain suggested a 
protein with the characteristics of an activated kinase39, consistent with the 
observation that phosphorylation of the single tyrosine residue present in the 
ErbBl kinase domain is not required for receptor activation40,41. Inactive ErbBl 
kinase domains were subsequently crystallised but only when bound to lapatinib, 
a tyrosine kinase inhibitor42. More recent structural data has shown that the 
ErbB 1 kinase domain can be activated by increasing its local concentration or by 
mutating a leucine residue (L843R) in the kinase activation loop34, providing 
evidence that kinase domains are autoinhibited until intermolecular interactions 
promote its activation. The data also showed that kinase domains can form an 
asymmetric dimer in a manner similar to Cyclin A activation of cyclin-dependent 
kinases (CDKs)34. The observed asymmetry provides a mechanism for receptor 
activation by homo- or hetero-dimerisation that allows ErbB3 to be part of an 
active dimer without possessing any enzymic activity. The currently accepted 
picture of ErbBl activation by EGF is shown in figure 3.2.
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Figure 3.2 The crystal structure derived model of ligand induced ErbB receptor 
activation. Binding of EGF ligand to domains I and III of the extracellular region 
results in a conformational change from a tethered monomer to an extended 
conformation capable of homo- or hetero-dimerisation with other ErbB receptors. 
Ligand binding may also stabilise pre-formed dimers. Dimérisation of receptors 
allows the formation of asymmetric intracellular tyrosine kinase dimers and 
transphosphorylation of c-terminal tyrosine residues on one receptor.
It must be noted that the solved crystal structures represent at best snapshots of 
the dynamic protein structure, a crucial caveat for the understanding of 
relationships between structure and function43. Furthermore, as proteins often 
contain flexible domains that cannot be crystallised, pictures of large protein 
structures are often a best guess composite of the different crystallisable 
domains. This is certainly the case with the picture of ErbB receptors which lacks 
structural information regarding three important sections of the receptor - the 
transmembrane domain, juxtamembrane domain and c-terminal domain8,30. It is 
known that isolated transmembrane domains, which are presumed to be helical, 
can associate with other transmembrane domains in cell membranes and may 
help stabilise dimers44. The juxtamembrane region contains non-tyrosine
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phosphorylation sites, several protein binding domains and is suspected of 
playing a part in the regulation of ErbB activity45. The conformation of the 
C-terminal domain has so far only been related to the position of the tyrosine 
kinase domain via FRET studies that have shown that the two become separated 
after receptor activation46. Additionally, ErbB receptors are known to be 
glycosylated at several sites4 7  and any oligosaccharides bound to the receptor at 
these sites are not fully visualised by the x-ray crystallography techniques30.
3.4 Beyond the crystallographic dimer model
Despite the insights provided by the structural studies of ErbB receptors, there is 
still no clear description of how the dimerisation and activation mechanisms 
allow the receptors to function in the plasma membranes of live cells. The 
binding of EGF to ErbBl is the most extensively characterised ErbB family 
signalling event, yet there are still a number of outstanding challenges in the 
understanding of ErbBl signalling that are not addressed by the structural 
studies.
Binding studies of EGF to ErbBl in many different cell types display two 
distinct classes of receptor that bind to EGF with different affinities48’ 49. The 
affinity of the receptor for its ligand depends on both the rate at which ligand 
binds (the ‘on’ rate, kj) and dissociates from the receptor (the ‘off rate, kr)50. 
Binding affinity is expressed in terms of the equilibrium dissociation constant, 
Kd
K d =T~  Eqn. 3-1kf
A small population of ErbBl receptors bind ligand with high affinity 
(Kd ~ 10 - 100 pM) while the majority of ErbBl bind to ligand with low affinity 
(Kd — 1 — 10 nM). There is evidence that an increased rate of ligand association 
is responsible for high affinity binding and that both affinity classes possess
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similar dissociation rates51. These affinity classes can be made selectively 
available to ligand by binding appropriate monoclonal antibodies to the receptors 
in the vicinity of the ligand binding site48, 51. High affinity ErbBl have been 
shown to be predominantly responsible for the transduction of most growth 
factor signals across the membrane48. Low affinity receptors are responsible for 
regulating the influx of Ca2+ into the cell immediately following ligand binding52. 
Interestingly, high affinity ligand binding to ErbBl is not seen outside of a 
cellular environment53. It was initially expected that the affinity classes of 
receptor would correspond to the tethered and extended conformations of the 
ErbBl extracellular region, but binding kinetics data and modelling has shown 
that it is not possible to account for experimentally measured EGF binding data 
with these two receptor states alone . The mechanism that confers different 
binding affinities to identical translation products is still elusive although it has 
be shown that variations in ErbB glycosylation can alter receptor affinity for 
ligand but without reproducing the Kd values seen in live cells47. It is also 
possible to reproduce the ligand binding results seen in cells using a model that 
invokes negative cooperativity between receptors (where Kd increases as a 
function of the occupancy of ligand binding sites) in an aggregating system54.
Also, imaging studies of ErbB receptors in cells have also consistently produced 
results that suggest that in a cellular context the structure of ErbB complexes is 
more complicated than the dimer model predicted by x-ray crystallography. 
Oligomers larger than dimers have been observed5 5 ’ 5 6  and there is evidence from 
single molecule FRET studies that they contain interfaces other than the back-to- 
back dimer57. There is also evidence that ErbB receptors form inactive dimers in 
live cells58,59.
3.5 ErbBl Signalling Networks
ErbB 1 is the most extensively studied member of the ErbB family and a diverse 
array of different intracellular molecular adapters and effector proteins and 
molecules has been found in complex with or to be phosphorylated by activated
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ErbBl40. These adapters and effectors act either to promote or inhibit the signal 
transduced in response to extracellular ligand binding. Most of the proteins that 
bind directly to the ErbBl intracellular domain bind to the sites of 
phosphorylated tyrosine residues (p-Tyr). The intracellular domain also contains 
binding sites with serine and threonine residues that can be phosphorylated. 
Adapter proteins are able to recruit other intracellular proteins (both enzymes and 
substrates) to form extended complexes with the activated ErbBl receptors in 
order to subsequently activate and propagate signalling pathways that eventually 
result in the promotion or inhibition of different gene transcription programs.
Simultaneous activation of multiple linear pathways is common after EGF 
stimulation ’ ’ and Figure 3.3 is a simplified diagram of some of the identified 
signalling pathways that are activated by ErbB 1. The mitogen activated protein 
kinase (MAPK) pathway is activated in response to ErbB 1 binding to the adapter 
protein Grb2 either directly or indirectly through Src homology and collagen 
binding protein (She)41, 60’ 61. Relocation of Grb2 and son of sevenless (SoS) 
complexes to the membrane facilitates activation of the serine/threonine kinase 
Ras by SoS. The MAPK pathway is an example of a kinase cascade in which 
activated kinases phosphorylate and activate multiple kinases in the next step of 
the cascade, producing an amplification of the signal. Activated MAPK is also 
able to dissociate GrbB2/SoS complexes through SoS phosphorylation providing 
a negative feedback mechanism to control the cascade.
Grb2 also mediates interaction of the protein Cbl with ErbB 1. Cbl adds ubiquitin 
molecules to ErbBl targeting these receptors for degradation upon endocytosis 
instead of recycling back to the membrane62. Consequently this interaction is 
considered one of the most important negative regulators of ErbBl activity63.
Activated ErbBl also directly and indirectly activates kinases and phosphatases 
involved in pathways that alter phospholipid metabolism such as 
phosphatidylinositol-3-kinase (PI3K) and phospholipase C-y (PLC-y). Both of 
these enzymes can produce activation of protein kinase C (PKC) which requires 
Ca2+ and the cofactor 1,2-diacylglycerol (DAG)40. PLC-y catalyses the hydrolysis
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of Ptdlns(4 ,5 )-P2 (PIP2 ) into inositol 1,3,5,-triphosphate (IP3 ) and DAG. IP3 
mediates the release of Ca2+ from intracellular stores facilitating PKC activation. 
PKC itself can bind to the juxtamembrane region of ErbB 1 and phosphorylate a 
threonine residue (Thr-654)64 causing an inhibitory effect on ErbB 1 activity and 
the loss of high affinity for EGF65. ErbBl stimulation of PI3K also activates a 
cell survival pathway mediated by the enzyme Akt41.
factors
Figure 3.3 Some of the signalling networks that are stimulated by activation of 
ErbBl receptors. Black lettering denotes adapter proteins and blue lettering 
denotes enzymes involved in signalling cascades. Black arrows represent 
associations that produce positive effects such as protein phosphorylation or 
production of secondary messengers. Red arrows represent inhibitory effects.
The vast majority of additional complexity due to cross-talk between signalling 
pathways, protein translocation throughout the cell, the formation of different 
signalling complexes and positive and negative feedback loops is ignored in 
figure 3.3. For example calcium release allows ErbBl activation to indirectly 
activate calcium dependent pathways such as NFkB6 6  and PKC is able to activate
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components of the MAPK and JNK pathways41. ErbBl is also known to interact 
with the actin and EGF stimulation causes rearrangement of the actin 
cytoskeleton mediated by substrates of the kinase c-Src68. ErbBl and Src share 
many substrates (such as PI3K) making it difficult to ascertain whether they are 
stimulated directly or indirectly by ErbBl41. Enzymes normally associated with 
cytokine receptor activation such as ST AT and JAK kinases are also known to 
associate with ErbBl41.
3.6 The influence of plasma membrane properties upon ErbB 
signalling
The plasma membrane is an inhomogeneous two-dimensional bi-layer system 
comprising of distinct localised microenvironments dictated by the distribution 
of different proteins and several types of lipids that make up the membrane69. 
The plasma membrane is an environment that is very distinct to that experienced 
by proteins in three-dimensional crystals, highlighting the important role played 
by cell based methodologies such as fluorescence imaging and FRET to provide 
complementary structural information in the plasma membrane. ErbB 1 has been 
observed in both caveolae and so called ‘lipid rafts’ - microdomains with 
decreased fluidity due to increased cholesterol and sphingolipid content70, 71. 
However, ErbB 1 is not exclusively associated with either of these microdomains 
and is randomly distributed at the plasma membrane72. Depletion of cholesterol 
from cell membranes results in an increase in surface EGF binding and an 
increase in ErbBl phosphorylation73, 74. This observation was made under 
conditions that inhibit phosphotyrosine phosphatases and under which receptor 
trafficking cannot occur indicating that the apparent increases in tyrosine kinase 
activity and available cell surface ErbBl are not due to a change in the rate of 
ErbB 1 dephosphorylation or translocation of extra ErbB 1 to the membrane from 
an intracellular source73. This suggests that depletion of cholesterol releases 
ErbBl receptors from the lipid raft environment which normally has an
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inhibitory effect on ErbBl binding and tyrosine kinase activity73’ 7 5 but this 
doesn’t appear to change the affinity of ErbBl for ligand72,73.
Three types of electric potential are associated with cell plasma membranes 76. 
Proteins contain many areas of charge density that allow them to interact with 
these electric potentials. In a resting state, the concentration of metal ions (for 
example Ca2+, K+, Na+ etc.) within a cell is strictly controlled so that there is a 
potential difference across the plasma membrane which varies with cell type and 
is commonly referred to as the membrane potential77. The associated chemical 
gradients are also exploited by the cells to regulate crucial cellular functions. For 
example, activation of PLC-y by ErbB 1 results in the production of IP3 and a 
release of Ca2+ from intracellular stores. Additionally, there is an influx of Ca2+ 
from outside the cell through voltage-independent calcium channels in response 
to EGF binding to low affinity ErbBl48,52. The result of this wave of calcium 
ions is to cause a transient increase in [K+] through activation of K+ channels. 
This causes a transient hyperpolarisation of the cell membrane78,79'. The increase 
in [K+] is only transient as PKC concurrently activated by Ca2+ downregulates K+ 
channel activity52.
There is also evidence that negatively charged regions at the surface of the 
ErbB 1 kinase domain and juxtamembrane regions bind electrostatically to acidic 
lipids in the inner leaflet of the plasma membrane80. This would provide a 
mechanism for the autoinhibition of the kinase domain. It has been proposed that 
this inhibition is removed by the binding of Ca2+/calmodulin (Ca2 +/CaM) 
complex to the juxtamembrane region81,82, causing a reversal of the net charge of 
the juxtamembrane domain that repels the intracellular region from the 
negatively charged inner leaflet80. Evidence that this mechanism may contribute 
to inhibition of ErbB 1 activity comes from a reduction in the initial rate of ErbB 1 
phosphorylation upon ligand binding81 and an increase in ErbBl activity in the 
absence of ligand in response to membrane permeable bases (sphingosine) and 
increased salt concentrations83.
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It is also interesting to note that this electrostatic interaction with the membrane 
can sequester PIP2 84, the precursor of PKC activating DAG and IP380. PKC 
phosphorylation of Thr654 inhibits calmodulin binding to the ErbBl 
juxtamembrane region8 5 and calmodulin has been observed to interfere with 
MAPK signalling and transactivation of ErbBl by PKC86. How the interplay 
between PKC and CaM might regulate ErbB 1 signal transduction has yet to be 
investigated.
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Figure 3.4 The electrostatic engine model for ErbB autoinhibition, a. Positively 
charged regions of the intracellular domain (red) interact electrostatically with 
negatively charged components of the plasma membrane inhibiting interactions 
between intracellular domains, b. Binding of Ca2+/CaM to the juxtamembrane 
region of the receptor causes the intracellular domains of the receptors to be 
repelled from the membrane, allowing them to interact.
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3.7 ErbB receptor trafficking
Although ErbB family members are predominantly localised at the cell surface, 
they are constantly trafficked to endosomes before being recycled back to the 
membrane87. The redistribution of membrane proteins within the cell is regulated 
by the presence or absence of motifs in their intracellular domain. ErbBl 
undergoes rapid endocytosis upon ligand binding8 8 and notably it is the only 
member of the ErbB family that does so89. Multi-ubiquitination of ErbBl by the 
protein Cbl is known to target ErbBl for destruction in lysosomes9 0  but only 
after disassociation of Cbl from the complex91.
There are two routes of receptor mediated endocytosis that act in parallel on 
different constituents of the membrane -  through clathrin coated vesicles and 
through lipid raft based caveolae92. Upon stimulation with a low dose of EGF 
ErbB 1 is efficiently endocytosed through the clathrin mediated pathway9 2 "9 5  and 
ErbBl recruitment to lipid rafts has been observed in response to ligand96. In 
response to a high dose of EGF, ErbB 1 internalisation proceeds mainly via the 
non-clathrin mediated route93. In the absence of ligand protein kinase A (PKA) 
activity appears to play a part in ErbB 1 avoidance of internalisation9 7  with PKA 
activity being reduced by activated ErbB 1. In contrast, protein kinase C (PKC) 
phosphorylation of ErbB 1 Thr654 enhances ligand induced internalisation, but 
prevents transport of receptors to lysosomes instead targeting them for recycling 
back to the plasma membrane98.
EGF dissociates from ErbBl at endosomal pH (~pH 5) and initially it was 
thought that the sole purpose of ligand induced internalisation was to desensitise 
the receptor to ligand (downregulation)87, " , but there is also evidence that 
receptors continue to signal in endosomes60, 100'102. ErbBl internalisation also 
serves to alter the availability of signalling substrates over time and different 
signalling outcomes result from receptors at the membrane and in endosomes100’ 
ioi, 1 0 3 defective downregulation of RTKs has been repeatedly implicated in 
the oncogenic transformation of cells63. ErbB 1 with a disruptive mutation to its 
only site of direct cbl binding produces stronger mitogenic signals than wildtype
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ErbBl99’ 104. In order to observe activated ErbBl receptors at the plasma 
membrane ligand-induced internalisation must be prevented. Ligand-induced 
internalisation occurs within minutes at 37°C, but can be slowed by reducing the 
temperature. At 4°C ligand induced internalisation of ErbB 1 is almost 
completely inhibited5 8  without preventing receptor activation upon ligand 
binding57’105.
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4 Design and commissioning of a multicolour confocal 
microscope for in situ  determination of membrane 
protein structure
This chapter describes the building, implementation and commissioning of a 
fluorescence microscope for making quantitative FRET measurements in cells. 
The microscope was built for the particular purpose of investigating the three- 
dimensional structure of membrane protein complexes and was used to develop 
the method described in chapters 5 and 6 . Optical sectioning is important to 
reject background fluorescence and ensure that the fluorescence signal used to 
determine FRET comes from the cell membrane. The method for protein 
structure determination involves measuring FRET between proteins specifically 
labelled with FRET donors and either (i) acceptor labelled proteins or (ii) 
acceptor labelled membrane. In (ii) the FRET efficiency is a function of acceptor 
density as well as donor-acceptor separation (discussed in Chapter 5.3) so FRET 
measurement by monitoring the reduction in donor fluorescence lifetime with 
fluorescence lifetime imaging microscopy (FLIM) is preferred to intensity based 
FRET imaging. As video rate imaging is not required, FLIM was implemented 
with TCSPC and laser scanning confocal microscopy. Multi-colour capability is 
required to identify cells co-labelled with multiple fluorescent dyes and to 
quantify FRET between donors and multiple acceptors.
The theory of optical sectioning with a confocal microscope is discussed along 
with the factors influencing the choice of individual components of the 
microscope. The optical layout and characteristics of the multi-dimensional, 
multi-colour microscope are outlined. The multi-colour sectioning capability of 
the microscope is demonstrated by simultaneously imaging members of the ErbB 
family of membrane receptors in cells that are labelled with different fluorescent 
probes. Finally the FLIM-FRET capability of the microscope is tested in cells 
expressing a diagnostic fluorescent protein consisting of a donor and acceptor 
linked by a short amino-acid sequence.
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4.1 O ptical sectioning and confocal microscopy
4.1.1 Optical Sectioning Techniques
A standard widefield optical microscope possesses poor axial resolution and 
consequently has weak sectioning ability. The resulting background fluorescence 
is disadvantageous for methods such as lifetime imaging that seek to quantify 
fluorescence properties and localise them to a specific volume of the sample. A 
number of techniques are commonly employed to obtain optical sectioning of 
fluorescent samples including confocal microscopy, multiphoton microscopy and 
structured illumination microscopy.
The image produced by a microscope is a convolution between the object and the 
microscope point spread function (PSF)1.
image(x,y,z) = Object(x,y,z)® PSF(x,y,z) Eqn. 4-1
Where the lateral axes x, y  define the plane perpendicular to the optical axis of 
the microscope (z). The PSF is the image produced by the microscope of a point 
object and indicates how the optical system blurs the object during the imaging 
process. The PSF of a microscope is the product of the PSFs for illumination and 
detection of a point object.
Confocal microscopy achieves optical sectioning by restricting the excitation and 
detection PSFs to a small diffraction limited volume that is raster scanned over 
the focal plane to acquire a digital image one pixel at a time. Multiphoton 
microscopy works in a similar manner except the excitation and detection PSFs 
are restricted to the focal plane (maximum excitation power) by non-linear 
excitation of fluorophores with multiple photons of energy lower than the 
excitation transition2. Widefield structured illumination takes a different 
approach. By imaging a repeating pattern of equally spaced lines onto the 
sample, the lateral spatial frequencies transmitted by the microscope are
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modulated with the frequency of the structured illumination . The image of the 
sample from the focal plane can be retrieved from three separate images with the 
structured illumination placed at three different positions4.
All three approaches have their advantages and disadvantages for different 
fluorescence imaging applications. Confocal fluorescence microscopy is a 
dependable technology that utilises visible wavelengths of light to excite 
fluorophores and can be used with many commercial lasers or relatively 
inexpensive diodes. Multiphoton excitation requires expensive, pulsed infra-red 
lasers to produce the high energy densities required but requires no confocal 
pinhole to reject out of focus light providing the advantage of increased detection 
efficiency. Reduced scattering of lower energy photons improves the depth to 
which a sample can be sectioned, but the reduction in photodamage often 
attributed to multiphoton imaging is still under debate5-8. Both confocal and 
multiphoton microscopies suffer from long acquisition times due to the point 
scanning nature of the techniques although video frame rates can be achieved 
with expensive kHz scanning mirrors, multi-aperture scanning methods such as 
Nipkow discs9 or scanned line illumination. It must be noted that all three 
techniques also provide an improvement in lateral resolution over widefield 
microscopy, although in the case of the structured illumination method 
considered above this is only in the direction perpendicular to the direction of the 
illumination line structure10. Programmable array microscopes (PAMs) use a 
spatial light modulator (either a digital micromirror array or liquid crystal layer) 
to produce an arbitrary illumination (and/or detection) pattern and image the 
response on a CCD11-13. PAMs can utilise the most appropriate sectioning 
technique for a given experiment with fast image acquisition rates without the 
need for macroscopic moving parts14.
It must be noted that all of these techniques also provide an improvement in 
lateral resolution over widefield microscopy, although in the case of the 
structured illumination method this is only in the direction perpendicular to the 
direction of the lines imaged onto the sample10.
1
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4.1.2 Single Point Confocal Microscopy
The basic principle of confocal microscopy is displayed in figure 4.1. The 
illumination on the sample is confined to a diffraction limited spot and a pinhole 
confocal to this spot suppresses light from out of focus regions of the sample.
A digital image of a section through the sample can be formed one pixel at a time 
by either scanning the sample through the focal point or scanning the focal point 
over the sample. This requires computer control of the scanning method in order 
to ensure that the detector output is attributed to the correct pixels. The use of 
infinity optics makes it possible to obtain stacks of optical sections by altering 
the axial position of the objective with respect to the sample. These can be used 
to produce three-dimensional reconstructions of samples.
Figure 4.1 The principle of confocal microscopy. A point light source and a 
pinhole are confocal with the focal point of the objective. Light from outside the 
focal plane will form an extended disc in the plane of the pinhole, preventing the 
majority of out of focus light from reaching the detector (dotted lines).
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4.1.3 Resolution of confocal fluorescence images
The image formed of an incoherent point source by an imaging system will be an 
Airy disc, which is the Fraunhofer diffraction pattern of a circular aperture and 
proportional to the square of the Ji Bessel function15. The Rayleigh criterion is a 
commonly used measure of the resolving power of an imaging system and states 
that two incoherent point sources of equal intensity will be just resolved when 
the centre of one Airy disc coincides with the first minimum of the second Airy 
disc15. The distance from the centre of an Airy disc to the first minimum Lo then 
defines the lateral resolution of the imaging system. For an objective lens with a 





In confocal microscopy, the illumination PSF is the size of the focal spot 
produced by the objective and both this and the detection PSF are determined by 
the NA of the objective. The overall PSF for identical excitation and detection 
wavelengths is
PSF„f = \P S F j  Eqn, 4-3
The position of the first minimum will remain the same despite the fact that the 
full width at half maximum (FWHM) of the confocal PSF is smaller than that of 
the excitation PSF, making direct application of the Rayleigh criterion 
inappropriate. However, a reasonable approximation can be made to relate it to 
the FWHM of the PSF of an imaging system1
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Eqn. 4-4
Using the approximation in Eqn. 4-4 and further approximating the central peak 
of the PSF to a Gaussian distribution, it can be shown that the FWHM of the 
lateral confocal PSF, FWHM^onf is related to that of the lateral excitation PSF 
by
FW H M  * L0
FWHMLconf v ^ F W H M i ,  0 6U ej 
~ n a 4 i
Eqn. 4-5
However, when dealing with fluorescent samples, the detected light is of a longer 
wavelength than the illuminating light due to the Stokes shift and the 
illumination and detection PSFs are different. Then FWHM1: ,  becomes





where /? is the ratio of the excitation and detection wavelengths, /? = Aex / /Ldet . 





FWHMzconf — = = F W H M l
V i+ ^ yll + j32 U^l)
2nA„ Eqn. 4-8
where n is the refractive index of the object medium. It should be emphasised 
that these are only approximations for the lateral and axial resolutions of a 
confocal microscope. However, they are useful to estimate the digital image 
resolution required to avoid undersampling and the introduction of artefacts into 
the image. Nyquist’s sampling theorem which pertains to the discrete sampling
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of continuous signals states that the sampling frequency should be at least twice 
the maximum frequency in the signal in order to accurately reconstruct the 
signal1, 16. In practice the maximum lateral spatial frequency in the scanned
17confocal fluorescence signal is set by the lateral resolution of the microscope 
given by Eqn. 4-6. Hence to fulfil the Nyquist criterion the size of each pixel Px 





For a given wavelength of excitation and emission only one pixel size and hence 
only one digital ‘zoom’ magnification will fulfil this criterion. It also follows that 
for simultaneous multi-colour excitation and detection the pixel size can only be 
set to fulfil this criterion for one fluorophore and images of the others will either 
be slightly under- or oversampled. By fulfilling Eqn. 4.9 for the fluorophore with 
the shortest wavelength excitation and emission images of all other fluorophores 
will be oversampled which will ensure faithful image reproduction at the expense 
of increasing photobleaching and reducing the size of the scan area.
4.1.4 Aberrations in image forming systems
Geometric optics treats light as rays that propagate through an optical system 
obeying the laws of reflection and refraction. This is also known as first order or 
Gaussian theory and assumes that the angle light rays make with the optical axis 
are infinitely small, allowing the following simplifying identity to be used
s i n # » #  Eqn. 4-10
This is known as the paraxial approximation and allows the derivation of the 
Gaussian formula for thin lenses
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where /  is the focal length of the lens, n\ is the refractive index of the lens 
material, and R\ and R2 are radii of curvature of the two lens surfaces.
Aberrations are deviations of the image formed by an optical system from the 
image expected from Gaussian ray-tracing. They can be split into two categories: 
monochromatic and chromatic. Monochromatic aberrations are a consequence of 
the breakdown of the paraxial approximation for rays entering the entrance pupil 
of the optical system at larger angles and occur independently of the wavelength 
of the propagating light. Chromatic aberrations arise because the refractive 
indices of lens materials are wavelength dependent. Both kinds of aberrations are 
discussed in the following two sections as well as ways in which they can be 
minimised.
= («, -  l)yo Eqn. 4-11
/ R, R2 y
4.1.4.1 Monchromatic Aberrations
There are five primary monochromatic aberrations; spherical (SA), coma, 
astigmatism, field curvature and distortion. These are displayed in figure 4.2.
Spherical aberration arises because a wide beam of rays incident on a lens 
parallel to the optical axis is not brought into focus at a unique point. This is 
shown in figure 4.2a. Incident rays hitting the lens further from the optical axis 
are focused to a point closer to lens than the paraxial focal point. Longitudinal 
spherical aberration is the separation of the focal point of a ray and the paraxial 
focus along the optical axis. The traverse SA is the height at which a ray crosses 
paraxial focal plane. The circle of least confusion exists in the plane where the 
traverse spherical aberration is minimised. The effect of SA on the image of a 
point object is to transfer intensity from the central peak of the airy disc into the 
surrounding rings. The SA of a single plano-convex lens can be minimised by
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Figure 4.2 The five primary aberrations (monochromatic), a. Spherical, b. 
Coma. c. Astigmatism, Ft and Fs are the focal points of tangential and sagittal 
rays respectively, d. Field curvature, e. Distortion.
Coma is named after the comet like appearance of the image of a point object 
located just off the optical axis. As can be seen in figure 4.2b, oblique rays from 
an off-axis point are not imaged at a single point. Coma is dependent upon lens 
shape and can be made exactly zero for a single lens at a given object distance. 
The shape of this lens is nearly convex-piano, the lens configuration that also 
minimises SA.
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Astigmatism affects the imaging of objects that are away from the optical axis 
and arises from rays striking a spherical lens asymmetrically. Unlike the other 
panels in figure 4.2, figure 4.2c is drawn in perspective in order to display two 
orthogonal planes. The tangential plane contains the optical axis and the object. 
The sagittal plane is perpendicular to the tangential and also contains the optical 
axis. All rays outside of the tangential plane are referred to as skew rays 
(including those in the sagittal plane). Rays from the tangential and sagittal 
planes are brought to focus at different points. The distance between the two 
focal planes is referred to as the astigmatic difference. Objects on the optical axis 
have an astigmatic difference of zero due to the symmetry of tangential and 
sagittal rays incident upon the spherical lens.
In the absence of the above monochromatic aberrations, an optical system will 
form images of point objects that are on and off the optical axis. However, non- 
paraxial rays are imaged upon a curved Petzval surface. Consequently if the 
image is formed onto a flat plane then the centre of the image will be in sharp 
focus but the edges will be blurred. A combination of positive and negative lens 
can correct for field curvature.
The final monochromatic aberration is distortion. Distortion arises when the 
magnification of the optical system is a function of the off-axis image distance. 
This arises from different areas of a lens having different focal lengths and hence 
different magnifications. The effect of distortion is a misshapen image despite all 
points being in focus.
4.1.4.2 Chromatic Aberration
The refractive index of a material is a function of the wavelength of light 
propagating through it, an effect known as dispersion. Consequently the focal 
length of a lens is also wavelength dependent and rays of different wavelengths
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will propagate through an optical system along different paths. This is shown in 
figure 4.3a.
Positive and negative lenses with different dispersions can be combined to 
produce a system that minimises chromatic aberration at two or more 
wavelengths. Such compound lenses are called achromats.
Figure 4.3 a. Chromatic aberration in a single lens. The focal points of blue 
(solid lines), yellow (dashed lines) and red (dotted lines) light (Fb, Fy and Fr 
respectively) are marked, b. The focal points of the same wavelengths 
propagating through an achromatic doublet.
Two lenses separated by a distance d  have a combined focal length fc  that is 
related to the individual focal lengths f  and/2 by
f c
_L _L d
~ / i + / 2 f f 2
Eqn. 4-12
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As f\  and 7 2  are functions of rt(A) (equation 4.11) f c is also a function of 
wavelength of light propagating through it. If the two lenses in combination are 
to bring two specified wavelengths Aa and 7  to a common focus
1 _ 1
f C X a f c x b
Eqn. 4-13
by combining Eqns. 4.11 and 4.12 to obtain expressing for the combined focal 
lengths and substituting them into Eqn. 4.12 for the condition d=  0
P\ _ nixa nixb 
Pi n\xa ~ n\xb
Eqn. 4-14
A third wavelength Xc can be used to specify reference values for the focal 
lengths of the two lenses
7 -  +  7 -  =  (nUc -1  )a  +  [n2Xc
J \ X C J 2XC
which can be rearranged to give
Eqn. 4-15
Pi  _  (n2Ac j j  f l X c 
Pi ^P \X C ~  0  f \ X c Eqn. 4-16
Equating equations 4.14 and 4.16
fixc
f\xc
( n 2Xa - n 2Xb ) / { n 2Xc " I )
(«ua - « iaJ /( « uc - 1)
Eqn. 4-17
The dispersive powers of the two lenses are given by
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n \Xa n \Ab 
nu -1
and n T-K n 2 Ab
« 2 2  " I
Eqn. 4-18 and Eqn. 4-19
and their reciprocals V2 and V\ are known as the dispersive indices of lenses. As 
V2 and V\ are always positive, one of the lenses must have a negative focal length 
to satisfy
f\xc Kxc + f i \ c V2xc — 0 Eqn. 4-20
Fraunhofer lines are commonly used to provide precise reference values across 
the spectral range. For visible wavelength achromats, the C, F  and D3 Fraunhofer 
lines are used which correspond to wavelengths of 656.2816 nm, 486.1327 nm 
and 587.5618 nm respectively. A dispersive index calculated for these 
wavelengths is commonly designated Vd. For two lenses made with materials 
with dispersive indices V\d and V2d, equations 4.20 and 4.12 can be solved 
simultaneously to determine the individual focal lengths required to produce the 
desired compound focal length. Other factors to be considered include the 
avoidance of small individual focal lengths that would require highly curved 
lenses and the minimisation of monochromatic aberrations.
In such an achromatic doublet only the wavelengths of the C and F lines share 
the same focal point and the D3 wavelength serves as a reference only. This and 
all other intervening wavelengths do not have a common focus and the residual 
chromatic aberration is known as the secondary spectrum of the achromat. It is 
possible to produce triplets that bring three or four wavelengths to a common 
focus and exhibit reduced secondary spectra, but these require the use of calcium 
fluorite which is currently more expensive than other lens materials.
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4.1.5 The components of a Confocal Microscope
This section provides an overview of the important components of a confocal 
microscope and the considerations that informed the choice of individual 
components of the microscope described in section 4.2.
4.1.5.1 Scanning the focal spot
The concept of a point scanning microscope was outlined by Young and Roberts 
in 195118, and a confocal microscope had been developed by Minsky in 195519. 
However, confocal microscopy was neglected as a research tool for almost thirty 
years until fluorescent labelling emerged as a key technique in biological 
imaging . The first confocal microscopes developed for biological imaging were 
based on a sample scanning system where the focal point of the objective is static 
and the entire sample stage is raster scanned21,22. Although sample scanning has 
the advantage of a static optical arrangement that is free from off-axis optical 
aberrations, scanning speeds are slow due to the large mass that must be scanned 
and the forces involved in moving the sample can cause living samples 
suspended in solution to distort23. Laser scanning methods where the sample is 
stationary and the focal spot is scanned are now used in most modem confocal 
microscopes20.
Close coupled scanning mirrors are employed only for scanning the focal spot 
over the imaged area, while large scale movement between different sample 
areas is accomplished with a translating microscope stage. Figure 4.4 shows the 
optical arrangement required to produce nearly distortion free scanning using 
close coupled scanning mirrors20. A simple telescope arrangement was 
implemented to ensure that the raster scanning of the mirrors was translated into 
a rotation of a collimated excitation beam about the back aperture of an infinity 
corrected objective. Infinity corrected objectives allow optical components to be 
placed in the light path of the microscope without introducing additional 
aberrations. This produces raster scanning of the focal spot in the focal plane.
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The degree to which the beam is scanned off-axis is exaggerated in Figure 4.4 for 
clarity, but efforts must still be made to reduce off axis aberrations in the scan 
optics. The beam will still undergo a small amount of translation across the 
objective back aperture as the mirrors scan, but by ensuring that the beam 
overfills the back aperture inhomogeneous excitation of the imaged area can be 
avoided. Commercial microscopes often solve this problem without discarding 
excitation illumination by using a hemispherical mirror system that accomplishes 
perfect translation of mirror scanning to beam rotation about the objective back 
aperture20. Fluorescence (or reflected light) is collected by the same objective 
and is de-scanned by the scanning mirrors allowing a stationary confocal pinhole 
to be used.
Figure 4.4 The scanning of laser focal point using close-coupled scanning 
mirrors and an infinity corrected objective. The excitation beam (blue) is 
reflected to the first scanning mirror by a dichroic beam splitter. The beam is 
then reflected in the direction out of the page to the second scanning mirror that 
redirects the beam to the scan optics and the objective. Rotation of the scanning 
mirrors about the dotted red axes produces raster scanning of the focused laser 
spot in the focal plane. Fluorescence emission (green) is collected by the same 
objective and de-scanned by the scanning mirrors before passing through the 
beam splitter and along the detection optical path.
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Scanning mirrors are not the only way to implement laser scanning confocal 
microscopy. Multiple focal spots can be used to acquire pixel intensities in 
parallel using a Nipkow disc24. The disc contains a spiral pattern of pinholes such 
that every point in the imaged area receives an identical amount of illumination 
as the disc is spun. A second rotating disc is placed between the objective and the 
dicroic beam splitter to provide the necessary confocal pinhole for each 
excitation pinhole on the first disc. The original Nipkow disc design has been 
improved by the use of microlenses that increase the light efficiency through the 
discs by focusing light through the second disc pinholes9. The benefit of multi­
point confocal systems is that they are capable of faster real-time image 
acquisition but may suffer from cross-talk between pinholes. Line scanning can 
also be employed to increase the speed of image acquisition and is used in the 
commercially available Zeiss LSM 5 LIVE. However, the benefits of line 
scanning can only be realised with the use of a line CCD as a detector. Figure 4.5 
compares these two different methods of parallel pixel acquisition.
Programmable array microscopes (PAMs) are a class of microscopes 
characterised by the use of digital nicromirror devices (DMD) or liquid crystal 
layers to produce arbitrarily modulated illumination and/or detection patterns. 
This provides PAMs with the flexibility to perform optical sectioning in many 
ways; scanning multi-aperture patterns in a manner similar to Nipkow disc 















Figure 4.5 Two methods of parallel pixel acquisition in confocal microscopy a. 
Nipkow disc confocal microscopy. Only one beam is shown passing through the 
discs for clarity, b. Line scanning confocal microscopy.
4.1.5.2 Objectives for confocal microscopy
The objective is among the most important components in a confocal microscope 
as it both focuses the excitation light onto the sample and collects the light that is 
detected. Confocal microscopy forms a digital image and an increase in 
magnification is achieved by sampling a smaller area with the same number of 
pixels. This ‘digital zoom’ is limited by the microscope resolution which depends 
upon the NA of the objective and is discussed in greater detail in section 4.1.3. In 
order to maximise the confocal resolution high NA oil or water immersion
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objectives (NA > 1.3) are used. These objectives are designed to minimise 
aberrations introduced by refractive index mismatch when they are used with 
sample coverslips of the correct material and thickness. When using coverslips it 
is also important to ensure that the coverslip thickness does not exceed the 
working distance of the objective (the separation of the objective and the focal 
plane).
4.1.5.3 The confocal pinhole
The confocal pinhole is responsible for reducing the sensitivity of the microscope 
to detecting out of focus light. The size of the pinhole compared to the image of 
the Airy disc formed before the detector determines the sectioning strength and 
the improvement of lateral resolution over widefield microscopy of the confocal 
microscope. Smaller pinholes will improve the lateral resolution at the expense 
of the detected signal level. The maximum pinhole size that does not cause a 
reduction of the axial resolution is 65% of the diameter of the Airy disc1. The 
pinhole size that produces the greatest possible increase in lateral resolution 
results in a signal level 5% of the maximum possible26. Most implementations of 
confocal microscopy use pinhole sizes that offer minimal improvement in lateral 
resolution, but guarantee optical sectioning with good signal to noise ratio.
4.1.6 Optical sectioning with fluorescence lifetime imaging 
microscopy (FLIM)
Fluorescence lifetime imaging microscopy involves the measurement of the 
characteristic lifetime of the fluorescent light that contributes to each pixel in a 
fluorescence image. As discussed in chapter 2.2.2, the fluorescence lifetime of an 
ensemble of fluorescent molecules can be obtained via time-domain or 
frequency-domain measurements.
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Confocal and multiphoton microscopies can be combined with either time- or 
frequency-domain lifetime imaging27, 28. As each image pixel is acquired 
separately they are particularly suitable for combination with TCSPC29'31. 
TCSPC requires fast PMTs that give rise to narrow instrumental responses and a 
pulsed excitation source, but the rest of the TCSPC electronics may be treated as 
a separate module that replaces the scanned image acquisition system. There are 
currently two major commercial suppliers of TCSPC modules for scanning 
microscopes: Becker-Hickl GmbH and Picoquant. The requirement of low 
excitation powers for TCSPC to avoid biasing photon density distributions to 
shorter arrival times (through pile-up) can result in long acquisition times30. The 
total acquisition time required to record sufficient photons in each pixel for 
fitting the data to multi-exponential models is dependent upon the number of 
pixels and the count-rate of photon arrivals at the detector. As a general rule at 
least 1000 photons should make up the photon density distribution for accurate 
fitting to a multi-exponential decay model29, 30 and acquisition of a lifetime 
image fulfilling this criterion can take minutes even at count-rates as high as 
106 s'1. However, it is often preferred to other methods because of its accuracy 
and because low-intensity of illumination conditions are beneficial for 
minimising the photobleaching of samples. TCSPC benefits from nearly ideal 
counting efficiency conferring an advantage when imaging weakly fluorescent 
samples27,32.
Widefield sectioning allows much faster acquisition of sectioned images than 
point scanning methods. In order to maintain this advantage, widefield FLIM 
systems have previously utilised time-gating to obtain lifetime images and 
widefield optical sectioning by structured illumination has been integrated with 
time-gated detection on a standard widefield microscope4. A recently developed 
wide-field photon-counting detector now makes it possible for microscopes 
capable of multi-aperture illumination and detection to take advantage of 
TCSPC33. A DMD based PAM has been combined with a modulated image 
intensifier based FLIM system14 and Nipkow disc confocal microscopes have 
been adapted for frequency domain34 and time-gated FLIM35.
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4.2 Implementation of a multi-dimensional, multi-colour laser 
scanning confocal microscope
Figure 4.6 displays the components of a multi-dimensional, multi-colour 
confocal microscope that achieves laser beam scanning with close-coupled 
scanning mirrors.
The design was implemented using a Zeiss Axiovert 135 inverted microscope as 
sample stage. Three different laser beams are input into the optical path via 
optical fibres and combined before being sent to the objective. The use of optical 
fibres allows laser sources to be located on a separate optical table to avoid 
introducing mechanical vibration to the microscope. The laser sources can also 
be shared with other microscopes. The returning fluorescence emission is split by 
wavelength and the output of the detectors can be sent to a either the confocal 
image acquisition system (4C’s Enterprises, Somerset UK) or a TCSPC lifetime 
imaging system (Becker-Hickl GmbH).
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Dichroic beam splitters
Figure 4.6 A multi-dimensional, multi-colour laser scanning confocal 
microscope. The upper part of the diagram consists of components that are in the 
optical layout placed on an optics bench. All other components are involved in 
scanning mirror control and data acquisition. Neither the scan optics or the 
objective and sample temperature control components are shown.
Table 4.1 lists the laser sources available for input into the microscope.
The design of the microscope allows for all three detector outputs to be routed to 
the Becker-Hickl TCSPC lifetime imaging system so that three lifetime images 
can be simultaneously acquired31. However, the Ti: Sapphire laser system that 
was used for the FLIM/FRET measurements of in situ ErbBl structure can only 
excite a sample with pulsed excitation one wavelength at a time. An upgrade is 
currently underway to utilise a recently purchased supercontinuum laser source 
(Fianium) that will make full use of the colour versatility of this confocal 
microscope. The PMC-100 detectors are preferred for lifetime imaging as they 
yield an instrument response function with a much shorter width (< 200ps) than 
standard PMTs.
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520 -  640 408 (Maximum 
achieved at 545 
nm)






400 -  500 107 (Maximum 
achieved at 440 
nm)
100 fs pulses, 76 
MHz repetition 
rate
PTIIQ4C 445 445 25 Continuous Wave 
(CW)
Melles Griot 35- 
LAL-415 Ar+
488 145 cw
NLC 800GL 514 100 CW
LCS-DTL-317 532 50 cw
PTI IQ4C 639 639 17.5 cw
Table 4.1 Available laser sources for single photon excitation of visible 
wavelength fluorescence dyes
Sections 4.2.1 -  4.2.3 describe; the optical layout, confocal scanning control and 








Figure 4.7 Optical layout of a confocal microscope with three excitation inputs 
(Exl -  3) and three emission pathways (Eml -  3). Optical fibres input each 
excitation beam into a spatial filter and the beam width is controlled with two 
plano-convex lenses (A and B). The layout contains five dichroic beam splitters 
that can be swapped to accommodate different combinations of fluorescence 
excitation and emission wavelengths. Four of these beam splitters (BS1 -  4) 
serve to combine excitation wavelengths or split emission wavelengths. The fifth 
is the main dichroic beam splitter (MBS) that separates the excitation and 
emission paths. Between the MBS and the objective multiple excitation and 
emission wavelengths are present in the optical path. Achromatic doublet lenses 
are used in positions along this section to minimise chromatic aberrations. EF1 -  
3 are emission filters placed before the detector pinholes. All detection pinholes 
are 50pm in diameter and placed before a 100mm tube lens.
The three optical fibre inputs (Exl -  3) are a single-mode, multi-mode and 
single-mode fibre respectively. The divergent light exiting each fibre is 
collimated before being passed through a spatial filter to guarantee a beam with a 
Gaussian profile. Two steering mirrors are used to align each beam into the same 
excitation path and beam combination is achieved using suitable long pass beam
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splitters in positions BS1 and BS2. Flippable plane mirrors can also be used 
when a suitable dichroic mirror is unavailable and/or when simultaneous 
excitation with different wavelengths is not required to increase the efficiency of 
fluorescence detection. The width of the three beams is approximately matched 
by selecting combinations of spatial filter lenses A and B that expand the beams 
by the required amount. The beam widths can only be matched approximately 
due to restrictions imposed by the available standard focal lengths of plano­
convex lenses. Matching of beam widths ensures that the achromatic scan optics 
expand all three beams to fill the back aperture of the objective. Achromatic 
doublets with focal lengths of 100 mm and 150 mm (Thorlabs, AC264-100-A1 
and AC264-150-A1 respectively) form the scan optics. The residual chromatic 
focal shift of these two lenses calculated by ray-tracing software (Zeemax) is 
shown in figure 4.8. The scan optics acts as a 1:1.5 beam expander (although the 
residual chromatic focal shift of the achromats will result in minor differences 
between wavelengths) and the back aperture of the objective is 10mm in 
diameter. The beam width of the three beams entering the scan optics must be 
greater than 6.7 mm to fill the objective back aperture. The objective itself is a 
Zeiss Fluar 1.3 NA oil immersion objective. This objective was chosen for its 
high numerical aperture and high transmission of visible wavelengths which 
makes it particularly suited to photon counting applications with weakly 
fluorescent samples. Table 4.2 lists the details of the spatial filters.
Figure 4.8 Chromatic focal shift of the achromatic doublets used in the scan 
optics. Left-AC264-100-A1. Right -  AC264-150-A1.
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Excitation Optical Focal length / mm Expansion Final beam
Input fibre type A B factor width / mm
Exl Single mode 25.4 50.0 1.97 7
Ex2 Multimode 35.0 50.0 1.43 8
Ex3 Single mode 30.0 75.0 2.50 7
Table 4.2 Details of excitation inputs. Spatial filter lens A and B produce an 
expansion of the collimated beam exiting the fibre coupler. The focal lengths of 
A and B are chosen to produce three beams of approximately equal width.
Scanning of the beams is accomplished with GSI lumonics VM2000 scanning 
mirrors. To minimise aberrations, the resting positions of the mirrors when 
powered on are set so as to align the beams through the centre of the scan optics 
achromatic doublets. The system that controls the scanning mirrors and image 
acquisition is described in section 4.2.3.
The setup of the microscope is completely flexible in terms of the excitation and 
emission wavelengths that can be selected, requiring only an alteration of the 
relevant dichroic beam splitters and adjustment of spatial filters to compensate 
for any chromatic aberration in the plan-convex lenses. Combinations of 
fluorescent dyes that can be excited and imaged simultaneously in the 
microscope are, however, limited by the commercially available multi 
wavelength dichroic mirrors that are available to separate the excitation and 
emission paths at the MBS position. Two multi-wavelength dichroic beam 
splitters were found that can be used with the most commonly used combinations 
of fluorescent probes. These are designed for use with the dye combinations; 
CFP, YFP and Cy5 (61009bs, Chroma), and FITC, Cy3 and Cy5 (61005bs, 
Chroma) but are suitable for use with any probes with similar spectral 
characteristics. The transmission of these beam splitters as a function of the 





Figure 4.9 Transmission profiles of a. the Chroma FITC -  Cy3 -  Cy5 beam 
splitter b. the Chroma CFP -  YFP -  Cy5 beam splitter. Laser lines that coincide 
with regions of near zero transmission of each beam splitter are shown.




Main Beam splitter (MBS)
CFP -  YFP -  Cy5 FITC -  Cy3 -  Cy5
BS1 Nikon DM580LP Nikon DM580LP
BS2 Nikon DM455 LP Nikon DM51 OLP
BS3 Nikon DM51 OLP CHROMA Q555LP
BS4 CHROMA Q625LP CHROMA Q625LP
EF1 HQ 700/75 HQ 700/75
EF2 HQ 535/30 HQ 610/75
EF3 HQ 470/30 HQ 525/50
Table 4.3 Beam splitter and emission filter combinations for different 
combinations of fluorescent probes.
4.2.2 Sample Temperature Control
The microscope uses a Delta T4 dish system (Bioptechs) to control the 
temperature of cell samples. Cells are cultured in Delta T glass bottomed culture 
dishes which can be heated by applying an electric current to a thin film coating 
the underside of the glass. A thermocouple in contact with the underside of the 
glass surface completes a feedback loop which maintains the desired 
temperature. To obtain temperatures lower than the ambient room temperature, a 
cooling ring (Bioptechs) connected to a refrigerated water bath can be lowered 
into the Delta T dish.
In order to maintain the microscope objective at the same temperature of the 
sample an objective heating collar and an objective cooling collar (both 
Bioptechs) were attached to the objective. Nitrogen gas is flowed past the back 
aperture of the objective to prevent the formation of condensation.
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4.2.3 The ‘Confocalscope’ Image Acquisition system
The ‘Daresbury Confocalscope’ system that controls the GSI Lumonics scanning 
mirrors and converts detector output into intensity images was designed and built 
by 4C’s Enterprises (Somerset, UK). The system is based upon 4C’s Enterprises 
C-vision image analysis software running on a network of four Windows 2000 
PCs. Two PCs each contain an individual intensity data acquisition card and a 
third contains a lifetime imaging data acquisition card (discussed in the next 
section). A master PC controls the GSI Lumonics scanning mirrors and remotely 
handles the acquisition of intensity confocal images through the network. As 
such the system is currently capable displaying the confocal data from two 
detectors simultaneously as it is acquired in real-time. 128 x 128, 256 x 256 and 
512 x 512 pixel resolutions are supported. At the lowest pixel resolution an 
image can be scanned of a 65 x 65 pm area in 1.02 s facilitating the optimisation 
of confocal pinhole and lens positions, and the position of the objective in real­
time. A line profile through the centre of the image that updates in real-time can 
also be used to optimise the focus of the microscope. Additionally, the C-vision 
software allows intensity images to be displayed with a colour coded logarithmic 
scale for finding regions of interest in weakly fluorescent samples.
Intensities are generated by counting the number of photons that arrive at each 
detector while the excitation spot is scanning across a given pixel. The intensity 
imaging system operates separately to the lifetime imaging system discussed in 
the next section but the C-vision interface is capable of remotely operating the 
lifetime imaging software. A manual electronic switch (designed and constructed 
by Steve Davis at the STFC Daresbury Laboratory) is used to send detector 
signals to either the Confocalscope or lifetime imaging data acquisition cards. No 
external pixel clock is used to operate the scanning mirrors.
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4.2.4 Time-domain Confocal Fluorescence Lifetime Imaging 
Microscopy
The lifetime imaging capability of the microscope is provided by a Becker-Hickl 
SPC-730 TCSPC module. The module contains all the TCSPC electronics (CFD, 
TAC, ADC and histogram memory) on a single computer card. The SPC-730 
contains enough onboard memory to acquire FLIM data with a pixel resolution 
of 256 x 256 pixels and a temporal resolution of 64 time bins. The number of 
time bins can be increased by reducing the pixel resolution.
Three sets of input signals are required by the SPC-730; the signal from a fast 
PMT detector, a synchronisation signal from the pulsed excitation source and 
timing signals from the scan mirror controllers. A pixel clock signal is also 
required in order for the module to assign detected photons to the correct image 
pixels. In the absence of an external pixel clock in the confocal image acquisition 
system, the internal pixel clock of the SPC-730 was used and manually set to the 
pixel time of the confocal scan settings. A relay switch designed and built by 
Steve Davis at STFC Daresbury Laboratory is used to divert signals from the 
PMC-100 detectors to either the confocal image acquisition system or the SPC- 
730 module. The synchronisation signal is produced by a photodiode in the 
Ti:Sapphire laser system that is connected to the SPC-730. To ensure correct 
recording of photon density distributions the length of the synchronisation signal 
cable can be adjusted to maintain the correct delay between the synchronisation 
and detector signals.
4.2.4.1 Analysis of fluorescence lifetime images
This section mainly describes the features of the SPCImage 2.9 (Becker-Hickl 
GmbH) lifetime image analysis software used extensively throughout this thesis 
to analyse the lifetime images produced by the multi-dimensional, multi-colour 
confocal microscope described in this chapter.
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The time-resolved information in fluorescence lifetime images needs to be 
extracted by post-processing of the data. Each pixel contains a photon density 
distribution which is derived from the emission of many fluorophores, all of 
which can be in different photophysical states due to their existence is different 
microenvironments. In order to characterise the form of the density distribution a 
suitable model for the density distribution must be specified and for each pixel 
the model parameters are found that best fit the model to the data. Colour coded 
images are then used to display the model parameter of interest. SPCImage fits 
time domain lifetime data to a multi-exponential decay model with a maximum 
of three exponential components
F(t) = a0 + ^ q /e ^x‘ Eqn. 4-21
j
where a/ and r;- are the exponential decay coefficients and lifetimes respectively. 
J  = 1, 2, 3. «o is an offset that can take into account ambient light and detector 
dark noise.
The graphical interface of SPCImage version 2.9 is displayed in figure 4.10. The 
interface is split into five panels labelled a-e in the figure. They contain an 
intensity image obtained from summing all of the photons counted in each pixel 
(a.), a colour coded image displaying a user selected model parameter (b.), a 
histogram of the pixel frequency of the same model parameter (c.) and the 
recorded photon density and model fit for the pixel selected by the blue cross 
visible in a. and b. The final panel (e.) allows the user to select the number of 
exponential decay components used in the model and allows the model 
parameters to be manually fixed.
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Figure 4.10 Screen capture of the SPCImage 2.9 time domain lifetime image 
analysis program. The file under analysis is a lifetime image of HEK293 cells 
transiently transfected with CFP and YFP linked by 16 amino-acids (see section 
3.3 for further details). The lifetime data has been fit to a bi-exponential decay 
model. The software interface displays a. an intensity image, b. a colour coded 
image of a selected model parameter (here the weighted mean lifetime of the two 
exponential decay components), c. the intensity weighted pixel frequency 
histogram of the mean lifetimes present in the colour coded image, d. the photon 
density distribution and multi-exponential fit of the pixel selected with the blue 
cursor. The total number of photons in the distribution is shown in the bottom 
right of the panel, e. Multiexponential decay model parameters.
Once the number of components in the exponential decay model has been 
selected, additional parameters that account for shift, scatter and offset of the 
photon density distribution in the time window can be fixed and specified. The 
shift parameter defines where the instrumental response function is in relation to 
the rising edge of the photon density distribution. The scattering parameter 
accounts for photons that arise from scattering of excitation light that breaks 
through the emission barrier filters instead of fluorescence emission. The offset 
parameter accounts for a non-zero baseline in the data due to detector noise or 
the detection of ambient light and is estimated from the average number of 
photons in histogram bins preceding the rising edge of the photon distribution.
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The software requires ~ 6 bins preceding the rising edge of the photon density 
distribution to calculate the offset. The position of the leading edge in the 
histogram can be adjusted by altering the length of the electrical cables carrying 
the detector and synchronisation signals to introduce a delay between the two.
Before the model is fitted to the data, two more parameters must be set: the 
threshold and binning. The threshold parameter defines the number of photons in 
the peak bin of the photon density distribution required for the pixel to be fitted 
to the model. The threshold can be set so that pixels that only contain scattered 
light are ignored completely, reducing computation time and suppressing outliers 
in the parameter histogram. The number of photons recorded in each pixel can be 
increased by binning pixels and sacrificing spatial resolution. This might be 
required to increase the signal-to-noise ratio of the image.
A region of interest (ROI) can be selected using a rectangle tool or a polygon 
tool with user defined points. The specified model is fit to the time resolved data 
contained within the pixels in the ROI using least-squares fitting that seeks to 
minimise the chi-squared value between the data and the model function. Once 
the model fitting is complete, the user can choose which model parameters are to 
be displayed in the colour coded image and pixel frequency histogram. In order 
to gauge whether fitting has been successful the chi-squared value is one of the 
parameters that can be displayed. The other parameters include the individual 
model parameters a, and z>-, the weighted mean lifetime rm,
Eqn. 4-22
the relative quantum yield (the fractional contribution of each component to the 
steady state fluorescence intensity) qj,
a ,T,
qj = ^ J J Eqn. 4-23
L ° J T J
121
the intensity weighted mean lifetime, r,.
t, = ~  J 1 Eqn. 4-24
L a,rj
The intensity weighted mean lifetime with pile-up correction can also be 
calculated if the total measurement time, laser repetition rate and detector dead 
time are precisely known.
4.3 Dem onstration of multicolour optical sectioning and lifetime 
im aging
The first imaging test of the multi-dimensional, multi-colour confocal 
microscope was to image optical sections of fluorescently labelled ErbB family 
members in live A431 cells. The A431 cell line is derived from a human 
epithelial carcinoma which express at their plasma membranes ~ 1-2 x 106 ErbBl 
receptors per cell36. These cells also express low levels of ErbB2 and ErbB3, but 
lack endogenous ErbB437. Labelling of endogenous ErbBl was achieved by 
binding EGF-Cy3 or EGF-Alexa 647 to membrane localised receptors. ErbB2 
and ErbB3 fused to variants of GFP were transiently transfected into A431 cells. 
Two colour images and single colour z-stacks of the fluorescently tagged ErbB 
receptors were acquired to demonstrate the imaging ability of the microscope.
HEK293 cells, a cell line generated by transformation of human embryonic 
kidney cells38 were used to ascertain the correct functioning of the Becker-Hickl 
fluorescence lifetime imaging module. These cells were used as they are 
straightforward to transfect with genes for non-native proteins. They were first 
transiently transfected with the gene for CFP and observed with the lifetime 
imaging mode of the microscope. CFP lifetimes measured by time-domain 
techniques previously reported in the literature range between 2.49 - 2.72 ns39’42. 
As a positive control, the ability of a multi-colour microscope to demonstrate
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FRET was tested using HEK293 cells that were transfected with CFP linked to 
YFP by a short (16 amino acid) linker. In these samples quenching of the CFP 
fluorescence by FRET is expected and can be unambiguously demonstrated by 
observing the recovery of the reduced CFP lifetime after photobleaching the 
acceptor.
4.3.1 Materials and Methods
4.3.1.1 Maintenance of Cell Cultures
A431 and HEK293 cells were were obtained from the European Collection of 
Animal Cell Cultures. Both were cultured adhered to 75 cm2 flat bottom flasks in 
Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine 
serum, 2 mM glutamine and 1% penicillin/streptomycin (all Invitrogen), but 
without phenol red which leads to increased cellular background fluorescence. 
Cells were incubated at 37°C in the presence of 5% CO2 in air.
Both cell types reached 70-80% confluency after 2-3 days of incubation at which 
point they were passaged using the following procedure. First the media was 
removed from the culture flasks and the cells washed in Hanks’ balanced salt 
solution (HBSS, Invitrogen). After removal of the HBSS 1 ml of Trypsin (0.5% 
in EDTA w/v, Invitrogen), diluted in HBSS to a total volume of 10 ml was added 
to each flask and the cells were incubated at 37°C in the presence of 5% C02 in 
air for either 15 minutes (A431 cells) or 10 minutes (HEK293) cells. This was 
sufficient to detach the majority of the cells from the surface of the flask as 
observed by light microscopy. 3 ml of culture media was added to the flasks at 
this point to reduce further trypsination of cell surface proteins. Centrifugation 
for 5 minutes at 500 g was then used to separate cells from the trypsin soultion. 
After removing the supernatant with a pippette, pellets of cells were resuspended 
in 10 ml of culture media. 2 ml of resuspended cells (constituting -20% of the 
harvested cells) was placed into a new 75 ml flask each containing 10 ml of 
culture media. The density of cells in the remaining suspension was determined
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using a haemocytometer and used to plate glass bottomed dishes as required. All 
liquid waste including unwanted cells adherent culture or in suspension were 
placed in Virkon, a broad spectrum disinfectant, for 24 hours before disposal. 
Flasks, pipette tips and falcon tubes used for cell culture were also placed in 
Virkon for 24 hours before being autoclaved and removed for incineration.
4.3.1.2 Binding of EGF fluorescent probe conjugates to A431 cell 
surface ErbBl receptors
1.5xl05 A431 cells were plated onto DeltaT glass bottomed dishes (Bioptech) in 
complete medium and incubated overnight at 37°C in the presence of 5% CO2 in 
air to achieve -80% confluency. Murine EGF (mEGF) was obtained from 
Peprotech, both Cy3 and Alexa 647 dyes were obtained from Invitrogen and 
conjugations of dyes to the N-terminus of mEGF were performed by Cambridge 
Research Biochemicals. Pre-chilled cells were incubated at 4°C with either an 
excess (>200 nM) or physiological concentration (15 nM) of mEGF-Cy3, or 100 
nM mEGF-Alexa 647 for 30 minutes in the presence of 5% CO2 in air. The cells 
samples were subsequently washed three times with ice cold PBS to remove 
unbound fluorescently labelled mEGF before imaging.
4.3.1.3 Preparation of DNA plasmids
DNA Plasmids encoding cyan fluorescent protein (CFP), yellow fluorescent 
protein (YFP) and CFP linked to YFP by 16 amino-acids (CFP-16aa-YFP) were 
a gift from Dr Nick Gay of the University of Cambridge. Plasmids encoding 
ErbB3 fused with enhanced green fluorescent protein (ErbB3-eGFP) were a gift 
from Dr Maddy Parsons of King’s College London. Plasmids encoding 
ErbB2-eYFP were a gift from Dr Mads Lerdrup of The University of 
Copenhagen. The A206K mutation was introduced to these two ErbB fusion 
protein constructs with site directed mutagenesis by Dr Selene Roberts at the 
STFC Daresbury Laboratory. The two mutants were designated
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ErbB3-eGFPA206K and ErbB2-eYFPA206K. The A206K mutant of GFP 
variants is advantageous as it does not homo-dimerise43. Stock solutions of 
plasmids in tris-EDTA (TE) were stored at 4°C.
Large quantities of plasmids for the transient transfection of mammalian cells 
were obtained from the original stock plasmid solutions using the Maxiprep 
procedure (Qiagen, Germany). The desired plasmid is replicated by bacteria 
grown in culture before being removed using alkaline lysis and purified. An 
outline of the procedure follows and a list of the buffers referred to in the 
procedure and their compositions can be found in table 4.4.
DH5a E. Coli were transformed with the DNA plasmids and cultured on Luria- 
Bertani (LB) agar plates. 1 L of LB media contains lOg of Bacto-tryptone, 5 g of 
Bacto-yeast extract and 10 g of NaCl in distilled water, pH 7.0. The selective 
antibiotic for all constructs was kanamycin which was included in all LB media 
at a concentration of 25pgml" . For each construct a single colony was picked 
and used to innoculate 3 ml of LB media. These cultures were grown up 
overnight at 37°C with 225 rpm agitation. 0.5 ml of each suspended culture was 
then removed and added to 500 ml of LB media and further incubated at 37°C 
overnight. Cultures were removed from the conical flasks and centrifuged at 
6000 rpm for 10 minutes at 4°C. The supernatant was removed and the pellets of 
bacteria were resuspended in 10 ml of resuspension buffer. To lyse the bacteria, 
10 ml of a lysis buffer containing sodium dodecyl sulfate (SDS) was added to the 
resuspended cells and mixed vigorously (without vortexing as this may shear 
genomic DNA) until a homogenously coloured suspension was obtained. The 
lysis reaction was allowed to proceed for no more than 5 minutes at room 
temperature before 10 ml of neutralization buffer containing potassium acetate 
was added, again with vigorous mixing. At this point a white precipitate 
containing genomic DNA, protein and cell debris was visible. This was cleared 
from the lysate by filtration using a QIAfilter cartridge. The filtered lysate was 
collected in a Qiagen HiSpeed Maxi tip that had been previously prepared by 
allowing 10 ml of equilibration buffer to flow through it. The HiSpeed tip 
contains a resin that binds plasmid DNA but allows the lysate to pass through the
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tip by gravity flow. 60 ml of wash buffer was allowed to flow through the 
HiSpeed tip before eluting the DNA with 15 ml of elution buffer.
Buffer Composition Storage
Temperature
Resuspension buffer 50 mM Tris-Cl, pH 8.0 
lOmMEDTA 
100 pgml"1 RNase A
2-8°C after addition 
of RNase A
Lysis buffer 200 mM NaOH 
1 % SDS (w/v)
15-25°C
Neutralisation buffer 3.0 M potassium acetate, pH 5.5 15-25°C
QIAfilter wash buffer 1 M potassium acetate, pH 5.0 15-25°C
Equilibration buffer 750 mM NaCl 
50 mM MOPS, pH 7.0 
15% isopropanol (v/v) 
0.15% Triton X-100 (v/v)
15-25°C
Wash buffer 1.0 M NaCl 
50 mM MOPS, pH 7.0 
15% isopropanol (v/v)
15-25°C
Elution buffer 1.25 M NaCl 
50 mM Tris-Cl, pH 8.5 
(15% isopropanol (v/v))
15-25°C
TE 10 mM Tris-Cl, pH 8.0 
ImM EDTA
15-25°C
STE TE with 100 mM NaCl 15-25°C
Table 4.4 List of buffers used in the Qiagen Maxiprep procedure with their 
compositions and storage conditions.
The eluate was collected in a Vulcan tube and the DNA precipitated by adding 
10.5 ml of isopropanol and incubating at room temperature for 5 minutes. The 
tube and its contents were then centrifuged for 30 minutes at 110000 rpm. The 
isopropanol was poured off and 5 ml of 70% ethanol in deionised water added to 
the pellet before being centrifuged for a further 5 minutes. The ethanol was then 
removed and the pellet of DNA left to dry in air for 5 minutes before being
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resuspended in 500 ul of TE and transferred to an eppendorf tube. DNA purity 
and concentration were assessed from the absorbance of the resuspended sample 
at 260 nm and 280 nm, which are the peaks of DNA and protein absorption 
spectra respectively.
4.3.1.4 Transient transfection of A431 cells
1.5xl05 A431 cells were plated onto DeltaT glass bottomed dishes (Bioptech) in 
antibiotic free medium and incubated overnight at 37°C in the presence of 5% 
CO2 in air to achieve -80% confluency.
The media in each dish was then replaced with a transfection mixture comprising 
2 pg of DNA plamids encoding either ErbB3-eGFPA206K or 
ErbB2-eYFPA206K, 6 pi the transfection reagent fugene and 2 ml of serum free 
media. Cells were incubated in the transfection mixtures at 37°C in the presence 
of 5% CO2 in air before being replaced with fresh complete medium. The 
samples were then incubated for 1 8 - 2 4  hours before imaging the expressed 
fluorescent proteins.
4.3.1.5 Transient transfection of HEK293 cells
1.5xl05 HEK293 cells were plated onto DeltaT glass bottomed dishes (Bioptech) 
in antibiotic free medium and incubated overnight at 37°C in the presence of 5% 
CO2  in air to achieve -80% confluency.
The media in each dish was then replaced with a transfection mixture comprising 
lpg of DNA plasmids, 2.5 pi of lipofectamine (a different transfection reagent 
best suited for these cells) and 2 ml of serum free media. Transfection mixtures 
contained either the CFP construct alone, CFP and YFP constructs (present in a 
in a 1:1 molar ratio) or the CFP-16aa-YFP construct. Cells were incubated in the 
transfection mixtures for 4 hours at 37°C in the presence of 5% CO2 in air before
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being replaced with fresh complete medium. The samples were then incubated 
for 18 -  24 hours before imaging the expressed fluorescent proteins.
4.3.2 Distribution of endogenous and transiently transfected ErbB 
family members in A431 cells
Figure 4.11 shows two confocal images obtained by this microscope during its 
initial commissioning phase. The images show optical sections through a sample 
of live A431 cells that have been exposed to an excess of mEGF-Cy3. The 
sample was excited with 545 nm pulsed excitation light (76 MHz repetition rate) 
and Cy3 fluorescence was detected between 572.5 and 647.5 nm. The images are 
of a 65 x 65 pm field of view at a resolution of 512 x 512 pixels. A431 cells are 
distinguished by their irregular shapes and sizes as they grow in an uncontrolled 
fashion. The cells were imaged at room temperature.
Figure 4.11 A431 carcinoma cells probed with an excess of EGF-Cy3 at room 
temperature. Both images are of a 65 x 65 pm field of view.
The largest source of fluorescence is located the membrane of the cells (where 
ErbBl resides), but a consequence of the temperature being above 4°C, some of 
the mEGF-Cy3 ligands have been internalised via receptor mediated endocytosis 
and are visible as large vesicles and an increase in background fluorescence
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within the confines of the cell membranes. In the left hand image, some 
philopodia are also visible.
To demonstrate multi-colour sectioning and correct imaging of cell samples 
A431 cells were transfected with either ErbB2-eYFPA206K, or ErbB3- 
eGFPA206K before incubation with mEGF-Alexa 647. Of the two fluorescence 
protein constructs, the expressed ErbB2-YFPA206K was known not to be 
transported to the cell membrane and should not co-localise with 
mEGF-Alexa 647 (from a personal communication with Dr Mads Lerdrup, The 
University of Copenhagen). In contrast, the expressed ErbB3-eGFPA206K was 
known to be transported to the cell membrane therefore should co-localise with 
mEGF-Alexa 647. Samples were excited with 488 nm and 639 nm light. 
GFP / YFP fluorescence was detected between 500 and 550 nm. Alexa 647 
fluorescence was detected between 662.5 and 737.5 nm. Figure 4.12a and b 
shows 65 x 65 pm fields of A431 cells where several cells are expressing 
ErbB2-eYFPA206K. Cells transiently expressing fluorescent protein fusion 
products usually display cytosolic fluorescence from proteins being produced 
inside the cell and transported throughout the cell. No fluorescence in the 
transfected cells appears to co-localise with the mEGF-Alexa 647 visible at the 
cell membrane. This is in contrast to figure 4.12c which shows A431 cells 
transiently transfected with ErbB3-eGFPA206K which appears to be localised in 
the cytosol and the cell membrane.
a. l b .  I c.
Figure 4.12 Two colour images of mEGF-Alexa 647 bound to ErbBl (displayed 
as red) and ErbB2-eYFPA206K (a, b.) or ErbB3-eGFPA206K (c.). In all three 
images fusion proteins are displayed green. Samples were imaged at 4°C. The 
field of view of the images is 65 x 65 pm.
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The sectioning ability of the microscope was further tested by imaging z-stacks 
through A431 cell samples labelled with mEGF-Cy3 bound to endogenous 
ErbBl or A431 cells transiently transfected with ErbB3-eGFP. The z-stacks 
through a volume of each sample are shown in Figures 4.13 and 4.14. Both 
image series begin just above the basalateral membrane of the cell (the 
membrane in contact with the glass coverslip) and the focal plane of the 
microscope was moved through the sample using the piezo-electric objective 
positioner. The apical surface of the layer of A431 cells appears to occur between 
18 - 20 pm from the axial position of the first image. Both image stacks show 
different distributions of fluorescence throughout the samples that highlight 
differences between the ways the receptors have been tagged with fluorophores 
in each figure.
Figure 4.13 Endogenous ErbBl in A431 cells after exposure to 15nM 
mEGF-Cy3 at room temperature for 10 minutes, a. A section close to the 
basalateral membrane of the cell sample, b -  j are sections imaged at 2 pm 
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Figure 4.14 ErbB3-eGFPA206K transiently expressed in A431 cells. Images 
a - 1 are sections taken at 1 pm intervals from the imageable section closest to the 
basal membrane. The field of view of the images is 65 x 65 pm.
The images in Figure 4.13 show the distribution of ErbBl receptors that can bind 
mEGF-Cy3 at the plasma membrane, or that have bound to mEGF-Cy3 before 
being internalised. All the cells in the field of view are labelled. The reduced
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fluorescence intensity of 4.13a compared to 4.13b-j could be due either to 
reduced amounts ErbB 1 receptor in the region of the basalateral membrane or a 
consequence of restricted mEGF-Cy3 diffusion to the bottom of the cell layer.
The images in figure 4.14 show the distribution of all ErbB3-eGFP fusion 
proteins expressed by the two cells in the field of view that have been 
successfully transfected. As each ErbB3 receptor is transcribed labelled 1:1 with 
eGFP, all ErbB3-eGFP complexes are seen immediately after eGFP maturation 
after which the eGFP labels become fluorescent. Receptors observed include 
membrane localised ErbB3 is seen as well as protein that is being produced and 
transported around the inside of the cell. A gradual loss of membrane bound 
fluorescence between images 4.14i-m can be observed and as cytosolic 
ErbB3-eGFP can still be seen this indicates that the ErbB3 distribution in A431 
cells is polarised. Membrane bound ErbB3-eGFP is found only in the bottom half 
of the cell, whereas the top half appears to contain mainly cytosol localised 
receptor only.
4.3.3 FLIM of fluorescent proteins in live cells
Figure 4.15a is a fluorescence lifetime image of a group of HEK293 cells 
expressing CFP which can be seen throughout the cytosol. CFP was excited with 
440 nm pulsed excitation (76 MHz repetition rate) and the CFP fluorescence was 
detected between 455 and 485 nm. The samples were kept at room temperature. 
CFP fluorescence emission is characterised by a temperature dependent bi- 
exponential intensity decay . The data was fitted to a bi-exponential decay 
model and the image displays the weighted mean of the two lifetime 
components, rm. rm values between 1 and 4 ns are represented by a continuous 
range of colours from red to blue respectively. The mean of the rm distributions 
from the pixels in each cell were obtained for a total of 31 transfected cells. The 
average value of rm over all the cells was 2.82 ns with a standard deviation of 
0.06 ns. This is similar to the mean CFP fluorescence lifetimes previously
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measured using TCSPC FLIM (2.72 ns 40 and 2.50 ± 0.02 ns 41) and a novel time 
















CFP-16aa-YFP After 1 YFP After 5 YFP
photobleaching scan photobleaching
scans
Figure 4.15 Confocal lifetime images of CFP xm in HEK 293 cells transfected 
with a. CFP only b. CFP and YFP (unlinked) c. Top - Lifetime images of CFP xm 
when linked to YFP by a 16 amino-acid linker before and after photobleaching of 
YFP. The corresponding YFP intensity taken after the lifetime images is shown 
underneath each lifetime image. All images are of a 63 x 63 pm field of view.
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Expression Average CFP rm Standard Number of cells
product / ns deviation / ns sampled
CFP 2.82 0.06 31
CFP + YFP 2.75 0.02 37
(unlinked)
CFP-16aa-YFP 1.78 0.09 34
Table 4.5 The value of CFP xm in HEK 293 cells measured by confocal FLIM 
and averaged over all cells.
Figure 4.15b is a fluorescence lifetime image of CFP in HEK293 cells transiently 
transfected with both CFP and YFP (unlinked, negative control of FRET). It can 
be seen qualitatively that the CFP lifetimes in these cells are similar to those in 
figure 4.15a. The average value of rm was 2.75 ns with a standard deviation of
0.02 ns. This demonstrates that there is negligible quenching of the CFP lifetime 
due to random association with YFP within the cells. This is in stark contrast to 
the results from samples transfected with the CFP-16aa-YFP construct where 
each CFP donor is positioned close enough to its linked YFP acceptor partner to 
be able to transfer excited state energy via FRET (figure 4.15c and table 4.5). 
The average value of rm was 1.78 ns with a standard deviation of 0.09 ns. 
Figure 4.16 compares the intensity weighted pixel frequency of the rm values 
contained in images 4.15a (dark green dotted line) 4.15b (light green dashed line) 
and the first FLIM image of 4.15c. This plot clearly shows the differences in 
fitted CFP lifetimes between the three sample types.
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Figure 4.16 The intensity weighted distribution of CFP fluorescent lifetimes (xm) 
from the pixels contained within the lifetime images in figure 4c. Shown is 
CFP-16aa-YFP before YFP bleaching (continuous orange), after a single YFP 
photobleaching scan (dashed green) and after 5 YFP photobleaching scans 
(dotted blue-green).
Using
EPRET= l - Tm(CFP-'6aa-YFP) Eqn.4-25
T m(CFP)
the average efficiency of FRET between CFP and YFP in the CFP-16aa-YFP 
fusion protein was calculated to be 0.37 ± 0.03. Neglecting the possibility of 
FRET between CFP and YFPs from other constructs the average separation r of 
CFP and YFP in the construct was estimated by using the equation
R6
E f r e t  : „6 eT Eqn. 4-26
K 0 +  r
Taking R0 = 4.92 ± 0.10 nm for the CFP/YFP FRET pair44, r = 5.38 ± 0.13 nm.
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The value of r determined is reasonable close to that expected from a straight 
chain of 16 amino-acids (6.4 nm). The difference may be due to flexibility of the 
16 amino-acid linker and the fact that the errors quoted do not take into account 
uncertainties that arise from assuming an average value of the orientation factor 
and are likely to be larger.
To confirm the presence of FRET, the YFP in the CFP-16aa-YFP construct was 
photobleached by direct excitation with 514 nm CW laser light scanned slowly 
across the image region (63.45s per scan). After each photobleaching scan, the 
resulting YFP intensity image was saved before the acquisition of a new CFP 
lifetime image. Figure 4.15c shows these images for an area of cells after 1 and 5 
photobleaching scans. Figure 4.17 plots the mean value of CFP rm for each 
successive photobleaching scan and compares them to the values for CFP in the 
absence of YFP and when connected to YFP by 16 amino acids.
w
a. 3000
Figure 4.17 Bar chart of mean CFP fluorescent lifetimes comparing the results 
from HEK 293 cells transfected with CFP only, CFP-16aa-YFP and CFP-16aa- 
YFP after YFP photobleaching. All results from CFP-16aa-YFP expressing cells 
are derived from the same field of view. Error bars represent the standard 
deviation of the average CFP fluorescent lifetime from a sample of 31 cells 
(expressing CFP only) or 18 cells (expressing CFP-16aa-YFP).
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It is clear after the first bleaching scan that the photobleaching of YFP causes 
some recovery of the CFP lifetime, confirming that the quenching of the CFP 
lifetime is indeed due to FRET between CFP and YFP. However, even after 
repeating the photobleaching scan 6 times and reducing the YFP fluorescence 
intensity to <10% of its initial value, complete recovery of the CFP only lifetime 
does not occur. It is possible that the CFP lifetime is quenched as a result of 
fusion to the linker and YFP even when the YFP chromophore has been 
photobleached. Other studies that have failed to recover the donor only reference 
value of the CFP lifetime upon the complete photobleaching of linked YFP have 
been attributed to the creation of photoproducts during YFP irradiation that 
contaminate the CFP fluorescence detection channel41.
4.4 Summary
A multi-dimensional, multi-colour confocal microscope for the quantitative 
measurement of FRET between donor and acceptor labelled proteins in situ has 
been designed and implemented. Multi-colour optical sectioning of biological 
samples was demonstrated by imaging fluorescently labelled ErbB receptors in 
live cells. Two different approaches to the 1:1 labelling of ErbB receptors with a 
fluorophore were tested; the binding of fluorescently labelled ligand to the 
extracellular domain and expression of the receptor fused at the c-terminus with a 
fluorescent protein. The capability of the system to quantitatively measure FRET 
efficiencies using FLIM was tested in live cells expressing a fluorescent protein 
consisting of a FRET donor and acceptor linked by a short peptide sequence. The 
use of the microscope described in this chapter for developing a FRET-based 
method for investigating the three dimensional structure of membrane proteins in 
situ is described in the chapters that follow.
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5 Towards FRET measurement of the distance of closest 
approach between a protein and the plasma 
membrane
This chapter describes the steps taken in preparation for using a bi-directional 
FRET method developed to investigate the 3D structure of transmembrane 
proteins with respect to the plasma membrane of cells in adherent culture. The 
method requires the use of two different FRET pairs: (i) to probe the lateral 
distance between EGF ligands bound to cell surface ErbB 1 where each ligand is 
covalently bound in a 1:1 ratio with a FRET donor or acceptor (ii) to determine 
the distance between bound EGF and the plasma membrane and acquire a 3D 
view of the ErbBl receptors comprising the EGF-ErbBl complexes. In (ii) the 
acceptor is not covalently bound to any protein but is instead a fluorescent 
lipophilic probe that inserts itself into lipid environments (such as cell plasma 
membranes). The donor fluorophore is covalently bound to the ligand EGF 
molecules as in (i).
Quantitative FRET measurement requires a number of calibration steps. The first 
is the determination of the Förster radius of the FRET pair to be employed which 
is required to derive distances from the associated FRET measurement. The 
series of measurements performed to calculate the Förster radii are described in 
section 5.1. Choosing the right FRET pair for a particular distance measurement 
is crucial as different pairs have different ranges of donor-acceptor separations 
over which variations in FRET efficiency can be unambiguously detected. As 
this range is centred around the Förster radius it can be used to gauge the 
applicability of the pair to study proteins of a given size (which will determine 
the likely range of distances involved in dynamic interactions) when planning a 
FRET experiment. The suitability of the FRET pairs chosen to investigate the 3D 
structure of the ErbBl receptor (a > 10 nm long, 170KDa protein) was 
ascertained from the Förster radius measurements and the measurement of the
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steady state anisotropy of the dyes involved. Anisotropy measurements 
determine the accuracy of the distances that can be derived via FRET for a given 
donor/acceptor pair.
The FRET pair chosen to investigate the separation of EGF binding sites in EGF- 
ErbBl complexes was Alexa 546 and Atto 647N and the one chosen to measure 
the distance of closest approach of these sites to the cell surface was Alexa 546 
and Vybrant CisDiD. Considering the known ErbBl crystallographic structures 
and results of previous FRET studies of EGF binding site separations the 
calculated Forster radii are large enough for measurements on ErbBl receptors. 
The suitability of the Alexa 546 / Vybrant CisDiD FRET pair for use in adherent 
cells is confirmed in section 5.2 by a preliminary experiment that tests whether 
there are ErbBl conformations in cultured cell membranes that produce 
unexpected EGF-membrane separations.
The chapter ends with a description of an extended FRET theory required to 
move from this preliminary experiment to a quantitative distance determination 
in the experimental situation where the ratio of donors and acceptors is dynamic 
and non- stoichiometric, which is the case when donors are bound to a membrane 
protein and acceptors are free to diffuse in the membrane.
5.1 Measurement of the Forster radius of FRET pairs
The calculation of the Forster radius of a FRET pair requires the donor quantum 
yield, donor emission spectrum and acceptor absorption spectrum to be known. 
Additionally, an average value for the orientation factor must be specified. 
Measurement of the steady-state anisotropy of the donor and acceptor conjugates 
is required to determine the likely error introduced by using this average value. 
This section describes the measurement of these physical properties and the 
calculation of the Forster radius for the FRET pairs mEGF-Alexa 546 and 
mEGF-Atto 647N, and mEGF-Alexa 546 and Vybrant CisDiD.
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5.1.1 Materials and Methods
5.1.1.1 Preparation of Donor and acceptor samples in solution
Stock solutions of mEGF (Peprotech, USA) conjugated to Alexa 546 (Invitrogen, 
USA, conjugation to mEGF performed by Cambridge Research Biochemicals, 
UK) and Atto 647N (Atto-Tec GmbH, Germany, EGF conjugation by Cambridge 
Research Biochemicals, UK) were diluted in PBS to a concentration such that the 
absorbance of the fluorescent dye at its emission maximum was less than 0.1, in 
order to avoid inner filter effects (caused by reabsorption of fluorescence photons 
by fluorescent dye molecules). A suspension of small phosphatidlylcholine 
vesicles in PBS (highly diluted to minimise light scattering by the vesicles) was 
labelled with Vybrant C^DiD (Invitrogen, USA), again such that the absorbance 
of the fluorescent dye at its emission maximum was less than 0.1. Small 
phosphatidlylcholine vesicles were prepared by sonication from multilamellar 
vesicles prepared by vortex mixing of 50 mM sodium phosphate buffer and 
0.1 M NaCl (pH 6.0) over a film of phosphatidlylcholine deposited in a glass 
tube. Table 5.1 lists the properties of the fluorescent dyes used.
Probe Excitation 
max / nm
Emission max / 
nm
Sa  / M'Vm'1
Alexa 546 556 572 0.99x10'
Atto 647N 644 669 1.50x10s




Table 5.1 Spectral properties of the fluorophores used in this chapter. Excitation 
max and Emission max are the wavelengths of peak excitation and fluorescence 
emission respectively, ¿x is the absorption coefficient at the wavelength of peak 
absorption.
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5.1.1.2 Donor and acceptor samples in glycerol
Samples of EGF-conjugates were prepared as in 5.1.1.1 except that the PBS 
buffer was substituted for glycerol. Dye conjugates were mixed slowly with the 
viscous glycerol gel to avoid introducing air bubbles to the sample. EGF-dye 
conjugates in glycerol will have almost completely restricted mobility.
5.1.1.3 Measurement of absorption and emission spectra
Samples were placed in a quartz cuvette and the absorption spectra of 
mEGF-Alexa 546 and Vybrant C^DiD in the 500-750 nm range were measured 
using a PerkinElmer Lambda 35 spectrophotometer. The emission spectrum of 
mEGF-Alexa 546 was measured over the same wavelength range using a Jobin 
Yvon Fluorolog fluorimeter with a Xenon arc-lamp light source. These spectra 
were corrected with the absorbance or emission spectra of the appropriate buffer 
over the same wavelength range.
5.1.1.4 Measurement of the EGF-Alexa546 donor quantum yield
Samples of mEGF conjugated to Alexa 546, prepared as in section 5.2.1, were 
further diluted in PBS to obtain samples that ranged in maximum absorbance 
between 0.01 and 0.1. The absorption spectra of these mEGF-Alexa 546 samples 
were measured over a wavelength range of 500-650 nm with a PerkinElmer 
Lambda 35 spectrophotometer. The fluorescence emission spectra of the samples 
over the same wavelength range were also measured when excited at a 
wavelength of 545 nm using a Jobin-Yvon Fluorolog fluorimeter with a Xenon 
lamp illumination source.
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Reference samples of unconjugated Alexa 546 and tetramethylrhodamine (TMR) 
were prepared in same manner as the mEGF-Alexa 546 conjugate. Alexa 546 in 
PBS has a quantum yield Q = 0.79 (Invitrogen) and TMR in PBS has a Q
be excited at the same wavelength as mEGF-Alexa 546 and emit fluorescence in 
the same wavelength range, simplifying comparison of their quantum yields. 
Accordingly, the absorption and emission spectra (545nm excitation) of these 
samples were also recorded between 500-650nm, along with the spectra of a 
blank sample consisting only of PBS.
The appropriate blank spectrum was subtracted from all emission spectra to 
obtain the corrected emission spectra F(A). The integrated fluorescence intensity
was evaluated for each emission spectrum using the integration function of the 
Origin 7.5 data analysis software. This function uses the trapezoid method of 
numerical integration.
5.1.2 Forster radius calculations
5.1.2.1 Evaluation of overlap integrals
Figure 5.1 shows the peak-normalised emission spectrum of mEGF-Alexa 546 
when excited with 545 nm light. The absorption spectrum of Vybrant CisDiD in 
lipid vesicles and mEGF-Atto 647N in PBS are also plotted.
The overlap integral for the FRET pairs mEGF-Alexa 546 / Vybrant CisDiD and 
mEGF-Alexa 546 / mEGF-Atto 647N was calculated from Eqn. 5-2 both by 
numerically integrating the numerator and denominator using Origin and by 
using a simple summation3 between A\ and A2



















Figure 5.1 The peak normalized fluorescence emission spectrum of mEGF- 
Alexa546 (solid blue line) plotted with the peak normalized absorption spectra of 
Vybrant CigDiD (dashed red line) and mEGF-Atto 647N (dotted red line).





mEGF-Alexa 546 / 
Vybrant CigDiD
1.10306xl016 1.10304xl016
mEGF-Alexa 546 / 
mEGF-Atto 647N
2.44572xl0li 2.44569x10°
Table 5.2 Values of the overlap integral evaluated by numerical integration in 
Origin or the simple summation method.
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As can be seen in table 5.2, the results are identical for both methods of 
evaluating the overlap integral up to five significant figures. It is notable that 
despite the similarity of the absorption spectra of Vybrant CigDiD and 
Atto 647N, the values of their overlap integrals differ by an order of magnitude 
due to the slightly larger shoulder of Vybrant CigDiD absorption between 
550 and 650 nm and the smaller absorption coefficient of Atto 647N. The 
consequence of this will be a smaller Forster radius for the mEGF-Alexa 546 / 
mEGF-Atto 647N FRET pair.
5.1.2.2 Calculation of the EG F-Alexa546 quantum  yield
For each sample the fluorescence emission spectra was measured and the 
integrated fluorescence intensity calculated. This was repeated three times to 
account for fluctuations in the excitation intensity and the mean integrated 
fluorescence intensity was plotted as a function of the absorbance at 545nm for 
each sample which is shown in figure 5.2. The data from each sample was fit to 
the form of a straight line passing through the origin using the linear regression 
function in Origin. The standard deviations of the mean integrated intensities 
were used to weight each data point when minimising a sum of the squares of the 
residuals to find the most likely parameters. The best fit parameters are 
summarised in table 5.3.
The gradients of these fits were used first to check that the values of the 
reference quantum yields were consistent with each other before calculation of 
the quantum yield of mEGF-Alexa 546. Taking Alexa 546 as the reference first 
(Q = 0.79, Invitrogen) yields Q = 0.23 for TMR. This is the average of the 
published values quoted in section 5.1.1.4 and consequently the two reference 
samples were deemed consistent with each other. The value obtained for the 
quantum yield of mEGF-Alexa 546 using either the Alexa 546 quantum yield or 
the average TMR quantum yield was 0.71.
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Figure 5.2 Mean integrated fluorescence intensity plotted as a function of 
Absorbance for TMR in PBS (black squares), mEGF-Alexa546 in PBS (blue 
circles) and Alexa546 in PBS (red circles). Error bars represent the standard 
deviation of three measurements of the integrated fluorescence intensity made on 
each sample.
Sample B Error N R-
Alexa 546 in PBS 7.834xlOy 1.824x10“ 7 0.990
mEGF-Alexa 546 
in PBS
7.069xl0y 2.266xl08 9 0.972
TMR in PBS 2.285xlOy 3.964xl07 6 0.996
Table 5.3 Best fit parameters for the data in figure 5.2. fitted to a straight line of 
the form Y=BX, where B is the gradient of the line. N is the number of data 
points fitted. R2 is the square of the correlation coefficient of the fit and 
represents the proportion of variation in Y that is accounted for by the 
determined line of best fit.
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5.1.3 Orientation factor: Measurement of steady state fluorescence 
anisotropies
In order to gauge the accuracy of calculating Ro values for the FRET pairs using 
the dynamic averaging limit of the orientation factor, the steady state 
fluorescence anisotropies of mEGF-Alex 546, mEGF-Atto 647N, 
EGF-fluorescein (Invitrogen) and Vybrant C^DiD (in lipid vesicles) samples 
were determined using an L-format Jobin-Yvon Fluorolog fluorimeter with a 
Xenon lamp as an light source. mEGF-fluorescein is used in section 5.2 and its 
steady state anisotropy is also measured in this section in order to check the 
validity of using the Forster radius of the fluorescein / CigDil FRET pair 
calculated in the literature4 to interpret FRET experiments using an EGF- 
fluorescein conjugate. Each sample was illuminated with vertically polarised 
light and the integrated fluorescence intensities (integrated over 1 s) from vertical 
and horizontal emission polarisations were measured. EGF-Alexa 546 was 
excited at 545nm and fluorescence detected at the peak of fluorescence emission, 
572 nm. Vybrant C^DiD and Alexa 647N were excited at 639nm and their 




Figure 5.3 Geometry of the L-format fluorescence anisotropy measurement with 
a. vertically polarized excitation and b. horizontally polarized excitation.
The anisotropy can be calculated using the formula5
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r = Eqn. 5-3IVV 1
i VH G
where is the measured intensity with excitation polarization X  and emission 
polarization Y. V and H represent vertical and horizontal polarizations 
respectively. The G-factor (the ratio of the responses of the fluorimeter for 
vertically and horizontally polarised light) for each combination of excitation and 
emission wavelengths was determined by measuring the response of the 
fluorimeter to a weak scattering solution (Ludox in deionised H2 O) when 
illuminated with horizontally polarised light. In the L-format method, 
horizontally polarised excitation is perpendicular to both detected polarisation 
orientations. Therefore variations the intensities Ihv and IHH are due to the 
response of the fluorimeter only and the G- factor was calculated using
Eqn. 5-4
Once the G-factors had been determined, Eqn. 5-3 was used to calculate the 
fluorescence anisotropies of the samples. Measurements of dye conjugates in 
glycerol were also performed in order to determine their limiting anisotropies.
The steady state anisotropies of mEGF-Alexa 546, mEGF-Atto 647N, 
mEGF-fluorescein and Vybrant C^DiD in lipid vesicles are shown in table 5.4 
for samples prepared in PBS and glycerol. From these results their depolarisation 
factors, D, are calculated using the identity
r = r0D Eqn. 5-5
These depolarisation factors can be used to lookup the likely minimum and 
maximum values of k2 even though the depolarisation factor due to energy
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transfer is not known6,1. Additionally for FRET pairs where both fluorophores 
exhibit anisotropies < 0.22, the error introduced into donor-acceptor separations 
determined using a Förster radius calculated using a value of k2 = 2/3 is <10%8.
The minimum and maximum values of k2 for both FRET pairs were found by 
comparing the depolarization factors in table 5.4 to those expected from 
numerical simulations reported in the literature7 of ensembles of FRET pairs with 
different relative orientations and values of k2. The minimum and maximum 
values of k for mEGF-Alexa 546 / Vybrant CigDiD FRET pair are 0.35 and 1.8 
respectively. The minimum and maximum values for the mEGF-Alexa 546 / 
mEGF-Atto 647N FRET pair are 0.3 and 2. As the steady-state anisotropy of 
mmEGF-fluorescein was found to be very small (and hence the fluorescein 
molecule retains a large amount of rotational mobility), using the Förster radius 
of unconjugated fluorescein and CigDil found in the literature to interpret FRET 
experiments between the EGF-fluorescein conjugate and Dil should not 
introduce considerable extra errors.
Probe Buffer Steady State Depolarisation
Anisotropy Factor
mEGF-Alexa 546 PBS 0.194 0.537
Glycerol 0.361
mEGF-Atto 647N PBS 0.203 0.567
Glycerol 0.358
mEGF-fluorescein PBS 0.077 0.246
Glycerol 0.313
Vybrant CigDiD lipid vesicles (PBS) 0.154 0.428
Table 5.4 Steady state anisotropies of EGF-dye conjugates and Vybrant CigDiD 
in a lipid environment.
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5.1.4 Calculated Förster radii of the different FRET pairs
The Förster radius for FRET between mEGF-Alexa 546 and Vybrant CigDiD 
was calculated using a value of l.lxlO16 M 'cm 'nm4 for the overlap integral 
J(X), ß D=0.71 and assuming the dynamic averaging value of the orientation 
factor k2 = 2/3. The Förster radius for mEGF-Alexa 546 and mEGF-Atto 647 was 
calculated to be 5.5 nm using J(k) = 2.4xl015 M 'cm 'nm4.
The values of R0 were also calculated using the values for minimum and 
maximum values of k2 given in the previous section. The resulting minimum and 
maximum values of Ro were 6.4nm and 8.4nm for the mEGF-Alexa 546 / 
Vybrant C^DiD FRET pair and 4.9nm and 6.7nm for the mEGF-Alexa 546 / 
mEGF-Atto 647N FRET pair. From these values, the error resulting from using 
k2 = 2/3 is between 10 - 20%.
5.1.5 Estimation of the range of distances that can be measured 
with the FRET pairs
The variation of the FRET efficiency (within a single FRET pair) with donor- 
acceptor separation for the Ro values calculated in section 5.1.4 plus the 
fluorescein / CigDil FRET pair are displayed in figure 5.4.
Due to the dependence of FRET efficiency on the inverse sixth power of the 
donor-acceptor separation, changes in separation produce large changes in FRET 
efficiency in a limited range around the Forster radius. This range for 
mEGF-Alexa 546 and Vybrant C^DiD is approximately between 4.5 and 10.0 
nm. For mEGF-Alexa 546 and mEGF-Atto 647N this range is approximately 
between 3.5 and 8.0 nm. For fluorescein and C^Dil this range is approximately 
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Figure 5.4 FRET efficiency (EFret) as a function of donor-acceptor separation 
for FRET pairs with experimentally determined Forster radii of 5.5 nm (red solid 
line) and 7.0 nm (blue dotted line). The FRET efficiency as a function of 
separation of a fluorescein and CisDil pair (black dashed line, R0 =3.5 nm)4 is 
also shown.
The current picture of the three dimensional organization of ErbBl receptor 
extracellular domains on the surface of cells is heavily influenced by x-ray 
diffraction studies of crystallised ErbBl fragments9'12. These studies suggest that 
the receptor exists as a tethered monomer, extended monomer or a dimer of 
extended monomers mediated by receptor-receptor contacts but stabilized by the 
binding of a ligand such as EGF. EGF is able to bind to all three conformations 
which are assumed to adopt an upright orientation with respect to the membrane.
Although the separation of ligands bound to ErbB 1 in a back-to-back dimer can 
be unambiguously determined from the crystal structures, the separation of 
ligands and the cell surface cannot. The positions of the ligand binding sites with 
respect to the membrane in a tethered ErbBl monomer, an extended ErbBl 
monomer and a back-to-back ErbB 1 dimer have been estimated using atomistic 
molecular dynamics simulations of ErbBl extracellular domains with their 
transmembrane a-helices in a phospholipid bilayer by Johannes Kastner and
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Martyn Winn of Collaborative Computational Project 4 (CCP4, currently 
unpublished). As the full ErbBl extracellular region together with the 
transmembrane region has not yet been crystallised, the IIVO crystal structure11 
of an ErbBl back-to-back dimer was used as a starting point and the missing 
domain IV regions included based upon the co-ordinates from the 1NQL tethered 
monomer crystal structure10. Transmembrane helices previously modelled for an 
ErbB2 homodimer13 but mutated to the ErbBl sequence were added to the two 
domain IV C-termini to anchor the extracellular regions to an atomistically 
modelled phosphatidylcholine bilayer. The structure was simulated for 70 ns and 
from this the separation between the EGF N-termini and the surface of the outer 
leaflet of the bilayer was estimated to be 8 nm. The strcuture of the extended 
ErbB 1 monomer was assumed to be the same as a single ErbB 1 from this dimeric 
structure. Similar simulations of the 1NQL tethered monomer crystal structure 
with the transmembrane helix estimated the EGF N-terminus to be 7 nm from the 
surface of the phospholipid bilayer. Figure 5.5 is a cartoon representation of the 
three structures in the membrane and displays the estimated distances of the EGF 
binding sites to the membrane and the separation of EGF binding sites.
11 nm
◄-------------►
f f f f f f B m m f f m i  ff Plasma
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Figure 5.5 Conformations of the ErbBl extracellular region in the membrane 
derived from published crystal structures and molecular dynamics simulations 
(by Kästner and Wynn, CCP4, unpublished). The extracellular region consists of 
four distinct domains. EGF binds to both domains I and III to stabilize the 
receptor in an extended conformation that can form a dimer through interactions 
of domain II of the receptor.
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Measurements made with suspended, isolated A431 cell membranes suggest that 
the mean separation between ErbB 1 EGF binding sites and the surface of isolated 
A431 cell membranes is between 5.2 and 8.2 nm 14. This falls within the range of 
distances for which the mEGF-Alexa 546 / Vybrant C^DiD FRET pair are 
suitable, suggesting that this would be a suitable FRET pair to investigate the 
distance between ErbBl ligand binding sites and the surface of cells.
However, it is already known that this model doesn’t represent all the possible 
conformations the receptor can adopt at the plasma membrane. The separation 
predicted by the crystal structures between EGF binding sites in an ErbB 1 dimer 
are ~ 11 nm. However, numerous ensemble15'18 and single molecule FRET 
measurements19 with other EGF conjugated FRET pairs have shown significant 
FRET efficiencies between donor and acceptor labelled EGF. These results are 
inconsistent with the crystallographic dimer being the only ErbBl interaction 
present in cells. mEGF-Alexa 546 and mEGF-Atto 647N has a Forster radius 
equal or larger than those previously employed and is therefore suitable for 
investigating of EGF-EGF distances. It is possible that in intact adherent cells 
other receptor conformations might exist for which the mEGF-Alexa 546 and 
Vybrant CisDiD FRET pair is unsuitable. The next section describes a 
preliminary experiment performed to ascertain if this is indeed the case.
5.2 Probing for unexpected ErbBl ectodomain conformations 
using FLIM-FRET of EGF-fluorescein in Ci8DiI labeled 
cells
This section describes a FRET experiment performed to investigate if there are 
activated ErbB 1 ectodomain conformations present in adherent cells that produce 
separations between the EGF-binding site and the cell surface different to those 
predicted by the current model of ErbBl signalling (shown in figure 5.5 in the 
previous section). This was done using the EGF-fluorescein / CisDil FRET pair 
which has a short Forster radius (3.5 nm)4 to investigate the EGF-membrane
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distance in the high-affinity and low-affinity classes of ErbBl receptors in 
adherent cells. The labelling strategy is shown in figure 5.6. To attempt to 
observe receptors in inactive as well as active conformation, light fixation was 
employed before or after binding of the EGF-fluorescein conjugate.
EGF-Fluorescein
Figure 5.6 Labelling strategy for control FLIM-FRET based observations of 
EGF-membrane FRET. The mEGF-fluorescein FRET donor is bound 
specifically to the extracellular region of ErbBl. The acceptor, Vybrant C^Dil is 
free to diffuse in the outer leaflet of the cell membrane.
5.2.1 Materials and Methods
5.2.1.1 Cell culture
A431 cells were obtained from the European collection of Animal Cell Cultures 
and cultured in Dulbecco’s modified Eagles medium without phenol red and 
supplemented with 10% fetal bovine serum, 2mM glutamine and 1% 
penicillin/streptomycin. Cells were incubated at 37°C in the presence of 5% CO2 
in air. lx l05 A431 cells were added to glass bottomed dishes and incubated until 
they reached 80% confluency. Cell cultures were maintained as described in 
section 4.3.1.1.
157
5.2.1.2 Blocking of low-affinity EGF binding to cell surface ErbBl 
receptors
Before labelling with fluorescent probes, half of the samples of A431 cells were 
treated with 200 nM anti-ErbB 1 clone 2E9 (mAb 2E9) and incubated with gentle 
rocking at 4°C for 4 hours. This antibody binds to low-affinity (LA) ErbBls and 
prevents EGF binding to this class of ErbBl receptor20.
5,2.1.3 Fluorescent labelling of cell membranes with lipophilic dye
The culture medium was removed from glass bottomed dishes containing A431 
cells to be labelled with membrane probe and replaced with 100 pi of 5 pM 
Vybrant CisDil in serum free media. Cells were incubated at 37°C in the 
presence of 5% CO2 in air for 10 minutes before washing off excess Vybrant 
CigDil with PBS. The CigDil was observed to be uniformly distributed across 
cell plasma membranes.
5.2.1.4 Binding of EGF-Fluorescein to cell surface ErbBl 
receptors and cell fixation
Cells were lightly fixed with exposure to 1% paraformaldehyde (Electron 
Microscopy Sciences) for 10 minutes at room temperature either before or after 
binding of fluorescein tagged EGF. This causes sufficient cross-linking within a 
complex containing ErbBl to inhibit further conformational changes of the 
receptor and lateral diffusion in the plasma-membrane19, 21. Murine epidermal 
growth factor (mEGF) singly labelled at the N-terminus with fluorescein 
(Invitrogen) was added at a saturating concentration (100 nM in phosphate 
buffered saline) to A431 cells at 4°C to inhibit ligand-induced internalisation of
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ErbBl receptors. After 30 minutes, the cells were washed three times with 
chilled PBS to remove unbound mEGF-fluorescein.
5.2.1.5 FLIM measurement of FRET between EGF-Fluorescein 
and Ci8DiI
Fluorescence lifetime images of EGF-fluorescein (the FRET donor) bound to 
ErbBl in cell membranes of A431 cells with or without Vybrant CixDil (the 
FRET acceptor) were acquired using the multicolour, multidimensional confocal 
microscope described in chapter 4. mEGF-fluorescein was excited with 460 nm 
pulsed laser light using a frequency doubled Titanium:Sapphire laser (Coherent, 
76 MHz repetition rate) and fluorescein fluorescence was detected between 480 
and 520 nm. Time-resolved images were collected with SPC-730 time correlated 
photon counting (TCSPC) electronics and analysed using SPCImage FLIM 
analysis software (both Becker-Hickl GmbH).
5.2.2 Results and Discussion
Time-resolved images of A431 cells were fitted to mono-exponential (for cells 
labelled with mEGF-fluorescein only) or bi-exponential (cells labelled with both 
EGF-fluorescein and Vybrant CisDil) decay models. To the right of Figure 5.7a 
and 5.7b are representative examples of analysed lifetime images of donor and 
acceptor labelled cells. Figure 5.7a shows cells in which the LA receptors have 
been blocked with mAb 2E9 and figure 5.7b shows cells in which all cell surface 
ErbBls are able to bind to mEGF-fluorescein. The colour coded parameter 
displayed in the images is the intensity weighted mean lifetime rm.
The distributions of rm shown to the left of figure 5.7a are from images of cells 
where mEGF-fluorescein binding to LA ErbBls was blocked with mAb 2E9 and 
labelled with Vybrant CigDil acceptor (solid lines) or without acceptor (dotted
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lines). Each distribution represents a different imaged field of view. Samples 
labelled with donor and acceptor produce distributions that peak at much shorter 
lifetimes than those labelled with just the donor. As expected, this change in rm 
cannot be due to acidification effects in the local environment of the cell 
membrane (figure 5.8) and was found for cells fixed before (red) and after (blue) 
binding mEGF-fluorescein. The corresponding distributions from images of cells 
not exposed to mAb 2E9 contains contributions from both LA and HA (< 10 %) 
receptors but unlike the previous data do not show a large and consistent 
reduction in peak rm (figure 5.7b). This suggests that there is FRET between 
mEGF-fluorescein and Vybrant CisDil when the mEGF-fluorescein is bound to 
HA ErbBl but not LA ErbBl. The mean FRET efficiency calculated from the 
observed reductions in EGF-fluorescein rm when bound to HA ErbBl was 0.5. 
The FRET efficiency calculated when EGF-donor is bound to the whole receptor 
population was negligible. The absence of FRET in the LA case is unlikely to be 
due to preferential partitioning of Vybrant CisDil in the membrane as ErbBl has 
been observed in all domains of the membrane including lipid rafts22.
It therefore appears possible that the positions of EGF binding sites with respect 
to the cell surface are very different for the two different affinity classes of 
receptor. If all ErbBl receptors adopt the same extended crystallographic 
configuration upon binding EGF, this implies that HA and LA ErbBl receptor 
ectodomains would need to adopt different orientations with respect to the cell 
surface. As there is no change in FRET efficiency between cells fixed before and 
after binding mEGF-fluorescein, these different orientations would appear to be 
constitutively adopted by the receptors. However, there are some important 
caveats to the interpretation of these FLIM-FRET results. First, the absence of 
FRET observed within the combined LA and HA receptor population may be 
hiding differences between active and inactive conformations that are out of the 
range of the FRET pair used. Although it appears that the distances involved in 
this case are too long for FRET within the mEGF-fluorescein / C^Dil pair, the 
mEGF-Alexa546 / Vybrant CisDiD FRET pair has a longer i?0 value that should 
be suitable for measuring these longer distances.
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a.
Figure 5.7 a. Distributions of xm for mEGF-fluorescein bound to ErbBls in 
A431 cells where LA binding is blocked by mAb 2E9 and whose plasma- 
membranes were labelled with Vybrant CisDil and fixed before (solid red lines) 
or after (solid blue lines) binding mEGF-fluorescein. Control FLIM data from 
mEGF-fluorescein bound to HA ErbBls in the absence of Vybrant C)8DiI are 
shown as dotted lines. Each curve represents a different field of view, an 
example of which is shown to the right. Curves are normalized as photon- 
weighted fluorescence lifetime distributions, b. The equivalent distributions and 
example image obtained when mEGF-fluorescein is allowed to bind to all cell 
surface ErbBls.
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Figure 5.8 pH dependence of mEGF-fluorescein fluorescent lifetime between pH 
5 and pH 7.5.
Second, the exact stoichiometry of this FRET experiment is unknown. Although 
the EGF binding sites of the ErbB 1 receptors are specifically labelled in a 1:1 
ratio with EGF-fluorescein, the Vybrant CisDil acceptor is free to diffuse in the 
cell membrane and individual donors may have multiple FRET partners or none 
at all. The FLIM-FRET results in this chapter cannot distinguish between a 
change in separation and a change in acceptor availability for FRET. In order to 
fully quantify the distance between the EGF-binding sites and the acceptor 
labelled membrane would require repetition of the experiment over a range of 
acceptor surface densities14’ 23. The theory behind this is discussed in the next 
section of this chapter.
5.3 Extended FRET theory for measurements between multiple 
donors and acceptors
Forster’s theory for resonant energy transfer within a single donor-acceptor pair 
was discussed in chapter 2.4. The rate of energy transfer from the donor to the
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acceptor in this simple case depends upon the spectral properties of the donor 
and acceptor, their spatial separation and the relative orientations of the relevant 
transition dipole moments. Situations where there are multiple donors and 
acceptors must also take into account their stoichiometry. In the case of a donor 
situated a fixed distance 1 Ro from two identical acceptors (all free to rotate in 
their fixed positions such that the dynamic averaging limit can be applied to k2, 
Figure 5.9a) the rate at which energy is transferred to each acceptor and the rate 
at which excited state energy is lost by fluorescence are equal.
The efficiency of FRET that would be measured in this case would be 0.67, 
larger than the value of 0.5 expected from a single donor and acceptor with the 
same separation (Figure 5.9b). Without considering the stoichiometry of the 
systems, the FRET efficiencies would lead to the erroneous conclusion that the 
donor-acceptor separations in each case are different. Likewise, if donors are in 
competition to transfer energy to the same acceptor the efficiency of FRET 
measured will be lower than that expected for a single FRET pair (Figure 5.9c).
Figure 5.9 The FRET efficiency (EFREt) measured between multiple donors 
(orange) and acceptors (red) is dependent upon fluorophore stoichiometry.
163
5.3.1 FRET between donor labeled membrane proteins and 
membrane localised acceptor
There has been considerable interest over the last 40 years in finding solutions to 
the problem of FRET between many donors and acceptors distributed in a plane, 
or distributed within two spatially separated planes23'27. This is because of the 
potential of measuring FRET between donors and acceptors in membrane 
systems where donors and acceptors are unlinked and their stoichiometry and 
separation can be dynamic. FRET experiments have been used to probe the 
domain structure of model and cell membranes, aggregation of proteins in cell 
membranes and find the distance of closest approach of membrane protein 
domains to the cell membrane14, 24, 27 ’ 28. Figure 5.10 illustrates the added 
complexity in experiments of this kind with an example of a possible FRET 
experiment aiming to provide spatial information regarding the position of a 
protein domain with respect to the cell membrane. The donor is specifically 
tagged to a position on the protein and the acceptor is localised to the outer 
leaflet of the membrane where it is free to diffuse laterally. As the donor- 
acceptor separations and stoichiometry are dynamic, the measured FRET 
efficiency is dependent upon both the separation of the donor and the surface of 
the cell membrane and the density of acceptors around the donor labelled protein. 
In order to determine the distance of closest approach of donors to the membrane 
in this experiment, the FRET efficiency must be measured over a range of 
acceptor densities and compared to the results expected for a range of donor- 
membrane separations. Due to the complexity of the problem, it is necessary to 
calculate the expected FRET efficiency for a given distance of closest approach 
and acceptor density from numerical approximations or computer intensive 
simulations.
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Figure 5.10 Cartoon representation of a FRET acceptor (red) labelled membrane 
containing a membrane protein specifically labeled at a single domain with a 
donor fluorophore (orange). A high FRET efficiency can be caused either by a. 
changes in protein conformations that places the donor closer to the acceptor 
labeled membrane or b. increased density of acceptors around the donor labeled 
protein.
5.3.2 Analytical solutions for FRET between multiple donors and 
acceptors in 2-dimensions
Before it was possible to produce computer intensive simulations or complicated 
numerical solutions using desktop computers, analytical solutions were sought 
for the problem of Forster energy transfer in two dimensions. These calculations 
are complex and involve assumptions that restrict their validity to specific 
Forster radii, ranges of acceptor density or donor-acceptor plane separations.
One of the most popular analytical solutions has proved to be that derived by 
Wolber and Hudson for the case when the orientation factor is independent of 
donor-acceptor separation23. Its appeal to experimental scientists, particularly 
biologists derives from two points. First, the solutions for given distances of 
closest approach of donors and acceptors can be accurately approximated by a bi­
exponential equation allowing quick and easy graphical comparison with 
experimental data
E f r e t  = 1 - +  A2e klD j  Eqn. 5-6
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where D is the two-dimensional density of acceptors and the values of the fitted 
parameters A \,A 2, k\ and k2 can be found for a given distance of closest approach 
(expressed as a fraction of the Forster radius) in a look-up table23. Figure 5.11 
shows some of these approximations graphically.
Figure 5.11 FRET efficiency (EFREi)as a function of acceptor density for a plane 
of randomly distributed donors and a plane of randomly distributed acceptors 
separated by a distance d. FRET efficiencies for plane separations ranging from 
1.3Ro to the case when the plane separations are negligible compared to Ro were 
plotted using the table of look-up values for the Wolber et al. analytical solution 
to this problem
Secondly, the value of Ro doesn’t appear in the expression for FRET efficiency, 
but is part of a scaling factor for the acceptor surface density. The same solutions 
can therefore be applied to any donor-acceptor pair if acceptor density is in units 
of acceptors per Ro .
However, the approximation given by Eqn. 5-6 is only accurate for acceptor 
densities between 0 - 0.5 acceptors per Ro2, for donor-acceptor distances of 
closest approach less than 1.3i?o and apply only to randomly distributed donors 
and acceptors in the same, or two separate planes. To obtain solutions for 
complicated situations, such as when distribution of fluorophores is non-random
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due to conjugation to proteins, exclusion regions resulting from membrane 
proteins or partitioning in lipid domains as is commonly encountered 
experimentally in cell membranes it is now more common to turn to 
computational simulations.
5.3.3 Computer intensive simulation of FRET between multiple 
donors and acceptors
Monte-Carlo simulations are being used increasingly often to calculate FRET 
between donors and acceptors in many different situations including random 2D 
and 3D distributions of donors and acceptors29, a single donor bound to a protein 
in a plane of acceptors30 and FRET between fluorophores on actin filaments31. A 
variety of methods for obtaining FRET efficiency from the simulations have 
been implemented such as calculating the quantum yield decrease of the donor or 
by using the mean of randomly generated decay rates. More recently, algorithms 
for calculating FRET efficiency from explicitly simulated fluorescence and 
FRET events have been used24,21.
This simpler approach models the incoming excitation radiation as discrete 
'excitons' as well as a distribution of fluorophores, allowing effects such as 
photobleaching, competition between donors for acceptors and experimental 
conditions such as the light source to be easily incorporated into the model. 
Figure 5.12 is flowchart for this kind of Monte-Carlo algorithm as implemented 
by Bemey and Denuser27, and Corry24.
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Figure 5.12 Flowchart for a basic Monte-Carlo algorithm that simulates FRET 
between a distribution of donors and acceptors.
168
The basic steps of the simulation process are
1) Generate fluorophore positions for donors and acceptors
2) Calculate probabilities of energy transfer
3) Generate a schedule of excitons
4) Play excitons and record the number of time a donor fluoresces or 
transfers energy to an acceptor
5) Calculate FRET efficiency
Repeat steps 1-5 for many configurations
In step one fluorophore positions are pseudo-randomly generated depending 
upon the situation being modelled. For example donors might be generated in 
pairs to simulate tagged protein dimers and surrounded by randomly distributed 
acceptors. Alternatively fluorophore positions might be generated and randomly 
assigned to be donors or acceptors to simulate competitive binding of fluorescent 
probes to the same site of a protein. Each randomly generated fluorophore 
position must be checked to ensure that it does not overlap with another and any 
overlaps are adjusted by annealing the position of one of the overlapping 
fluorophores. A buffer region around the simulated area must be included to 
ensure that donor positions around the edge of the simulation have as many 
neighbouring fluorophore positions as those well inside the area and prevent 
underestimation of the overall FRET efficiency.
Once the fluorophore positions are assigned, the separations of each possible 
donor-acceptor pair Ry are calculated. The probability of transferring energy from 




Specifying the value of Ro here simplifies the model as the fluorophore transition 
dipole orientations need not be considered and the orientation factor, k2, need not
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then be calculated for every possible FRET pair. Instead it can be dealt with 
during the determination of the Forster radius.
In step three an exciton schedule is generated based on the properties of the 
illuminating laser and the size of the irradiated area. The flux of excitons and the 
time interval for irradiation gives the total number of excitons. Each exciton is 
then given a random arrival time within the time interval, and randomly assigned 
a target donor.
The excitons are then played in chronological order to see whether they are 
absorbed by their target donors and if they are whether that donor fluoresces or 
transfers energy to an available acceptor. If the target donor is unavailable 
because it is already excited, then that exciton is discarded. The time taken for an 
excited donor to release its energy is decided using the formula
Td = r r lnyD Eqn. 5-8
where yo is a uniformly distributed random number between 0-1 and i j  is the de­
excitation rate of the donor due to radiative and non-radiative transfer
r"1 = r ' 1lT 1D
{  A ,  \  free
i+2X Eqn. 5-9
where td is the experimentally measured donor lifetime in the absence of 
acceptors and Afree is the total number of acceptors available for energy transfer. 
Once a release time has been decided the simulation must decide the method of 
de-excitation. The probabilities of de-excitation by fluorescence emission or 
resonant energy transfer to an acceptor are given by
— , and —  P„ 
t d  * d
Eqn. 5-10
170
respectively. A cumulative histogram of each possible de-excitation event is 
produced and a uniform randomly generated number between 0 and 1 used to 
pick which release class will be used and which acceptor will be involved in 
energy transfer if necessary. A score is then simply kept that counts how many 
excited donors fluoresce (retained in a variable, FLUOR) and how many transfer 
energy to an acceptor (retained in a variable, FRET). Acceptor unavailability 
from previous excitation can be included in the exact same way as donor 
availability for subsequent excitons. The time the acceptor remains in the excited 
state is decided using
Ta = a Eqn. 5-11
where ta is the experimentally measured acceptor fluorescence lifetime and yA is 
a uniform random number between 0 and 1.
Once all excitons have been played, the FRET efficiency (Efret) is simply 





The simulation is then repeated many times for new fluorophore distributions 
and exciton schedules in order to obtain a mean FRET efficiency over many 
configurations. The results of this averaging can be improved by increasing the 
size of the modelled area or by increasing the number of repeats. It has been 
shown that this kind of simulation can accurately describe FRET between 
randomly distributed fluorophores in three and two dimensions24,21.
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5.4 Sum m ary
Determination of distances from quantitative FRET measurements requires as a 
minimum the Förster radius of the FRET pair involved to be known. The Förster 
radius has been calculated for two FRET pairs that can be used to investigate the 
three dimensional structure of signalling ErbBl receptor complexes at the cell 
surface. These two FRET pairs EGF-Alexa 546 / CigDiD and EGF-Alexa 546 / 
EGF-Atto 647N have Förster radii of 7.0 nm and 5.6 nm respectively. The 
former pair is used in the next chapter to investigate the separation of the EGF 
binding site to the cell surface while the latter pair is suitable for measurements 
investigating the lateral separation of EGF binding sites in receptor complexes. 
The distances expected from the high resolution structure of ErbB 1 dimers and 
monomers, plus previous studies of FRET between donor and acceptor labelled 
ErbBl ligands suggest that these FRET pairs will be suitable. A control 
experiment using a previously characterised FRET pair4 with a low Förster 
radius confirmed a previously unknown structural difference between the 
functionally distinct high- and low-affinity classes of ErbB 1 receptors that should 
be detectable by the EGF-Alexa 546 / CigDiD FRET pair.
Accurate determination of distances from ensemble FRET efficiencies must also 
avoid biasing of the FRET efficiencies through incorrect assumptions regarding 
the stoichiometry of donors and acceptors. In the case of the EGF-Alexa 546 / 
CigDiD FRET pair where the donor is bound to a membrane protein and the 
acceptor is free to diffuse in the outer leaflet of the cell membrane the 
stoichiometry is dynamic during measurement of the donor lifetime. 
Quantification of the distance of closest approach of donors to the acceptor 
labelled cell surface requires computational simulation of the experiment in order 
to predict how the measured average FRET efficiency will vary with the density 
of acceptors in the membrane, for a given distance of closest approach.
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6 Investigating three-dimensional structural variations 
in activated ErbBl receptors
The motivation for developing the bi-directional FRET technique and its 
adaptation to adherent cells was to investigate the three dimensional 
conformation of ErbB 1 with respect to the plasma membrane. In this chapter the 
method is described and used to confirm structural differences between the low- 
and high-affinity classes of the ErbBl receptor in adherent cells. It is then 
demonstrated how the results of the FRET measurements can be related to the 
early signalling functions of the receptor by repeating the FRET measurement 
under experimental conditions that disrupt normal receptor function and 
correlating them with complimentary information regarding receptor 
oligomerisation and phosphorylation states.
6.1.1 The 3D architecture of signaling ErbBl complexes
In chapter 2 the currently accepted model of the 3D architecture of the ErbB 
family of receptor tyrosine kinases and the currently proposed mechanism of 
signal transduction by ErbBl was discussed. This model is a composite of 
biochemical evidence1’2 and structural insights derived from crystallography3'8. 
However, a wealth of evidence from the literature has suggested that the 3D 
architecture of signalling ErbBl complexes on the surface of cells is more 
complex than that put together from crystallographic data of ErbB 1 fragments9'
l4. As discussed in the previous chapter, ensemble and single molecule FRET 
experiments designed to measure the distance between ligand binding sites in 
cellular ErbBl complexes have consistently returned mean donor-acceptor 
separations much shorter and therefore inconsistent with the ~ 11 nm distance 
found between ligand binding sites in the crystallographic back-to-back dimer. 
The results shown in section 5.2 suggest that in a ligand-bound extended state3,4
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ErbBl adopts at least two different conformations with respect to the cell 
membrane that place the ligand binding site at different distances from the cell 
surface and are associated with the two binding affinity classes of ErbB 1 found 
in cells. That this has not been observed before is perhaps unsurprising as 
previous FRET studies aiming to measure ErbBl ligand-membrane separation 
have investigated receptor in non-cellular contexts where ErbB 1 receptors do not 
display high binding affinity for ligand15. The mean distance of closest approach 
of the ErbBl ligand binding site to the surface of isolated membranes is 6.7 nm16. 
It has been proposed that high affinity ErbBl might adopt a ‘flat’ conformation 
parallel to the cell surface whereas low affinity receptors could be perpendicular 
to it standing ‘proud’13. This would enable high affinity receptors to form 
interactions other than the back-to-back dimer inaccessible to the low affinity 
population. It is also notable that this is unanticipated from the crystal structures 
alone, although very recently, protein tomography studies of ErbB 1 in fixed cells 
performed at the same time as this work detected receptor ectodomains that were 
oriented parallel to the membrane17.
Because ErbBl is expressed as a single translation product18 and given that HA 
and LA ErbBl ectodomains appear to adopt their orientation relative to the 
membrane prior to and unaffected by growth factor binding13, it would follow 
that ErbB 1 ectodomains need to be somehow be ‘primed’ after translocation to 
adopt the very different ectodomain orientations associated with high or low 
affinity EGF-binding status. A similar observation has been previously reported 
for the Integrin receptor19. Whether priming of EGFR actually occurs and/or 
which interactions may be involved is not yet known.
6.2 M aterials and methods
6.2.1 Cell Culture
A431 and HeLa cells were purchased from the European Collection of Animal 
Cell Cultures. A431 cells were cultured in Dulbecco’s modified Eagles medium
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without phenol red and supplemented with 10% fetal bovine serum, 2 mM 
glutamine, and 1% penicillin/streptomycin. HeLa cells were cultured in 
minimum essential medium with Earle’s salts without phenol red, supplemented 
with 10% fetal bovine serum and 2 mM glutamine (all Invitrogen). Cells were 
incubated at 37°C in the presence of 5% CO2 in air. Maintanence of cells in 
culture was performed as described in section 4.3.1.1.
6.2.2 Fluorescent labelling
In this chapter two fluorescent probes are used to specifically label the EGF 
binding site of ErbBl with a FRET donor or acceptor to investigate the 
oligomerisation of receptors. A third membrane localised acceptor is used in 
separate experiments with the same donor to investigate the distance of closest 
approach of the EGF binding site to the membrane surface.
Murine Epidermal Growth Factor (mEGF, Peprotech) singly labelled at the N- 
terminus with Alexa 546 (Invitrogen) or Atto 647N (AttoTec) binds specifically 
in a 1:1 ratio with ErbB 1 (conjugation of mEGF and dyes performed by 
Cambridge Research Biochemicals). These dyes have emission and excitation 
spectra suitably separated for two colour imaging but can act as a FRET pair. 
Vybrant C |8DiD (Invitrogen) is a lipophilic phospholipid analogue that is able to 
insert into and freely diffuse in the outer leaflet of the cell membrane, and 
exhibits similar fluorescence spectra to Atto 647N. The Forster radii for these 
two FRET pairs calculated in chapter 5 are 7.0 nm for mEGF-Alexa 546 / 
Vybrant CisDiD and 5.6nm for mEGF-Alexa 546 / mEGF-Atto 647N.
Samples with acceptor labelled membranes were prepared by adding 100 pL of 
5 pM or 1 pM Vybrant CisDiD in serum free media to A431 or HeLa cells that 
had been deprived of serum for 16 hours upon reaching 80% confluency. This 
was done to remove the effect of EGF and other growth factors present in serum. 
After incubation at 37°C for 8-15 minutes excess Vybrant CisDiD was washed 
off with serum free media. 40-80% of cells were found to have incorporated
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Vybrant CigDiD into their membranes after this treatment. Example confocal 
images of A431 cells labelled in this way with Vybrant CigDiD and excited with 
a 639 nm CW laser are shown in figure 6.1. It was found that although individual 
cells had uniformly labelled membranes, variation was observed in the amount of 
membrane probe incorporated by different cells and Vybrant CigDiD was not 
completely restricted to the plasma membrane.
Figure 6.1 a-c. Confocal images of A431 cells labelled with Vybrant CigDiD. 
The image resolution is 256 x 256 pixels and the field of view is 63 x 63 pm.
Binding of dye-conjugated ligand to ErbB 1 in A431 cells was achieved either by 
adding a saturating concentration of EGF-Alexa546 (200nM) or 1:1 
mEGF-Alexa 546 : mEGF-Atto 647N (total EGF concentration 400nM) in PBS 
to cells at 4°C for 30 minutes. At this temperature ligand-induced endocytosis is 
inhibited. Cells were lightly fixed by exposure to 1% paraformaldehyde (electron 
microscopy sciences) for 10 minutes at room temperature either before or after 
ligand binding, which causes sufficient cross-linking within a complex 
containing ErbBl to inhibit further conformational changes of the receptor and 
lateral diffusion in the plasma-membrane20. It has been shown previously that 
cross-linking with 1% paraformaldehyde does not cause additional aggregation 
of ErbBl13.
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6.2.3 Blocking of low-affinity EGF binding to cell surface ErbBl 
receptors
A431 or HeLa cells were treated with 200 nM anti-ErbBl clone 2E9 and 
incubated with gentle rocking at 4°C for 4 hours. This antibody binds to low- 
affinity ErbBls on the surface of cells and prevents EGF from binding to this 
class of receptor21. This was done before depolarization of the plasma membrane 
or activation of PKC, after depletion of membrane cholesterol and during 
inhibition of ATP production in the sample treatments described in the following 
section.
6.2.4 Disruption of normal ErbBl function in cells
In order to demonstrate how the results of FLIM-FRET experiments designed to 
investigate ErbBl conformation and lateral organisation can be related to 
receptor function, cell samples were exposed to four treatments that disrupt the 
normal function of the receptor. These aimed to
1. Activate protein kinase C (PKC), an intracellular protein that binds to the 
juxtamembrane region of ErbBl inhibiting ErbBl kinase activity and 
abolishing high-affinity ligand binding (whilst ensuring that ErbBl is 
targeted for recycling ' )
2. Disrupt lipid rafts by depletion of membrane cholesterol. ErbBl localised 
in rafts is thought to be inhibited by the raft environment and cholesterol 
depletion results in an increase in receptor activity25,26
3. Inhibit cellular ATP production, which prevents receptor intracellular 
domain phosphorylation and hence phosphorylation dependent binding of 
intracellular effectors
4. Depolarise the tightly controlled plasma membrane potential which
27prevents EGF-induced hyperpolarisation of the membrane potential“
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Although these treatments do not specifically affect the ErbB 1 receptor only, any 
variation in ErbBl structure seen under the different experimental conditions 
would validate the bi-dimensional FRET methods ability to relate structure and 
function.
6.2.4.1 Incubation with PMA (PKC activation)
A431 cells were incubated in 100 nM. phorbol 12-myristate 13-acetate (PMA), 
diluted in PBS and containing 0.01% DMSO, for 30 minutes at 37°C to activate 
PKC.
6.2.4.2 Depletion of plasma membrane cholesterol
A431 cells were treated with 10 mM methyl-(3-cyclodextrin (MpCD) diluted in 
serum free media for 30 minutes at 37°C to deplete their membranes of 
cholesterol. Cells were then triply washed with PBS before treatment with mAb- 
2E9 if necessary and fluorescent labelling.
Ó.2.4.3 Inhibition of cellular ATP production
For experiments requiring the inhibition of ATP-dependent cellular processes, 
A431 cells were treated with 10 mM 2-Deoxyglucose + 10 mM Sodium Azide + 
0.1 %BSA (DSA) for 20 minutes at 37°C. This treatment inhibits the production 
of ATP by glycolysis and oxidative phosphorylation respectively.
181
6.2.4.4 Depolarisation of plasma membranes
The membranes of pre-chilled A431 cells were partially depolarised by 
incubation with 100 pM Ouabain diluted in PBS for 10 minutes at 4°C. Samples 
with acceptor-doped membranes were labelled with Vybrant CigDiD prior to 
depolarization. The partial depolarisation was maintained whilst the cells were 
incubated in dye conjugated mEGF solutions by diluting the mEGF-dye 
conjugates in PBS supplemented with 100 pM Ouabain. The total incubation 
time in Ouabain was 40 minutes at 4°C.
6.2.5 Measurement of intracellular calcium concentration during
EGF signaling in wildtype and partially depolarised A431 cells
A431 cells were simultaneously loaded with Fluo-4 and FuraRed Ca2+ indicators 
by incubation with a 5 pM Fluo-4 and lOpM FuraRed in PBS with 0.02% 
(weight per volume) Pluronic F-127 for 1 hour at 37°C. Pluronic F-127 is a non­
ionic detergent that assists in dispersing the non-polar Fluo-4 and FuraRed in 
aqueous media. The calcium indicator solution was then washed off with PBS. 
Some of these samples were then incubated with 100 pM Ouabain for 40 minutes 
before being imaged immediately.
The concentration of intracellular calcium as reported by the ratio of Fluo- 
4/FuraRed fluorescence intensity was measured in live A431 cells after the 
addition of mEGF at 21°C. Both dyes were excited by 488nm CW laser light 
from an Ar+ laser. Fluo-4 and FuraRed fluorescence was split by at 580 nm long 
pass dichroic mirror (Nikon DM 580) with Fluo-4 fluorescence detected between 
500 nm and 550 nm and FuraRed fluorescence detected between 572.5 nm and 
647.5 nm. 512 x 512 pixel images of both channels were scanned simultaneously 
every 30 seconds (frame time = 10 seconds) for 16 minutes. Cells were imaged 
in glass bottomed culture dishes that initially contained 0.5ml of PBS which was 
enough to cover the cells. At 120 seconds 0.5ml of 400nm mEGF was added
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drop-wise to give a final concentration of 200nM. This was done rather than 
perform a complete change of media to ensure that the focal plane was not lost 
whilst minimizing the time taken for the added mEGF to diffuse into the existing 
media.
6.2.6 FLIM-FRET measurements
Fluorescence lifetime images of mEGF-Alexa 546 (donor) bound to ErbBl in 
cell membranes prepared with or without Vybrant C^DiD acceptor were 
acquired using the multicolour, multi-dimensional laser scanning confocal 
microscope described in Chapter 4. mEGF-Alexa 546 was excited with 545 nm 
pulsed laser light (Coherent, MIRA-OPO. 76 MHz repetition rate) and the 
Alexa546 fluorescence was detected between 575 and 625 nm. The resulting 
time-resolved images were analysed using SPCImage (Becker-Hickl GmbH) 
FLIM analysis software.
Fluorescence intensity decays were fitted to a single exponential decay model 
when only donor was present and a bi-exponential model when both donor and 
acceptor were present to extract weighted mean lifetimes. The reduced £  
parameter was used to judge the goodness of fit, which was deemed acceptable 
when 0.8<22<1.2. The measured efficiency of FRET, E FREt, is related to the 
lifetime of the donor in the presence (xDA) and absence ( td) of acceptor by
E FRET Eqn. 6-1
For each imaged cell, a value for td or tda was obtained by taking the mean of 
the distribution of lifetimes of pixels in the cell membrane. For bi-exponential 
fits these distributions were of the weighted means of the two fitted lifetime 
components for each pixel, rm.
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In the case of FLIM acquisitions of cells labelled with both donor and acceptor, a 
corresponding confocal image of Vybrant C^DiD was taken afterwards. A 
639nm CW laser (PTI) was used to directly excite the membrane localised DiD 
and the emitted fluorescence was collected at wavelengths >670 nm from the 
same field of view as the FLIM data. Vybrant C^DiD images were acquired at a 
256x256 pixel resolution so as to be directly comparable to the FLIM images. 
ImagePro (Media Cybernetics) was used to manually obtain the mean Vybrant 
Ci8DiD fluorescence intensity in the plasma-membranes of cells. By taking 
advantage of the variation in Vybrant CisDiD labelling between cells exposed to 
the same Vybrant C^DiD loading solution, tda could be measured for a large 
distribution of acceptor densities with far fewer samples. Values of FRET 
efficiency and acceptor intensity were obtained from areas of individual cell 
membranes containing approximately the same intensity of membrane probe. 
Acceptor intensity was normalised to the 639 nm laser power at the time of 
measurement. Datasets were typically constructed from analysis of >100 cells. 
545 nm laser power incident on the sample was kept <125 ¿/W, 639 nm laser 
power was <100 juW.
6.2.7 Calibration of acceptor density in cell membranes
Phosphatidylcholine giant unilamellar vesicles (GUVs) in distilled water were 
prepared using a rapid GUV process51. Vybrant C^DiD (acceptor) and Vybrant 
CisDil (donor) were added to the GUV suspension to a total concentration of 
5pM and 0.5pM respectively and incubated for 20 minutes at 37°C. 0.5ml of the 
suspension was then added to a glass-bottomed microscope dish and labelled 
lipids spontaneously formed monolayers on the glass surface. FLIM images and 
corresponding CigDiD intensity images were acquired as in section 6.2.6 and 
acceptor photobleaching with 639 nm CW laser light was used to reduce the 
density of acceptors whilst keeping the donor density the same. The data was 
fitted to the analytical expression for zero distance of closest approach between 
donors and acceptors derived by Wolber et al28, as has been previously 
validated16.
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1 -  Efret = 0.6463e“4'749775 + 0.3537e“20618D , where D = KI Eqn. 6-2
Where D is the density of acceptor, /  is the measured Vybrant C^DiD 
fluorescence intensity and K  is a constant factor (with dimensions of inverse 
fluorescence intensity) that converts this into acceptor density. The units of 
acceptor density are acceptors per Rq . The value for K was found to be 
0.089+0.003.
6.2.8 Monte-Carlo simulation of FRET between ErbBl-EGF- 
Alexa546 and membrane localised Vybrant Ci8DiD
Pseudo-random fluorophore distributions produced by simulated annealing were 
obtained using a custom implementation in C++ produced by Dr Daniel Rolfe of 
STFC Daresbury Laboratory which was based upon the Monte-Carlo FRET 
algorithm developed by Ben Corry29. Dr Rolfe’s software simulated FRET 
between ErbBl-mEGF-Alexa546 and membrane localised Vybrant CisDiD and 
then fit the results of the simulations to the experimental data. The basic 
function of the algorithm is outlined in Chapter 5.3. Modifications to this 
algorithm to take into account the details of the experimental FLIM-FRET 
measurements being simulated plus the details of the fluorophore distributions 
used make up the rest of this section.
6.2.8.1 Simulated distributions of donors and acceptors
EGF-Alexa 546 (donors) bound to ErbBl in a membrane containing a random 
distribution of Vybrant C^DiD (acceptors) were modelled as two flat, 
independent planes of donors and acceptors separated by a distance, d  (Figure 
6.2a).
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Figure 6.2 a. Donors are modeled as occupying a flat two-dimensional plane 
positioned a distance d above a similar plane of acceptors. The separation Ry 
between each donor i and acceptor j  can be determined simply from d  and their 
lateral separation, b. FRET efficiency as a function of donor -  acceptor 
separation shown for two identical donors separated by 4.5 times the donor -  
acceptor Forster radius.
Donors and acceptors were considered to be circles of radius lnm for the purpose 
of producing distributions of non-overlapping fluorophores. The surface density 
of membrane bound ErbBl is in the range 50-1000 receptors per ¡um2 in A431 
cells30,31. The Forster radius, Ro, of the EGF-Alexa 546 / Vybrant CisDiD FRET 
pair is 7nm to the nearest nm. Simulations of receptor positions randomly 
distributed with a surface density of 1000 receptors per ¡urn showed that the 
mean separation of receptors was greater than 4.5 times this Ro. Because of this 
donors bound to individual receptors, or receptor oligomers are considered not be
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competing with donors on other receptor complexes to transfer energy to 
acceptors (Figure 6.2b).
Donors were modelled above the middle of an area of randomly distributed 
acceptors. A small exclusion zone underneath each donor is included to mimic 
the area excluded by the receptor transmembrane domain. As more than one 
dimeric ErbB 1 interface may be possible and the structure of ErbB 1 tetramers is 
uncertain9,10,13, these were simulated by placing donors at intervals of n or n/2 
radians around the circumference of a circle of radius Rmuit such that the oligomer 
orientation was random. This is a valid approximation that accounts for donors 
bound to receptors in a complex competing for acceptors because the FRET 
efficiency returned by the simulation (and indeed the experimental data) is an 
average over many acceptor distributions. Two different methods of generating 
the random distributions were used, depending upon the range of acceptor 
densities required. To produce simulated FRET results in the range 0-5 acceptors 
per Ro2, a simulated annealing procedure was used whereby random positions in 
the simulated area were allocated to acceptors and the position of any 
overlapping acceptors was randomly altered until no overlaps remained. 
However, this process failed to find non-overlapping acceptor positions for 
acceptor densities > 5 per Ro2, so a second procedure was used for simulations 
that required high acceptor densities. This second algorithm began with the 
simulated area completely saturated with hexagonally packed acceptor before 
randomly removing acceptors to achieve the required surface density. The 
position of each acceptor was then randomised one by one (with ten passes of 
randomisation in total). This procedure is capable of producing random 
distributions up to the hexagonal close packing limit and succeeds where the 
original simulated annealing procedure fails because it begins from a non- 
random but already non-overlapping distribution.
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6.2.8.2 The exciton Schedule
The exciton schedules used were generated using the properties of the 
illuminating laser used to obtain the FLIM-FRET data to be compared to the 
simulations. The excitation source was a MIRA-OPO pumped by a Ti:Sa laser 
that produced pulses of 545nm laser light, 200fs in duration at a repetition rate of 
76 MHz. Due to the confocal geometry of the FLIM-FRET experiment, 84% of 
the laser power falls within a radius Rm, the distance from the centre of the 
illuminated area to the first minima of an airy disc. All excited receptors fall 
within this region as experimentally, fluorescence from outside this region will 
be rejected by the confocal pinhole. To simplify the model, the laser profile was 






where PiaSer is the laser power measured exiting the microscope objective. From 
this the number of photons produced per pulse that reach the simulated area Asim 
can be easily determined by
N phot
Alaser ^ s im
h c fp u ls e
Eqn. 6-4
where f puise is the repetition rate of the pulsed excitation, h is Planck’s constant 
and c is the speed of light in vacuum. For each donor, the mean number of 
photons that excite it (hence the mean number of excitons per donor per pulse) 
can be calculated from the concentration of donor molecules Zdonor and their 
absorption cross-section at À, Xdonor
^ excitons ^  donor ^  donor ^  phot Eqn. 6-5
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A schedule for these photons was created one pulse at a time for a total of Npuises, 
set by the user. For each pulse the number of photons is sampled from a poisson 
distribution with mean NexcUon. The arrival time of each photon is selected from a 
random uniform distribution and randomly assigned to a donor.
6.2.8.3 Simulation results
Each simulation was repeated for 2000-6000 configurations for a given set of 
parameters, with new donor-acceptor distributions and exciton schedules 
generated for each configuration. From these repeats, the mean and standard 
deviation of the FRET efficiency were calculated. Table 6.1 contains a list of the 
parameter values used and an explanation of their origin. FRET efficiency as a 
function of acceptor density was determined using the Monte-Carlo algorithm for 
donor plane to acceptor plane separations, d, from 0.5 to 20nm in steps of 0.5nm 
for donors as monomers, dimers and tetramers.
These results are shown for the acceptor density range 0-2 acceptors per R(2in 
Figure 6.3. Note that the curves converge at large distances and also for 
increasing acceptor density at short distances. The effect of simulating multiple 
donors in close proximity is a reduction in the FRET efficiency for a given 
acceptor density and is most pronounced at short plane separations.
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Adon 5 0 0  pm"2 M ean  va lu e  o f  h e tero g en eo u s E rbB 1 d en sity  in
c e lls30’31
receptor typ e m on om er, d im er, 
tetram er
Rdon 1 nm L ength  o f  A le x a 5 4 6  fluorophore lo n g  ax is
Rexel 1 - 2  nm R adius o f  area ex c lu d ed  to  accep tors due to the  
ErbB 1 transm em brane dom ain
Rmult 2 nm B a sed  on  probe d im en sio n s  (R j0n)
donor life t im e , td 3 .2  ns E G F -A lex a 5 4 6  flu o rescen ce  life tim e
Xdonor 3 .3 x l0 " 16 cm 2 C alcu lated  from  the m easured  E G F -A lex a 5 4 6  
A bsorption  c o e ff ic ie n t  at 5 4 5 n m
Race 1 nm L ength  o f  V ybrant C jgD iD  fluorophore long  
ax is
accep tor life tim e , rA 1.2 ns F lu o rescen ce  life tim e  o f  V ybrant C ]8D iD
d on or-accep tor  Forster  
radius, R 0
7 .0 1 8  nm (d eta ils  o f  ca lcu la tio n  can  b e  fou n d  in sec tio n  
5 .7 )
tpulse 0 .0 0 0 2  ns P u lse  duration o f  C oherent M IR A
f pulse 7 .6 x 1 0 7 P u lses per seco n d  generated  b y  T i:S a  pum ped  
C oherent M IR A  O PO
Npulse 5 0 0
A 545  nm D o n o r  excita tion  w a v e len g th  (u sed  to ca lcu late  
num ber o f  p h oton s per p u lse  from  Piaser)
P laser 125 pW L aser p ow er in c id en t on  sam p le (m easu red  after 
m icro sco p e  o b jec tiv e )
Rm 0 .2 5 6  pm D ista n ce  from  centre o f  the d iffraction  lim ited  
co n fo ca l spot to  the 1st m in im u m  o f  an A iry  
d isc  for A = 5 4 5  nm
Nconfig 2 0 0 0 -6 0 0 0
Table 6.1 Parameter list for Monte-Carlo simulation of FRET between EGF- 
Alexa 546 bound to ErbBl in a flat membrane labeled with Vybrant CigDiD.
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Figure 6.3 Results of Monte-Carlo simulations of FRET between donors and 
randomly distributed acceptors occupying two spatially separated planes 
produced by Dr Daniel Rolfe. Simulated FRET efficiency as a function of 
acceptor density is shown for donor-acceptor plane separations, d, between 0.5- 
15 nm for monomeric (lines), dimeric (dashed lines) or tetrameric (dotted lines) 
donors. The Forster radius used in the simulation is 7nm.
6.3 Results and discussion
6.3.1 FRET between EGF-Alex 546 and Vybrant DiD in wildtype 
A431 cells
Figure 6.4 shows an example of A431 cells labelled with Vybrant DiD and 
lightly fixed after binding EGF-Alexa 546.
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Figure 6.4 Images of wildtype A431 cells labelled with Vybrant Ci8DiD and 
fixed after binding mEGF-Alexa 546. a. mEGF-Alexa 546 fluorescence intensity 
b. Vybrant C^DiD fluorescence intensity c. Composite fluorescence intensity 
image of mEGF-Alexa546 (green) and Vybrant CigDiD (red) 
d. mEGF-Alexa546 fluorescence lifetime. Images are of a 63 x 63 pm field of 
view.
Figure 6.4a is an intensity image of mEGF-Alexa 546 bound to ErbBl in the 
membranes of a cluster of A431 cells. Figure 6.4b shows the intensity of Vybrant 
CisDiD and displays clear variation in Vybrant C |8DiD surface density between 
cells. This could be because the poor solubility and consequent inhomgeneity of 
the diluted Vybrant CigDiD results in variations in the amount of probe that 
comes into contact with each cell during labelling. The density of acceptor in the 
membrane of each cell is much more homogeneous, presumably due to diffusion 
of Vybrant CisDiD through the cell membrane. Figure 6.3c is a false colour 
image of combined EGF-Alexa 546 (green) and Vybrant CigDiD (red) intensity. 
The corresponding fluorescence lifetime image of EGF-Alexa 546 is shown in 
figure 6.4d. Increasing levels of Vybrant C^DiD labelling correlate with a 
reduction in EGF-Alexa 546 lifetime due to FRET between the two fluorophores. 
Despite the fact that samples were prepared at 4°C to prevent ligand induced
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internalisation before fixation, EGF-Alexa 546 and Vybrant CigDiD is seen in a 
small number of vesicles as well as in the plasma membrane.
Figure 6.5 shows FRET efficiency as a function of Vybrant CigDiD density 
measured in wildtype A431 cells lightly fixed after binding EGF-Alexa 546. The 
data acquired from cells where low-affinity EGF-Alexa 546 binding was blocked 
with mAb-2E9 (red crosses) is visibly different to the data acquired from cells 
unexposed to the antibody (blue crosses). Each data point represents the average 
value from the pixels in the membrane of an individual cell.
Figure 6.5 FRET efficiency as a function of acceptor density measured between 
EGF-Alexa 546 bound to ErbBl and Vybrant CigDiD in the cell membrane of 
wildtype A431 cells. Blue crosses represent data from the whole cell surface 
population of ErbBl receptors and red crosses represent data where 
EGF-Alexa 546 binding to low-affinity receptors has been blocked.
Least squares fits of the model E vs Eacc curves shown in figure 6.3 to the data 
were performed by the modelling software to obtain the best-fit plane separation 
d. The software used linear interpolation in d  to obtain model curves for d  values 
between those simulated. The program estimated errors in the fitted values of d 
using the bootstrap procedure32, where 500 resampled datasets were generated
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from each dataset, and fitted using the same procedure as the real data. The 
distribution of fitted parameters from the resampled datasets gives an estimate of 
the parameter probability distribution arising from random errors in the data. 
Each resampled dataset has the same number of points as the real dataset, but the 
points were randomly selected (with replacement) from the real dataset. For each 
bootstrap fit the model curve was also randomised by adding a random Gaussian 
error to the FRET efficiency using the (small) standard error in the mean 
determined from the multiple Monte-Carlo configurations. This was done to 
propagate the random errors in the Monte-Carlo simulations into the bootstrap 
parameter distribution estimates.
Figure 6.6 shows the output of the fitting routine for the data acquired from 
ErbBl receptors wildtype A431 cells. The data obtained in the absence of mAb 
2E9 (Figure 6.6a) returns a best fit for the distance of closest approach of EGF 
binding sites to the cell surface of 6.34 nm. However, in the data from A431 
wildtype cells where LA binding is blocked with mAb 2E9 (Figure 6.6b), there is 
a clear plateau in the FRET efficiency and E tends to a value ~0.6 as the acceptor 
density increases. This does not fit the models, where E tends to a value of 1 as 
acceptor density increases and plane separation decreases. In addition, the same 
data shows an initial rise in E as a function of Eocc which is much steeper than in 
the models.
The discrepancies between the data and the model in this case suggest that some 
of the model assumptions do not hold for the mAb 2E9 challenged ErbBl 
dataset. Removing the assumption that the local acceptor concentration around 
the labelled receptors was the same as measured average acceptor concentration 
would account for the unexpectedly steep initial rise in FRET efficiency with 
acceptor density. To account for this in the model it was proposed that the 
experimentally measured mean acceptor density could be lower than the acceptor 
density in the submicroscopic region around the donors by some factor, S/ac. 
Applying a X/flC >1 effectively compresses the model curves by a factor E/ac. 
Unsurprisingly, when refitting the high-affinity data to the model curves with E/ac 
allowed to vary the effect of E/ac on the curves is correlated with that of the plane 
separation d, requiring constraints to be set on the permissible values of E/ac.
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Figure 6.6 Results of fitting model E vs ZaccR02 curves to the FRET efficiency as 
function of acceptor density obtained from a. the entire cell surface ErbBl 
population and b. high-affinity ErbBls only. Green curves represent the best fit 
curve and the corresponding donor-acceptor plane separation, d, is displayed in 
the bottom right of the panels along with the mean value of d obtained using the 
bootstrapping procedure.
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Dialkylcarbocyanine dyes preferentially dwell in phospholipid phases depending 
upon lipid chain length and have been observed to avoid sphingomyelin and raft- 
marker rich liquid ordered domains33, 34. The Vybrant C^DiD acceptor in the 
system being modelled has a chain length of 18 and therefore preferentially 
partitions with gel phase phospholipids of similar chain lengths. This partitioning 
is the most likely source of any discrepancy between the measured mean 
acceptor density and the actual local acceptor density around a donor. As the 
experimentally measured Vybrant CigDiD surface densities are low, it was 
assumed that this partitioning is independent of the total amount of probe 
incorporated with the membrane and that E/ac is not a function of £acc. An upper 
limit of YjfaC = 3 can be set from the experimentally measured partitioning 
coefficient (the ratio of dye concentrations in the gel phase and the fluid phase) 
of C 18 chain length dialkylcarbocyanine dyes in model membranes consisting of 
two pure phases at room temperature35. This will be the maximum factor by 
which the acceptor concentration can be enhanced given that cell plasma- 
membranes are of considerably lower purity than model membranes.
A similar option was considered to explain the unexpected plateau in the data. By 
removing the assumption that all donors can transfer their excited state energy to 
the acceptors through FRET by postulating there is a population of donors in the 
sample which are somehow unable to do this, the results of the Monte-Carlo 
simulations can be adjusted to take this into account. Possible reasons for 
supposing such a population exists, include: (i) some donors being attached to 
receptors in a conformation that places the donor >>~15 nm from the acceptor 
labelled cell surface; (ii) donors being attached to receptors localised to fractions 
of the membrane to which the DiD acceptor is somehow excluded (either through 
membrane level effects or aggregation of large protein complexes). Given the 
ErbBl ectodomain crystal structures reported in the literature so far, (i) was 
considered unlikely.
If an exciton is incident on one of these donors which cannot be involved in 
FRET, it is either absorbed leading to fluorescence emission from that donor, or 
not absorbed if that donor is already excited. If a fraction £Vrac of donors is
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potentially able to transfer energy to acceptors, while the fraction unable to 
FRET is 1-Efrac, then the effective FRET efficiency of the combined population is
E  f E,fra c  2
' a ll Eqn. 6-6
where A  \ is the proportion of donors which are not able to FRET but do absorb 
incident excitons and thus directly fluoresce. A2 is the fraction of those donors 
which are able to FRET but which absorb an exciton then directly fluoresce, 
while E2 is the fraction of donors able to FRET which do transfer their energy to 
an acceptor. A \, E 2 and A 2 can all be obtained from the simulation results, so for a 
given Efrac it is straightforward to calculate E aii vs Sacc curves.
Although it is not an ideal situation, combining Efrac with d  and Z /ac gives an 
extended model with three parameters which can be used to fit the available data 
to the available model E au \ s Eacc curves.
6.3.2 Results of extended model fitting
It cannot be assumed that the extended model is not applicable to the datasets 
that do not appear by eye to require the extra variable parameters Efrac and Zfac to 
fit the original simulations. Attempts were therefore made to determine realistic 
constraints on the extra parameters so that they could be applied to all datasets.
Fits of all three parameters to the two high-affinity ErbBl datasets that clearly 
require them (wild-type receptors and depolarised membranes), with Efrac 
constrained to the range 0-1 and £/ac to 0.1-3, returns best fit values of Z/ac = 3 
and EfraC ~ 0.55 to 0.65 (Figure 6.7) depending on which Monte-Carlo models are 
used (monomer, dimer etc.).
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Figure 6.7 FRET efficiency as a function of acceptor density for high-affinity 
ErbBl bound EGF-Alexa546 in a. wildtype and b. Ouabain treated A431 
membranes. Red curves show the best fit Monte-Carlo model for Xfac = 1 and 
Efrac = 1 showing how a model neglecting these parameters cannot fit the steep 
rise or plateau. Green curves show the best fit Monte-Carlo model allowing I fac 
and Efrac to vary. The values of Efrac returned are 0.55 and 0.65 for wildtype and 
depolarized cells respectively. In both cases the value of Zfac was 3.
The remaining datasets did not contain data over a sufficient XflCC range to 
constrain a three parameter model and confirm the presence of a plateau. As the 
availability of acceptor to ErbBl receptors should not differ between 
experimental conditions (note that cholesterol depletion disrupts the formation of 
lipid rafts, but Dialkylcarbocyanine dyes are excluded from these regions 
anyway), and since the datasets that did constrain a three parameter model 
returned a consistent E/ac value, this value was adopted and fixed for all datasets
It was decided that the consistent Efrac values could be used to set a lower limit 
on this parameter applicable to the other datasets. As there is no correlation 
between ErbB 1 distribution in the membrane and receptor binding affinity36, the 
majority of receptors are monomeric and low-affinity receptors are rapidly 
diffusing , it was assumed that for the wildtype and depolarised membrane high- 
plus low-affinity datasets Efrac would be equal or greater than these values. For 
the other datasets the assumption was also made that Efrac >0.55 because none of 
the other experimental conditions was expected to reduce the fraction of donors 
able to FRET further than that found in wildtype cells or cells with depolarised 
membranes for the following reasons. In PM A treated cells the high-affinity state 
is abolished. As low-affinity receptors have a substantially enhanced diffusion
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rate37 compared to high-affinity, receptors in PKC activated cells are less likely 
to be confined to particular areas of the membrane that restrict access to acceptor 
probes or to be part of large acceptor excluding protein complexes. Efrac must 
therefore be equal or larger than that for high-affinity wild type cells. Likewise, 
in DSA-treated cells ATP dependent processes are inhibited, including actin 
polymerisation. This would lead to a reduction in ‘corralling’ effects due to actin 
membrane-skeleton ‘fences’ that would compartmentalise the membrane . Both 
ErbBl receptors and CigDiD molecules will be able to diffuse in the membrane 
with greater freedom and we again expect Efrac in DSA-treated cells to be larger 
than in wild-type cells. Cholesterol depletion releases receptors from rafts (an 
environment with low acceptor levels), which will also have the effect of 
increasing the fraction of donors able to transfer energy to an acceptor from that 
in wild type cells.
In order to estimate the variation caused by several Monte-Carlo simulation 
parameters that were usually fixed (shown in Table 6.2), a range of best fit 
distances of closest approach of EGF-Alexa 546 to the membrane for each 
dataset were obtained as follows. For A431 wildtype high-affinity and 
depolarised high-affinity datasets three parameter fits were obtained to get best 
fit values of d, Yjfac and Efrac. These fits returned a value of E/ac = 3 as discussed 
above. The lowest of the measured values of Efrac came from the depolarised 
high-affinity datasets and this value was used as Efracmin, the lower bound of E/rac. 
For the remaining datasets, one dimensional fits were performed to plane 
separation only, adopting fixed values of Efrac = 1 and Efracmin and E/ac = 3. These 
sets of three parameter and one parameter fits were carried out for various 
Monte-Carlo simulations and for both the entire acceptor density range for each 
dataset and for the range 0< 'LaccRo <0.6. For each dataset, the minimum and 
maximum best fit separations obtained from all these fits were used as the most 
robust constraint on the plane separation. These separation constraints are shown 
in Figure 6.9. It should be noted that E/ac values < 3 will result in the same 
pattern of distance changes with proportionally smaller separations in all cases. 
E/ac values >3 will result in distances >15 nm between EGF and the membrane 
which are inconsistent with the expected crystallographic structure of the ErbB 1 
ectodomain.
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Multimer size lE'AX'/ Distribution algorithm
1 2 Hexagonal plus 
randomisation
1 1 Simulated annealing for
^accRo2 <5
1 1 Hexagonal plus 
randomisation
2 1 Hexagonal plus 
randomisation
4 1 Hexagonal plus 
randomisation
Table 6.2 The parameters varied in Monte Carlo simulations of donor and 
acceptor distributions to investigate the variation in the simulated results due to 
these parameters.
Note that the smallest value of d  for which a FRET efficiency curve was 
simulated was for d= 0.5 nm, and that the curves converge rapidly for d  <3nm.
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Figure 6.8 a-g. FRET efficiency between EGF-Alexa 546 and Vybrant CigDiD 
as a function of acceptor density for a. wildtype A431 cells (fixed) b. DSA 
treated A431 cells (fixed) c. MpCD treated A431 cells (fixed) d. PMA treated 
A431 cells (fixed) e. Ouabain treated A431 cells (fixed) f. live wildtype A431 
cells at 4°C g. Wildtype HeLa cells (fixed). Blue curves represent best fits when 
Xfac = 3 and Efrac = 1, green curves are best fit for Ifac = 3, Efrac = Efracmin. Panels 
with green curve only (a. and e.): curve is best fit allowing separation d, Zfac and 
Efrac to vary. Blue data points represent measurements upon samples where EGF- 
Alexa 546 can bind to the entire population of ErbBl receptors and red data 
points represent measurements upon samples where EGF-Alexa 546 is bound to 
high-affinity ErbB 1 only.
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Figure 6.9 Range of best-fit plane separations, d, obtained from model variations 
for each dataset.
In the following five sections the ranges of best fit EGF-Alexa 546 - membrane 
distances of closest approach obtained by fitting the extended model to the data 
are discussed in the context of the intended functional disruptions of the ErbB 1 
receptor under the various experimental conditions.
6.3.3 Distance of closest approach of wildtype ErbBl ligand 
binding sites to the cell surface in A431 and HeLa cells
Fitting the extended model to the data obtained in wildtype cells produces short 
distances of closest approach for ErbBl receptor binding sites to the cell surface
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when LA binding is blocked by mAb 2E9 (best fit <3.5 nm). The corresponding 
measurement when EGF can bind to all cell surface receptors is longer (6-9 nm). 
Consistent distances were found for high plus low affinity receptors in A431 and 
HeLa cells, which express >106 and ~5xl04 receptors respectively. The results 
suggest that ErbBl ectodomains adopt at least two different orientations with 
respect to the membrane3. If all ectodomains are locked in the extended 
crystallographic conformation then it is likely that high-affinity ectodomains lie 
flat on the membrane while low-affinity receptors stand proud.
6.3.4 Effect of inhibition of ATP dependent processes in A431 cells
EGF binding to ErbBl receptors bound to mAh 2E9 is preserved after DSA 
treatment and the range of the distance of closest approach between these sites 
and the cell surface obtained by model fitting was 9-12 nm. These distances can 
only be achieved by an ectodomain locked in the extended conformation if the 
ectodomains were to rotate -90° around an axis in the plane of the cell surface, 
from ‘flat’ to ‘proud’. The corresponding data from the high plus low-affinity 
population returns a range of fitted distances of closest approach between 8 and 
11 nm, which may be explained by the orientation change of the high-affinity 
receptors suggested above. The flat orientation associated with high-affinity 
receptors therefore appears to be actively maintained by ATP-dependent 
processes, but the results suggest these are not essential for high-affinity ligand 
binding.
6.3.5 Effect of A431 cell membrane cholesterol depletion
Cholesterol depletion should also preserve high-affinity binding ’ but M(3CD 
treated A431 cells do not return values of d  consistent with flat orientations in 
mAb 2E9 challenged cells (8-11 nm). The range of distances of closest approach 
obtained from data from the entire population of ErbB 1 s in cholesterol depleted
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cell membranes shows little difference from that seen in wildtype cells. These 
results imply that disruption of raft-mediated inhibitory interactions results in 
high-affinity ectodomains rotating towards proud orientations. By depleting 
cholesterol - a key component of rafts -  from the plasma membrane using 
methyl-(3-cyclodextrin (M(3CD) raft-localised receptors are relieved of the 
inhibitory effects of the raft environment, resulting in more effective signalling 
and decreased ligand-induced internalisation25. These effects are partially due to 
enhanced kinase activity and partially due to an increase in the number of sites 
that are phosphorylated25,26,36,39.
6.3.6 Effect of PMA treatment (PKC activation)
The data from cells treated with PMA in which high-affinity binding sites had 
been pre-selected using mAb 2E9 again returned best fits for the distance of 
closest approach between the EGF binding site and the cell surface in the range 
8-10  nm. However, unlike raft disruption, PMA treatment is also associated 
with even longer distances of closest approach (-11-13 nm) when mAb 2E9 is 
not bound to receptors. Although these distances are at the extreme range of that 
which could be expected from ErbB 1 crystal structures, the length of the EGF- 
bound donor probe is -  2 nm and the model fits are therefore still consistent with 
known structures. The archetypical example of an intracellular interaction that 
attenuates ErbB 1 signalling is that with protein kinase C (PKC) which is known 
to lead to phosphorylation of Thr-654 in the juxtamembrane region, abolition of 
high-affinity binding23, tyrosine-kinase inhibition23 and preferential receptor 
recycling . The range of distances of closest approach returned by the model 
fitting suggests that PKC-ErbBl interactions can result in the loss of flat 
ectodomain orientations. It is possible that both the orientations of high- and low- 
affinity ErbBl ectodomains are regulated via intracellular interactions and that 
low-affinity reorientation may also be necessary to indirectly abolish high- 
affinity binding, by a mechanism not yet understood. Alternatively, flat 
conformations may be a separate consequence of the mechanism responsible for 
different ligand binding affinities.
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6.3.7 Effect of depolarising the plasma membrane in A431 cells
PKC activators such as PMA cause transient membrane depolarisation27. As the 
membrane potential exerts electrostatic forces on membrane proteins, it is 
possible that the observed PMA-induced ectodomain re-orientation may be due 
to PKC modulation of ion channels. In order to check this, the Na+/K+ ATPase 
Ouabain was used to depolarise A431 cell membranes and see if a change in 
membrane potential independent of an intracellular ErbBl binding event can 
alter the distance of closest approach of ligand binding sites to the membrane. 
Ouabain does not alter intracellular [Ca2+] (figure 6.10) so it is assumed that it 
does not cause indirect activation of PKC.
The distances of closest approach returned by the model fitting are similar to 
those in wildtype A431 cells. The range of d returned for ErbB 1 receptors bound 
to mAb 2E9 is very narrow and centred at a distance of closest approach ~
0.5 nm. However, this is likely to be a consequence of the fact that the simulated 
model curves become difficult to distinguish for values of d less than 5 nm.
Membrane depolarisation does not appear to affect the orientation of either high 
or low-affinity ErbBl ectodomains and changes in the membrane potential 
therefore do not explain the PMA-induced variation in the distance of closest 
approach of EGF binding sites to the membrane. It cannot be ruled out that these 
differences are directly attributable to PKC binding to ErbBl. A possible 
mechanism for this sort of ‘priming’ of ectodomain orientation by intracellular 
interactions with PKC would involve phosphorylation of Thr-654 causing re­
orientation of ErbBl’s intracellular domain40. If the connection between the 
transmembrane and juxtamembrane regions isn’t completely flexible, this re­
orientation would be sterically sensed by the transmembrane regions41 allowing 
intracellular interactions to alter ectodomain orientations via a change in 
orientation of the transmembrane domain. In support of steric sensing, the same 
mechanism operating in the opposite direction would provide a natural 
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Figure 6.10 The concentration of intracellular calcium as reported by confocal 
ratio imaging of Fluo-4/FuraRed fluorescence intensity after the addition of 
200nM mEGF at 21°C. Data points and error bars represent the mean 
Fluo-4/FuraRed fluorescence intensity ratio and standard deviation respectively 
of a sample of 52 wildtype A431 cells (blue crosses) or 41 Ouabain treated A431 
cells (red dots). There is little difference in intracellular calcium concentration 
prior to the addition of EGF as a result of membrane depolarisation but the 
subsequent transient increase in calcium concentration normally seen in response 
to EGF is suppressed.
6.3.8 FRET between EGF-Alexa 546 and EGF-Atto 647N in A431 
cells
The efficiency of FRET between ErbBl bound mEGF-Alexa 546 and 
mEGF-Atto 647 (Ro=5.6 nm) added in a 1:1 ratio to A431 cells is shown in 
Figure 6.11. Error bars represent the S.D. of 25 cells. Eligh-affinity receptor data 
is red and data derived from the entire receptor population (including 
contributions from both high (<10%) and low (>90%) affinity sites) is blue.
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There is a clear difference in FRET efficiency between the high affinity and 
entire receptor population, but all the FRET efficiencies are below ~0.1. In order 
to begin to understand the cause of these low FRET efficiencies it is first useful 
to consider the result that would be expected if all ErbBl receptors were 
interacting as back to back dimers.
0 . 1 5 -
Figure 6.11 FLIM-FRET of mEGF-Alexa 546 and mEGF-Atto 647N bound to 
the entire cell surface ErbBl population (blue) or when binding to low-affinity 
receptors has been blocked with mAb-2E9 (red) in wild-type and treated A431 
cells.
The separation of ErbB 1 ligand binding sites in the crystallographic back to back 
dimer is ~ 1 lnm. The FRET efficiency that would be expected from an ensemble 
of such dimers can be estimated as follows:
The efficiency of FRET for a single donor -  acceptor pair separated by 1 lnm 
with Ro = 5.6 nm can be easily calculated
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= 0.017 Eqn. 6-7f s p  K  5.6s
FRET R60 +r6 5.66 +1 16
This is in the region where the efficiency of FRET is insensitive to changes in 
donor-acceptor separation, and as can be seen in figure 6.11 the standard 
deviation of the ensemble FRET measurements can be of the same order or 
greater.
However, this FLIM-FRET experiment measures E fret as a reduction in the 
fluorescence lifetime of an ensemble of EGF labelled donors and acceptors 
competing for the same ligand binding sites. Some dimers would also be doubly 
occupied by donors or acceptors. The probability of having a given number of 
acceptors (w) in an oligomer of n receptors can be estimated using a binomial 
distribution
P(w) n\
(n -  w).w\
p w q" 1 Eqn. 6-8
For a 1:1 donor: acceptor ratio and receptor dimers n=2 and the probability of a 
site binding an acceptor, p , and the probability of binding a donor, q, are equal 
with p=q=0.5. Substitution into Eqn. 6-8 yields P(l)=0.5 and F,(0)=0.25 (the 
case where w=2 in of no consequence as oligomers containing acceptors only 
remain unobserved). Therefore the fraction of observed dimers occupied by both 




The measured donor lifetime in the presence of acceptor will be the expectation 
value of the contributions of dimers with both donor and acceptor and donor only
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^  ^ d a  0-67td a  + 0.33rD Eqn. 6-10
where tsdpa is the donor lifetime that would be expected from the FRET efficiency
of a single FRET pair in a dimer and zD is the donor lifetime in the absence of 
acceptor. As the measured FRET efficiency is given by
Efret = \ - <Tda > Eqn. 6-11
* D
and
ETret = 1 - —  = 0.017 
Tn
Eqn. 6-12
E fret = 0.011 would be expected for a population consisting entirely of back to 
back ErbBl dimers. It is clear from Figure 6.11 that the measured FRET 
efficiencies are higher than this for measurements of both the entire receptor 
population and high-affinity receptors. Therefore the low but non-negligible 
FRET efficiencies observed cannot be due to back-to-back dimers alone. Single 
molecule fluorescence indicates that they are not due to a single population of 
oligomers with an inter-ligand binding site separation ~8 nm13. It is therefore 
more reasonable to suspect that there is always a large proportion of ErbBl 
monomers or a large population of ErbB 1 existing as part of hetero-oligomers 
with other non-EGF binding members of the ErbB family present in A431 cells. 
Either of these scenarios will produce a large donor-only population in the 
measured donor lifetime that would artificially reduce the measured FRET 
efficiency and could mask a smaller populations of donors placed in closer 
proximity to acceptors by other interactions.
Consequently it is not appropriate to convert the FRET efficiencies in figure 6.11 
to mean donor-acceptor separations. However, the results do semi-quantitatively 
reflect differences in the proportions of oligomers and the kind of receptor
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interactions present in the observed receptor populations that can give insight 
into the effects of the extracellular conformational changes indicated in sections
6.3.2 to 6.3.5. For example the higher FRET efficiency seen between donor and 
acceptor-labelled EGF for wildtype high-affinity receptors than the entire 
population suggests that this class contains a larger proportion of receptor- 
receptor interfaces different to the crystallographic back-to-back dimer, that 
place ligand binding sites <10nm apart. In order to determine which datasets had 
significantly different FRET efficiencies, a 2 sample independent t-test was 
performed, the results of which are shown in table 6.3. The 2 sample independent 
t-test is used to determine if the statistical means of a variable property of two 
populations are equal. The two data sets are assumed to have been drawn from 
populations that follow a normal distribution with constant variance.
From the results of the t-test the following can be concluded about the mean 
FRET efficiencies between mEGF-Alexa 546 and mEGF-Atto 647N (added to 
A431 cells in 1:1 ratio and competing for available ErbBl binding sites) to a 
significance level of 0.05.
1) Under all experimental conditions, when high-affinity receptors only 
were available for EGF binding the mean FRET efficiency obtained is 
higher than the corresponding FRET efficiency obtained when the entire 
receptor population was available.
2) The mean FRET efficiency obtained when the entire receptor population 
is available for ligand binding is higher in cells with depolarised plasma 
membranes than the other experimental conditions
3) Two pairs of experimental conditions do not produce mean FRET 
efficiencies between ligands that are significantly different for high- 
affinity receptors. Cholesterol depleted cells and cells with depolarized 
membranes, and wildtype cells and PKC activated cells
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(d) - - - - - - - - - 0.00107
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Key:
(a) Wildtype cells
(b) Cells in which cholesterol is depleted using MpCD
(c) Cells treated with Ouabain to depolarised plasma-membranes
(d) Cells in which phosphorylation is inhibited using DSA
(e) Cells in which PKC is activated by PMA
Null hypothesis: mean{Â)-mean{B) = 0
Alternative hypothesis: mean(À) -  mean
Table 6.3 Results of 2-sample independent t-tests on EGF-Alexa 546 / Atto 
647N FLIM-FRET datasets. The table shows the observed significance (P-value) 
- the probability of obtaining a test value as extreme from that expected by the 
null hypothesis by chance -  for each pair of datasets. At a significance level of 
0.05, dataset pairs whose means are significantly different are highlighted.
Point 1) is also valid to a significance level of 0.01. The results of the t-test 
suggest that most of the different experimental conditions cause changes in the 
oligomerisation states present in the population of high-affinity receptors from 
wildtype cells. The higher FRET efficiency measured between donors and 
acceptors bound to high-affinity ErbBls indicates that this population of
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receptors generally contains a higher proportion of non back-to-back interfaces 
than the low-affinity population. Depolarisation of the plasma membrane appears 
to have the effect of increasing non back-to-back interfaces in low-affinity 
receptors. Blocking of ATP production by DSA and the consequent 
dephosphorylation of receptors appears to reduce the proportion of non back-to- 
back receptors in the high-affinity population.
The observation of non back-to-back interfaces in agreement with the results of 
single molecule FRET experiments that show that in wildtype A431 cells the 
separation of EGF binding sites in ErbBl complexes can be less than 5.5 nm13. 
The only solved crystallographic interface capable of explaining the 
simultaneous occurrence of short inter-ligand separations and a short distance of 
closest approach of EGF to the cell surface is head-to-head dimer previously 
rejected as being unphysiological4. Flowever, molecular dynamics simulations of 
extended ErbBl extracellular domains (based upon the 11VO crystal structure5 
with missing domain IV residues reconstructed based upon the domain IV co­
ordinates of from the tethered 1NQL crystal structure7 with transmembrane ct- 
helices in a phospholipids bilayer have shown that ErbB 1 extracellular domains 
can lie almost flat with respect to the membrane in at least three different 
topologies, two of which contain a modified head-to-head interface that is more 
stable than the one first seen in the 1MOX crystal structure4 (unpublished 
observations made by Johannes Kastner and Martyn Winn of Collaborative 
Computational Project 4). One of the original objections to the head-to-head 
dimer was the lack of symmetry compared to the back-to-back dimer. However, 
it has recently been shown that the conformation of active ErbB 1 kinase domains 
is an asymmetric dimer6. In light of these results and the results of the bi­
directional FRET measurements, it is possible that the head-to-head ErbBl 
ectodomain interface is indeed physiologically relevant.
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6.3.9 Relating the position of EGF binding sites to receptor 
oligomerisation and tyrosine phosphorylation
It is not possible to decide from the FRET data alone whether differences in the 
ensemble FRET efficiency between donor and acceptor-labelled EGF bound to 
ErbB 1 are due to a change in the proportion of monomers, dimers and oligomers, 
or due to a change in the available interactions. Therefore the data from the bi­
directional FRET method was compared to the results of gel electrophoresis of 
ErbB 1 receptors from cells treated to the same experimental conditions outlined 
in section 6.2.4 before receptor cross-linking and cell lysis. These experiments 
were performed by Dr Selene Roberts and Dr Sarah Needham at the STFC 
Daresbury Laboratory and the results are reprinted in this section (figure 6.12) 
with their kind permission.
Gel electrophoresis separates proteins by mass which can then be probed with 
anti-ErbB 1 and anti-mouse conjugated to horseradish peroxidase and developed 
to show relative proportions of monomers, dimers and larger oligomers in the 
lysed cells. Alternatively the blots can be probed with antibodies that bind to 
phosphorylated ErbB 1 tyrosine residues to show the phosphorylation state of the 
receptors. The developed blots can be quantified to provide estimates of the 
proportion of receptors in each band or the average amount of tyrosine 
phosphorylation. Although no firm conclusions can be derived from these semi- 
quantitative western blots, comparison with the bi-directional FRET results 
suggests how the variations in ErbBl structure observed under the different 
experimental conditions might be related to receptor function. Figure 6.10a, c 
and e shows images of the probed blots. Receptor monomers appear just above 
the 171 kDa marker and dimers appear between the 268 kDa and 460 kDa 
markers. The band above 460 kDa is attributed to oligomers larger than dimers as 
the exact mass of the receptor complexes in this band could not be determined. 
The unmarked band in the western blot probed with anti-ErbB 1 (figure 6.12a) at 
270 kDa (which is not a multiple of the ErbBl monomer mass) could be due to 
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Figure 6.12 Semi-quantified western blots of cross-linked ErbBl 
immunoprecipitates under resting (-) and EGF-stimulated conditions (+). a. 
image of the western blot probed with antiErbB 1 c. and e. are images of western 
blots probed with anti-ErbBl phosphotyrosine-1045 where EGF is allowed to 
bind to all receptors or high-affinity receptors only. Colour coded arrows indicate 
ErbB 1 monomer (red), dimer (grey) and oligomer (blue) bands respectively, b, d. 
and f. are the corresponding semi-quantitative results and follow the same colour 
code.
From figure 6.12a and b it can be seen that in the absence of ligand the majority 
of high-affinity ErbB Is in wildtype A431 in the blot are monomers with a small
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proportion of dimers and oligomers. When stimulated with EGF the proportion 
of oligomers increases, but the majority of receptors are still monomers. 
Combined with the inter-EGF FRET results discussed in the previous section, 
this suggests that low-affinity ErbB 1 receptors are either monomers or back-to- 
back dimers. Only the small proportion of high-affinity receptor complexes 
would then be expected to contain head-to-head interfaces. As high-affinity 
receptors constitute < 5 % of cell surface ErbB Is, this would help to explain why 
ErbBl receptors with a point mutation designed to disrupt the head-to-head 
interface were not found to possess altered functional characteristics whereas a 
point mutation designed to disrupted the back-to-back interface eliminates high 
affinity binding and dimerisation4. Also consistent with this is the observation 
that a distance of closest approach that would preclude the head-to-head interface 
in dephosphorylated high-affinity receptors (see section 6.3.3) does not result in 
the loss of high-affinity binding.
Comparison of bi-directional FRET data and the biochemical results of the 
western blots do not provide any direct evidence that the head-to-head interface 
exists between ErbBl receptors in situ, but it is reasonable to propose that the 
dimers and oligomers of high-affinity ErbB 1 s may contain them. Evidence exists 
that ErbBl receptors form tetramers9' 10’ 13. These could either be formed by 
combinations of back-to-back oligomers placed side by side or asymmetrically 
by utilising the head-to-head interface. A combination of bi-directional FRET 
data, fully quantitative biochemical results and molecular modelling could be 
used in the future to correlate the possible ErbBl topologies with the different 
experimental conditions.
Although the different complexes discussed might represent only a fraction of all 
the possible receptor states , the results of the bi-directional FRET method 
provide a starting point to correlate receptor topology with function. 
Phosphorylation patterns of intracellular ErbBl tyrosine residues govern the 
signalling outcome of the activated receptors43. The results of the western blots 
probing the degree of phosphorylation of different tyrosine residues can therefore 
provide additional information regarding the signalling outcome from activated 
ErbB 1 receptors under the different experimental conditions that can be related
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to the bi-directional FRET results. Tyr-1045 is particularly important as it is the 
recruiting site for c-Cbl which can ubiquitinate ErbB 1, targeting it for trafficking 
to late endosomes44 although cbl dissociation and dephosphorylation of Tyr-1045 
is necessary for ErbBl to be degraded in lysosomes45. This is a major method for 
the downregulation of ErbBl signalling. It can be seen in figure 6.10c-f that the 
different receptor topologies associated with the different experimental 
conditions show different degrees of Tyr-1045 phosphorylation. Significantly, it 
appears that receptor degradation is inhibited under the conditions which also 
result in the loss of flat ectodomain orientations (cholesterol depletion and PKC 
activation). This suggests the intriguing possibility that different ectodomain 
conformations might be associated with different signalling outcomes and may 
play a part in determining the fate of the receptor.
6.4 Conclusions and summary
In this chapter a combination of FRET measurements probing ErbB 1 receptor 
interactions lateral to the membrane and the orientation of individual receptors 
with respect to the membrane has provided evidence of previously unknown 
variations in the ErbBl ectodomain topology that may be associated with 
interactions with intracellular effectors. In turn these different ectodomain 
topologies appear to lead to different signalling outcomes upon ligand binding, 
demonstrated by differential phosphorylation of ErbBl intracellular tyrosine 
residues shown in complementary biochemical data obtained under the same 
experimental conditions.
The different experimental conditions used disrupt normal ErbBl interactions 
with intracellular effectors that have been previously shown to be essential in the 
modulation of kinase activation, early ErbB 1 signalling events and the regulation 
of EGF binding affinity. It is possible that ‘priming’ of ErbBl ectodomains by 
intracellular interactions regulate ErbBl signal transduction in a manner 
analogous to that seen in the integrin receptor19. Such priming would provide a
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method for the cellular programming of the ErbBl receptor population to 
produce different signalling responses to the same EGF signalling molecule and 
a possible explanation of the complex functionality of ErbB 1 at the initial stages 
of signalling. From the results in this chapter it was proposed that steric 
regulation of ErbB 1 kinase domains (brought about by varying transmembrane 
domain orientations caused by the primed ErbB 1 ectodomain topologies) might 
result in preferential access of different tyrosine residues in the c-terminal tail of 
receptors to the kinase domains. The simple on/off nature of the ligand binding 
event would then lead to different signalling outcomes dependent upon ErbBl 
priming.
Finally, as receptor degradation is the ultimate path for downregulation of 
activated receptors, the ability to modulate c-Cbl-mediated degradation pathways 
hinted at by the data regarding Tyr-1045 phosphorylation is of particular interest. 
It is feedback mechanisms such as this that are defective in some cancers46 or 
used by cancerous cells to bypass treatments aimed at oncogenic targets47. 
Consequently, primed ErbB 1 ectodomain configurations should they exist, could 
be a robust target for anti-cancer treatments.
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7 Conclusions and Outlook
Experimental research into biological problems is an increasingly
interdisciplinary endeavour. It requires combination of the biological and 
biochemical skills required to prepare samples for investigation with the 
knowledge to develop and correctly deploy physical techniques to probe the 
properties of the biological system of interest. Sometimes it also requires 
computational simulations to build models from, or even interpret the 
experimental results. The need to relate the structure to the function of 
interacting proteins is of major importance for the understanding of human 
diseases, but it is clear that it will only be possible to do this by observing the 
structure of functioning proteins in their natural environments.
In this thesis a method based on FRET was developed to investigate the 3D 
structure of membrane proteins in cultured cells. The method involves two 
different FRET experiments performed under identical experimental conditions 
that provide information regarding the lateral topology of interacting membrane 
proteins and the distance of closest approach of a specifically labelled site on the 
protein to the cell surface. Obtaining spatial information in two directions in the 
frame of the plasma membrane is a step forward from previous studies which 
have only attempted to probe one direction or the other. The development of a 
microscopy based technique suitable for estimating the distance of closest 
approach of a protein to the plasma membrane in adherent cells was made 
possible by the implementation of the multidimensional, multicolour confocal 
microscope described in chapter 4.
The motivation for developing the bi-directional FRET method was to 
investigate the structure of signalling ErbBl receptor complexes and this 
biological system was used to demonstrate the method using fixed cancer cells in 
chapter 6. The bi-directional FRET method was successfully able to show that 
the ligand binding sites of ErbB 1 receptors display different distances of closest 
approach to the cell surface and distinct lateral topologies depending upon 
whether they were bound to the antibody mAb 2E9. mAb 2E9 blocks EGF
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binding to low affinity receptors1 and as it is accepted that the two functionally 
distinct affinity classes of receptor are the produced as the same translation 
product , this suggests that ErbB 1 receptors can adopt different orientations with 
respect to the cell surface that allow them to interact with other ErbB receptors in 
novel ways. In the same chapter it was shown that a further way to relate protein 
structure to function was possible by applying the bi-directional FRET method 
under experimental conditions designed to disrupt normal ErbBl receptor 
function. The variations in ErbBl receptor structure revealed under these 
different conditions were compared to semi-quantitative biochemical data which 
led to the suggestion that intracellular interactions might prime the orientations 
of ErbBl ectodomains, which in turn control the topology of ErbB Is within 
complexes and the eventual signalling outcome produced by ligand binding.
The bi-directional FRET method is complimentary to the single molecule FRET 
and fluorescence polarisation imaging techniques that have also been developed 
recently within the STFC Photon Science Department3,4. These single molecule 
methods have been used to remove the effects of ensemble averaging from the 
measurement of the distances between FRET donor and acceptor labelled EGF 
bound to ErbB 1, providing evidence for the existence of two extracellular ErbB 1 
interfaces in the cell membrane environment that are different from the 
crystallographic back-to-back dimer4,5’6. Despite this, they lack the capability to 
reference the positions of the fluorescent labels to the surface of the cell 
membrane in order to observe large scale conformational differences that might 
allow different interfaces (such as the head-to-head interface6) to form. They also 
currently depend upon incomplete labelling of receptor populations in order to 
achieve single molecule sensitivity, which limits their ability to ascertain the 
stoichiometry and lateral topology of larger receptor oligomers. This is not a 
problem, however, for super-resolution techniques based upon the high precision 
localisation (with 2-10 nm accuracy) of single stochastically activated, photo- 
switchable fluorescent molecules ’ which may soon provide an alternative 
method to FRET of observing the stoichiometry and lateral topology of receptor 
complexes in fixed cells.
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Both the single molecule fluorescence and bi-directional FRET techniques 
provide information that can be used to inform atomistic molecular dynamics 
simulations based upon the solved crystal structures of ErbBl receptors. The 
observation of short inter-ligand distances by single molecule FRET, ErbBl 
oligomers larger than dimers4 and the variation in the distances of closest 
approach of the ligand binding site to the cell membrane reported in chapter 6 of 
this thesis have prompted members of CCP4 to simulate ErbBl monomers, 
dimers and tetramers in a model membrane. This work is currently unpublished, 
but in all cases stable configurations with the receptors lying ‘flat’ on the 
membrane consistent with the unexpected experimental results have been 
simulated.
Although the bi-directional FRET method has proven to be very promising, there 
is still vast scope for improving the technique and for future work. The majority 
of cell samples used to test the technique in chapter 6 were lightly fixed. This 
was initially employed in a preliminary experiment described in chapter 5 to lock 
receptors in active and inactive conformations before imaging. It was continued 
for the experiments in chapter 6 partially to make the results directly comparable 
to the results of that preliminary experiment, but mostly to remove the vagaries 
of live samples from the process of developing the technique. In future, the use 
of live cells would greatly improve the validity of any insights into structure- 
function relationships claimed from the results of the method. A better way of 
observing inactive (ligand free) ErbB ectodomains would be to introduce a small 
peptide tag to the N-terminus to which a functionalised fluorescent dye could be 
specifically bound to receptors in situ9.
The need to invoke extra unknown variables to fit the simulated FRET 
efficiencies to experimental data (chapter 6.2.3) is also undesirable. In order to 
obtain quantitative results in a restricted period of time, it was assumed that these 
variables arose from variations in acceptor density on a scale below the 
resolution limit of the microscope and a fraction of donor labelled acceptors that 
were somehow excluded from acceptor. Efforts should be made to verify these 
assumptions experimentally by using different lipophilic dyes as the acceptor, 
which will partition in different areas of the cell membrane. Given more time, the
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Monte-Carlo FRET simulation could also be used to investigate the effect of 
different, non-random distributions of acceptor in the membrane.
Better methods for disrupting receptor function should also be investigated. In 
the case of ErbB 1 receptors, rather than using clumsy chemical methods to affect 
receptor function more specific perturbations of the functioning receptor such as 
ErbBl mutants that lack tyrosine kinase activity or contain point mutations of 
tyrosine residues could be used. Mutants that alter the binding affinities of the 
receptor would also allow the relationship between binding affinity and ErbBl 
ectodomain orientation to be investigated without the need for binding large 
antibodies to the receptor1,10.
As well as these possible avenues for improving the bi-directional FRET method 
and the results already obtained, the method offers the immediate opportunity to 
study the three-dimensional structures of ErbB hetero-oligomers simply by using 
other fluorescently labelled ErbB ligands. The ensemble FRET efficiencies 
measured between donor and acceptor labelled EGF in chapter 6 suggest that the 
majority of cell surface ErbB Is are either monomeric or interacting with 
receptors that do not bind to EGF. It would be particularly interesting to discover 
which the case is.
Finally, the bi-directional FRET method is not constrained for use with either the 
ErbB family of membrane receptors or the microscope described in chapter 4. 
Adaptation for the investigation of other membrane proteins requires only the 
characterisation of two FRET pairs appropriate for the expected dimensions of 
the protein of interest as described in chapter 5, followed by implementation of 
1:1, site specific labelling of the extracellular domain of the particular protein of 
interest with the FRET donor. The method could also be implemented on any 
other microscope capable of both donor FLIM and acquisition of an intensity 
image of the acceptor distribution. Indeed, as multidimensional microscopes 
capable of video rate time-domain FLIM are becoming a reality1113 and now 
have similar accuracy to slower TCSPC systems, a realistic aim for the future 
development of the bi-directional FRET method could be to follow the
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ectodomain structure of an ErbB receptor complex during, before and after 
ligand binding in real-time.
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